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 Paf1C co-localizes with Pol II and influences gene expression by regulating transcription 
initiation, elongation and termination. Some crucial functions of Paf1C include promoting co-
transcriptional histone modifications and recruiting termination factors. The mechanism of 
chromatin recruitment of Paf1C was obscure. We identified the importance of a conserved region 
within the Rtf1 subunit of Paf1C, termed the ORF association region (OAR), in chromatin-
tethering of Paf1C. I found that the interaction of Paf1C with the transcription elongation factor 
Spt5 was mediated by the Rtf1 OAR and the Spt5 C-terminal region (CTR). Binding assays 
established the direct nature of the Rtf1-Spt5 interaction and the sufficiency of the Rtf1 OAR and 
the Spt5 CTR for this interaction. ChIP assays demonstrated the ability of the OAR to mimic the 
chromatin association pattern of Paf1C, independent of Paf1C but dependent on the Spt5 CTR 
and the Bur1 kinase. This suggests that the targeting of the OAR tethers Paf1C to chromatin. 
Collectively, these results provide a molecular mechanism for coupling Paf1C with the 
transcription machinery.  
 Additionally, I found that substitution of OAR residues predicted to be important for the 
human Rtf1 OAR-Spt5 CTR interaction in the OAR-CTR co-crystal impaired the chromatin 
association of Paf1C supporting the relevance of the co-crystal interactions. Furthermore, I 
showed that strains that are doubly mutated in the OAR and the Cdc73 C-domain exhibited 
cumulative reduction in Paf1C chromatin occupancy. Consistently, I showed that cells lacking 
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both the OAR and the C-domain lose Paf1C-mediated histone modifications. This indicates that 
the Rtf1 OAR and the Cdc73 C-domain facilitate dual-attachment of Paf1C to chromatin. 
 My work has also provided better understanding of the function of the histone 
modification domain (HMD) of Rtf1. I found that overexpression of the HMD was essential for 
it to promote histone modifications. Additionally, I showed that the HMD is sufficient for the 
H2B K123 Ub, the mark upstream of the H3 K4 and H3 K79 methylation events, but the rest of 
Paf1C is required for the HMD to stimulate H3 K4 Me3 modification. Cumulatively, my 
findings provide additional insight into the regulation of histone modifications by the Rtf1 HMD. 
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1.0  INTRODUCTION 
The packaging of the eukaryotic genome into chromatin allows it to fit within the realm of the 
nucleus but makes the DNA inaccessible to DNA-templated processes such as transcription. A 
nucleosome, which is the smallest unit of chromatin, consists of a histone octamer containing 
two copies each of histone H2A, H2B , H3 and H4, around which is wrapped about 145-147 bp 
of DNA. Eukaryotes have evolved several accessory factors that facilitate the passage of Pol II 
through nucleosomes by sliding or evicting histones, incorporating histone variants or post-
translationally modifying histones. These chromatin alterations make the DNA more accessible 
by altering the stability of nucleosomes or by facilitating the recruitment of downstream effector 
proteins. Additionally, they also coordinate the co-transcriptional processing of mRNA.  
A subset of the multifunctional accessory factors categorized as transcription elongation 
factors associate with RNA polymerase II (Pol II), influence the rate of transcription or 
processivity of Pol II and regulate transcription not only at the elongation stage but also at the 
initiation and termination stages through various mechanisms. One such elongation factor that 
executes several crucial functions including regulating co-transcriptional histone modifications, 
nucleosome occupancy, phosphorylation of Pol II and RNA 3’-end formation is the Paf1 
transcription elongation complex (Polymerase-associated factor 1 complex). This complex 
regulates the expression of many genes including those involved in development, antiviral 
response and maintenance of stem cell pluripotency. Since my dissertation research involves 
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uncovering the mechanism of recruitment of this crucial transcription elongation complex and 
better understanding its role in regulating co-transcriptional histone modifications, this chapter 
reviews the current knowledge of the mechanisms of transcriptional regulation by various 
regulatory factors. 
1.1 CHROMATIN ALTERATIONS DURING TRANSCRIPTION 
Regulation of gene expression allows cells to respond to environmental cues and properly 
execute their functions. Several complex molecular mechanisms involving a plethora of proteins 
coordinately regulate the expression of genes. Control of transcription is essential for regulation 
of gene expression. Transcription involves the synthesis of an RNA transcript using DNA as the 
template. To accommodate meters long genomic DNA within the eukaryotic nucleus, it has to be 
compacted into chromatin. However, chromatin acts as a hindrance to DNA-templated processes 
such as transcription.  The smallest unit of chromatin is the nucleosome formed by the wrapping 
of 145-147 base pairs of DNA around a histone octamer that consists of two copies each of 
histone H2A, H2B, H3 and H4 [reviewed in (LUGER et al. 2012)]. Nucleosomes are stabilized by 
several hydrogen bonds and Van der Waals interactions between the histones and between the 
histones and DNA wrapped around them [reviewed in (LUGER et al. 2012)]. 
Chromatin is variable throughout the genome due to the presence of different post-
translational histone modifications and histone variants. These variations and the actual sliding 
of the nucleosomes by chromatin remodelers allow transcription, DNA repair, DNA 
recombination and DNA replication machinery to overcome the chromatin barrier [reviewed in 
(CLAPIER and CAIRNS 2009; TALBERT and HENIKOFF 2010)]. They make the DNA more 
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accessible to these processes either by weakening the histone-DNA interaction, by serving as 
docking sites for other chromatin regulators that aid this process or by sliding or evicting the 
histones.  
1.1.1 Histone chaperones and Histone variants 
Nucleosome assembly is believed to occur in a stepwise fashion and involves the deposition of 
an H3-H4 tetramer on DNA followed by addition of two H2A-H2B dimers, while nucleosome 
disassembly likely occurs in the reverse order (BOHM et al. 2011). Histone chaperones facilitate 
the assembly, eviction, exchange or redeposition of histones by binding to them. They generally 
have specificity for either H3-H4 or H2A-H2B dimers or histone variants. Disassembly of 
nucleosomes during transcription is facilitated by histone chaperones Nap1 and FACT that 
facilitate the disassembly of H2A-H2B dimers ahead of Pol II and nucleosome reassembly upon 
Pol II passage through the template DNA (DEL ROSARIO and PEMBERTON 2008; SCHWABISH and 
STRUHL 2004; SCHWABISH and STRUHL 2006) [reviewed in (ELSASSER and D'ARCY 2012)] 
(discussed in section 1.3.5). Asf1 and Spt6 also maintain the chromatin integrity over the 
promoter and the coding regions of transcribed genes but they selectively bind histone H3-H4 
[reviewed in (EITOKU et al. 2008)] (BORTVIN and WINSTON 1996; SCHWABISH and STRUHL 
2006). Pol II has been shown to be able to travel through a histone hexamer that lacks just one 
H2A-H2B dimer (KIREEVA et al. 2002).   
Histone variants are isoforms of the canonical histones and may differ from canonical 
histones in their biochemical characteristics or their positioning within the genome. The affinity 
of the histone chaperones for histone variants affects the incorporation of histone variants into 
nucleosomes. Histone variants alter the structure and stability of nucleosomes or their ability to 
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undergo compaction into higher order chromatin structure. Histone variant H2AX differs from 
the canonical histone H2A in its C-terminus where it can be phosphorylated at Ser139 by 
phosphoinositide kinase-like kinases in response to DNA damage (ROGAKOU et al. 1998) 
[reviewed in (SARMA and REINBERG 2005)]. This mark stabilizes or facilitates the association of 
DNA repair proteins with DNA at the sites of DNA damage. The centromeric histone variant 
(CenH3 in humans, chromosome segregation protein and Cse4 in yeast), found within the 
centromeric nucleosome instead of histone H3, is important for the association of the centromere 
with the kinetochore (WESTERMANN et al. 2003). Histone H2A.Z (Htz1 in yeast) is a variant of 
the H2A family. Nucleosomes containing H2A.Z acetylated at Lys14 are found at the promoters 
of active genes where they facilitate the recruitment of Pol II (TANABE et al. 2008; WAN et al. 
2009). Acetylated H2A.Z at the transcription start sites (TSS) has been shown to be involved in 
the activation of oncogenes while deacetylated H2A.Z at the TSS is associated with the 
repression of tumor suppressor genes in cancer cells (VALDES-MORA et al. 2012). 
1.1.2 Histone modifications 
Histones can be subjected to several posttranslational modifications including acetylation, 
methylation, ubiquitination, phosphorylation and sumoylation. Monoubiquitination of histone 
H2B K123 (H2B K120 in mammals), catalyzed by the ubiquitin conjugating enzyme and 
ubiquitin ligase, Rad6 (HR6A and HR6B in humans) and Bre1 (Rnf20 in humans), is a pre-
requisite for di- and tri-methylation of H3 K4 by Set1 methyltransferase (methylation of H3 K4 
in humans is catalyzed by at  least six methyltransferases including Set1A, Set1B, MLL/MLL1, 
MLL2, MLL3 and MLL4) as well as di- and tri-methylation of H3 K79 by Dot1 
methyltransferase (human homolog Dot1L; Dot1 like) (BRIGGS et al. 2002; KIM et al. 2009; 
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KOKEN et al. 1991; NG et al. 2002b) [reviewed in (RUTHENBURG et al. 2007)]. 
Monoubiquitination of H2B  K123 impacts downstream methylation of H3 K4 and H3 K79 by 
facilitating the recruitment of the proteosomal ATPases Rpt4 and Rpt6 and also by promoting the 
recruitment and activity of Set1 and Dot1 methyltransferases (EZHKOVA and TANSEY 2004; KIM 
et al. 2009; MCGINTY et al. 2008; OH et al. 2010; RACINE et al. 2012). H2B K123 Ub also 
stimulates the recruitment and activity of Set1 methyltransferase (KIM et al. 2009; RACINE et al. 
2012). Paf1C also regulates these modifications by facilitating the targeting of Rad6, Bre1 and 
Set1 to chromatin (KIM et al. 2009; KIM and ROEDER 2009; KROGAN et al. 2003a; NG et al. 
2003b; XIAO et al. 2005). Work from the Arndt laboratory also suggests that Paf1C may not just 
serve as a platform for recruiting these histone modifiers but also play an active role through 
physical association with the histones and hence could make them more accessible to these 
enzymes (PIRO et al. 2012). Consistent with this, Paf1C has also been shown to directly interact 
with histone H3 (CHU et al. 2013; MARAZZI et al. 2012). 
Histone methylation is a relatively stable mark and hence has been proposed to create a 
transcriptional memory for cells (NG et al. 2003b). The MLL1 methyltransferase positively 
regulates the expression of genes encoding the homeobox family of transcription factors (HOX 
genes) that regulate development. Translocations involving the MLL1 gene result in persistently 
high expression of the HOXA9 gene and hence are the underlying cause of childhood leukemias 
[reviewed in (RUTHENBURG et al. 2007; TAN et al. 2010)]. Methylation of H3 K79 by Dot1 
inhibits the promiscuous binding of the Sir proteins and hence indirectly facilitates the 
association of Sir proteins with specific loci where they can induce chromatin compaction (VAN 
LEEUWEN et al. 2002). The methylation of H3 K79 at the site of double stranded breaks leads to 
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recruitment of DNA repair protein 53BP1 (Rad9 in yeast) through association of the Tudor 
domain of 53BP1 with methylated H3 K79 [reviewed in (NGUYEN and ZHANG 2011)].  
Interestingly, the H2B monoubiquitination mark was also recently shown to be essential 
for the methylation of a non-histone protein Dam1 (LATHAM et al. 2011). Independent of its role 
in methylation, H2B ubiquitination acts as repressive mark at the promoters of quiescent genes 
while it has an activating effect when present at active genes (BATTA et al. 2011). Rnf20 has also 
been observed to exert opposing effects on tumor suppressor and oncogenes. Rnf20 positively 
regulates expression of tumor suppressor genes while it negatively regulates expression of 
oncogenes (SHEMA et al. 2008). Based on the effects observed upon downregulation of Rnf20 
such as increased cell migration and induction of tumorigenesis, Rnf20 has been implicated as a 
tumor suppressor (SHEMA et al. 2008). Consistent with this, cancer cells appear to downregulate 
the expression of Rnf20 by hypermethylating its promoter DNA (SHEMA et al. 2008). Further 
H2B K123 Ub has been shown to collaborate with the histone chaperone Spt16 to maintain 
nucleosome reassembly in the wake of Pol II (FLEMING et al. 2008). In vitro studies have also 
demonstrated an inhibitory effect of H2B K123 Ub on chromatin compaction (FIERZ et al. 2011). 
The regulation of both the recruitment and activity of the enzymes that catalyze histone 
modifications (writers) and the enzymes that remove these marks (erasers) results in a specific 
genome-wide pattern of distribution of histone modifications. The downstream effects of these 
modifications are facilitated by the proteins that recognize these modified histones (readers). The 
C-terminal domain (CTD) of Pol II also facilitates the establishment of the pattern of histone 
modifications by serving as a platform for recruitment of the enzymes catalyzing these 
modifications. The CTD of Pol II contains several repeats of the consensus sequence Tyr1-Ser2-
Pro3-Thr4-Ser5-Pro6-Ser7 (52 repeats in mammals and 26 in yeast) (ALLISON et al. 1985). The 
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differential phosphorylation of these repeats of Pol II CTD regulates the recruitment of Set1 and 
Set2 methyltransferases (Figure 1) (KROGAN et al. 2003a; NG et al. 2003b; XIAO et al. 2003) 
[reviewed in (ZHANG et al. 2012b)]. Set1 methyltransferase is recruited through association with 
Ser5 phosphorylated form of Pol II CTD and this form of Pol II is enriched over the 5’ ends of 
genes (NG et al. 2003b) (Figure 1). The localization of the tri-methylated H3 K4 residues near 
the promoters of active genes results in the recruitment of the H3 K14 NuA3 acetyltransferase 
complex through association of the plant homeodomain (PHD) of the Yng1 subunit of the NuA3 
complex with the histones trimethylated at H3 K4 (NG et al. 2003b; TAVERNA et al. 2006) 
(Figure 1).  These acetylated histones near the transcription start site can then recruit chromatin 
remodeling complexes by binding to their bromodomains and hence increase the accessibility of 
promoter DNA. Additionally, trimethylated H3 K4 can also be directly recognized by the PHD 
domain within the nucleosome remodeling factors (NURF) (WYSOCKA et al. 2006). On the other 
hand, the di-methylated H3 K4 mark is enriched downstream of the tri-methylated H3 K4 mark 
[reviewed in (SMOLLE and WORKMAN 2013)]. This mark triggers the chromatin association of 
the HDAC (histone deacetylase complex) Set3 through association with its PHD finger domain 
(Figure 1). This complex deacetylates histones and prevents cryptic intragenic transcription that 
could occur upon the passage of transcribing Pol II (KIM and BURATOWSKI 2009). Histones di- 
and tri-methylated at H3 K36 by the Set2 enzyme are enriched in the middle and at the 3’ ends of 
active genes [reviewed in (CRISUCCI and ARNDT 2011)]. This pattern of histones methylated at 
H3 K36 is established by targeted recruitment of Set2 through its association with the serine 2 
phosphorylated form of the CTD of Pol II, a form of Pol II that predominates over the 3’ region 
of genes (KROGAN et al. 2003a; XIAO et al. 2003) (Figure 1). The histones containing di- and tri-
methylated H3 K36 in turn recruit the histone deacetylase complex Rpd3S through interaction 
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with the chromodomain of the Eaf3 subunit of Rpd3S (CARROZZA et al. 2005; KEOGH et al. 
2005; LI et al. 2007; LI et al. 2009) (Figure 1). The hypoacetylation of the histones prevents 
spurious transcription from within these regions. Thus methylation of H3 K4, H3 K79 and H3 
K36 are marks mainly associated with active genes [reviewed in (MARTIN and ZHANG 2005)].  
Histone modifications can also facilitate gene silencing. Methylation of H3 K9, H3 K27 
and H4 K20 are linked with transcriptional repression [reviewed in (MARTIN and ZHANG 2005)]. 
Methylation of H3 K9 by SUV39 (Suppressor Variegation 3-9 homolog) and H3 K27 by 
Polycomb Repressive Complex 2 (PRC2) promotes the chromatin association of the 
Heterochromatin Protein 1(HP1) and PRC1 through association with the chromodomain within 
these proteins (LACHNER et al. 2001) [reviewed in (MARGUERON and REINBERG 2011)]. 
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Figure 1. Chromatin alterations during Pol II transcription 
H3 K4 methyltransferase Set1 is recruited by association with the Ser5 phosphorylated Pol II CTD. The tri-
methylated form of H3 K4 is enriched near the promoter while its di-methylated form is enriched downstream of 
this modification [reviewed in (CRISUCCI and ARNDT 2011)]. Tri-methylated H3 K4 recruits NuA3 histone 
acetyltransferase complex which catalyzes the acetylation of H3 K14 in the promoter region while di-methylated H3 
K4 recruits the HDAC Set3 via association with its PHD finger domain and facilitates the deacetylation of histones 
within this region [reviewed in (CRISUCCI and ARNDT 2011)]. H3 K36 methyltransferase Set2 is recruited by Ser2 
phosphorylated Pol II CTD (KROGAN et al. 2003b). Histones with di- and tri-methylated H3 K36 in the middle of 
the gene and at the 3’ regions facilitate the association of the Rpd3S HDAC thus maintaining these histones in the 
deacetylated state [reviewed in (SMOLLE and WORKMAN 2013)].  These histone modifications thus facilitate the 
passage of transcribing Pol II and maintain chromatin integrity in the wake of Pol II. 
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1.1.3 Nucleosome remodeling 
Chromatin remodeling complexes alter accessibility of DNA by altering the local positioning of 
the nucleosomes. They harness the energy from ATP hydrolysis to slide, evict or alter the 
composition of the nucleosomes. Based on domains flanking the conserved ATPase domain of 
the remodelers, they can be classified into four different families including SWI-SNF (Switching 
defective, sucrose nonfermenting), ISWI (Imitation switch), INO80 (Inositol requiring 80) and 
CHD (Chromodomain helicase DNA binding) [reviewed in (CLAPIER and CAIRNS 2009)]. The 
domains flanking the ATPase domain such as the chromodomain and bromodomain target the 
remodeling complexes to specific regions in the genome by binding to methylated and acetylated 
nucleosomes, respectively. Acetylated lysines in the histones recruit chromatin remodelers such 
as Swi/Snf or RSC through association with their bromodomains [reviewed in (CLAPIER and 
CAIRNS 2009)]. Methylated lysines on the other hand, facilitate the recruitment of chromatin 
remodelers containing chromodomains such as Chd1 in humans or the PHD finger domain such 
as BPTF (Bromodomain PHD finger transcription factor) [reviewed in (PETTY and PILLUS 
2013)]. Presence of both the chromodomain and the PHD finger within a chromatin remodeler 
such as the BPTF facilitates combinatorial recognition of histone marks i.e. BPTF binds histones 
that are acetylated at H4 K16 and di- and tri-methylated at H3 K4 using its bromodomain and 
chromodomain, respectively [reviewed in (PETTY and PILLUS 2013)]. 
In summary, the chromatin alterations mediated by histone chaperones, histone variants, 
chromatin remodelers and the post-translational modifications of histones together facilitate the 
transit of transcribing Pol II through the chromatin template and maintain the integrity of 
chromatin upon passage of Pol II. 
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1.2 STAGES OF TRANSCRIPTION 
The production of a mature mRNA transcript involves mainly three stages each of which can be 
regulated to control gene expression.  
1.2.1 Initiation 
The transcription cycle begins with the sequential assembly of the pre-initiation factors including 
TFIID, TFIIA, TFIIB, TFIIE, TFIIF, TFIIH and Pol II over the promoter of a gene [reviewed in 
(ORPHANIDES et al. 1996)]. In an ATP-dependent process requiring TFIIE and TFIID the 
hydrogen-bonded DNA strands are separated near the transcription start site (GOODRICH and 
TJIAN 1994). RNA synthesis is then initiated at the transcription start site through the catalytic 
formation of phosphodiester bonds between the first two nucleotide triphosphates 
complementary to the template DNA strand. Pol II has to relinquish its contacts with the 
promoter DNA and the transcription initiation factors in order to productively synthesize RNA. 
The pre-initiation complex contains the hypophosphorylated form of Pol II. TFIIH, which 
includes a sub-complex of cyclin H (Ccl1 in yeast), cyclin dependent kinase 7 (CDK7; Kin28 in 
yeast) and MAT1 (Tfb3 in yeast), mediates the phosphorylation of the CTD of Pol II at Ser5 
[reviewed in (EGLY and COIN 2011)]. This phosphorylation event marks the initiation of 
transcription.  
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1.2.2 Elongation 
Earlier studies were focused on the regulation of transcription at the initiation stage but in the last 
few years, the importance of regulation at the elongation stage has also been recognized. The Pol 
II CTD is one of the key targets for the regulation of transcription at the elongation stage. All the 
residues of the conserved heptapeptide sequence of the Pol II CTD (Tyr1-Ser2-Pro3-Thr4-Ser5-
Pro6-Ser7) other than the proline residues have been shown to be dynamically phosphorylated in 
a manner dependent on the stage of transcription [reviewed in (ZHANG et al. 2012b)]. The 
differentially phosphorylated CTD of Pol II serves as a binding platform for stage-specific 
recruitment of proteins that facilitate transcription by altering the chromatin template and 
regulating the co-transcriptional processing of nascent mRNA (See section 1.1.2 for examples of 
facilitation of transcription by altering the chromatin template). The Pol II CTD phosphorylated 
at Ser5 recruits the 5’-mRNA capping machinery and this 5’-capping of mRNA protects the 
nascent mRNA from RNAases and facilitates its cytoplasmic transport (FABREGA et al. 2003; 
MCCRACKEN et al. 1997).  
After initiation of transcription, movement of Pol II may be paused by association of 
NELF (negative elongation factor) with the Pol II-associated transcription elongation factor 
DSIF [5, 6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) sensitivity-inducing factor; 
human homologue of yeast Spt5]. Promoter proximal pausing has been shown to occur in 
metazoans and not in yeast since yeast lack a NELF homologue [reviewed in (GILMOUR 2009)]. 
Release of paused Pol II is facilitated by recruitment of P-TEFb (positive transcription 
elongation factor b), comprised of cyclin T and Cdk9, which phosphorylates DSIF at its C-
terminal repeats (CTR), NELF and/or transcriptional activators such as c-myc (FUJINAGA et al. 
2004; RAHL et al. 2010; WADA et al. 1998b; YAMADA et al. 2006; YAMAGUCHI et al. 1999). The 
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association of positive factors such as Paf1C and Human Immunodeficiency Virus Type 1 
regulatory protein, Tat (transactivator of transcription), with DSIF  has been suggested to 
mediate the transition  to the elongation  phase in biochemical assays measuring transcriptional 
activity (CHEN et al. 2009).  Additionally, Mediator, the coregulator complex, which includes 
cyclin C and Cdk8, has also been shown to act as molecular switch for transition from initiation 
to elongation stage by releasing its contacts with the initiation factor TFIID and binding to 
elongation factors such as eleven nineteen lysine-rich in leukemia (ELL) and ELL-associated 
factors (TAKAHASHI et al. 2011). Release of paused Pol II provides a mechanism of rapid 
induction of gene expression.  
1.2.3 Termination 
As Pol II approaches the 3’ ends of genes, the Ser2 phosphorylated form of Pol II is enriched. 
This form of Pol II serves as a binding platform for factors required for cleavage and 
polyadenylation of the nascent mRNA such as Pcf11 (Protein 1 of cleavage and polyadenylation 
factor I ) and Rtt103 (regulator of Ty1 transposition) (LUNDE et al. 2010) [reviewed in (HSIN and 
MANLEY 2012)]. In mammals, the addition of the poly(A) tail is directed by two regions flanking 
the cleavage and polyadenylation site.  These include the consensus sequences AAUAAA, which 
occurs 10-30 nucleotides upstream of the cleavage and the polyadenylation site and is a docking 
site for CPSF (cleavage polyadenylation specificity factor), and a U/GU rich region located 30 
nucleotides downstream of the cleavage site, which binds CstF (cleavage stimulation factor) 
[reviewed in (KUEHNER et al. 2011; RICHARD and MANLEY 2009)]. The 73-KDa subunit of 
CPSF complex catalyzes the endonucleolytic cleavage after which the addition of the poly(A) 
tail is catalyzed by poly(A) polymerase (MANDEL et al. 2006). Binding of the poly(A) binding 
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protein to the poly(A) site protects the nascent mRNA from degradation (MINVIELLE-SEBASTIA 
et al. 1997). In yeast, cleavage and polyadenylation is regulated by CPF (cleavage and 
polyadenylation factor) and CFI and II (Cleavage factors I and II) which is comprised of factors 
that are homologous to the factors of the mammalian complexes, CPSF and CstF. Two models 
had been proposed to explain the mechanism of transcription termination. The allosteric model 
of termination suggests that the swapping of  anti-termination proteins for termination proteins 
may elicit allosteric changes that trigger the release of Pol II (LOGAN et al. 1987). In accordance 
with this model, a major swapping of elongation factors for termination factors occurs at the 
poly(A) site (MAYER et al. 2010). The torpedo model proposes that the endonucleolytic cleavage 
provides an entry site for the Xrn2 exonuclease (Rat1 in yeast) that catalyzes the degradation of 
the RNA downstream of the cleavage site and hence promotes the release of the transcription 
elongation complex (CONNELLY and MANLEY 1988; KIM et al. 2004b). However, recent studies 
have suggested that transcription termination may involve a combination of the two mechanisms 
proposed by the two models for transcription termination [reviewed in (RICHARD and MANLEY 
2009)]. Thus recognition of the poly(A) site is crucial for termination to occur. The action of 
Ser5 phosphatases such as Ssu72 and Rtr1 and the Ser2 phosphatase Fcp1 ensures the 
regeneration of the hypophosphorylated form of Pol II, which can engage in another round of 
transcription (KUEHNER et al. 2011). 
In summary, all the stages of transcription are highly regulated by well-coordinated 
recruitment and exchange of accessory proteins that regulate the journey of Pol II along the 
chromatin template at different stages and orchestrate transcription with the co-transcriptional 
processing of mRNA (Figure 2).  
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Figure 2. Transcription Cycle 
The four main stages of transcription include initiation, promoter release, elongation and termination. Transition 
from one stage to the next involves exchange of factors mediating that stage with the factors regulating the next 
stage of transcription (GILMOUR 2009; MAYER et al. 2010).  
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1.3 ELONGATION FACTORS 
In the last few years, a plethora of information has been obtained about the roles of several 
transcription elongation factors that aid the passage of Pol II through chromatin during the 
elongation stage of transcription. Additionally, elongation factors also regulate the initiation of 
transcription, co-transcriptional processing of mRNA, such as mRNA capping, splicing and 
mRNA 3’ processing, as well the termination of transcription and mRNA turnover. Elongation 
factors can be divided into three main functional groups: ones that enhance the rate of elongation 
and inhibit transient pausing of Pol II such as Spt5; ones that facilitate the release of arrested Pol 
II such as TFIIS and Ccr4-Not complex; and ones that promote the passage of Pol II through the 
chromatin template such as P-TEFb,  FACT, Spt6, Chd1 and Paf1C (Table 1).  
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Table 1. RNA polymerase II elongation factors 
Elongation 
factor 
Important functions during transcription 
Spt5 (DSIF 
in humans) 
• Stimulates processivity of Pol II (HARTZOG et al. 1998) 
• Associates with NELF to induce promoter-proximal pausing (YAMAGUCHI et 
al. 1999) 
• Facilitates recruitment of capping machinery, Paf1C and CFI [reviewed in 
(HARTZOG and FU 2013)] 
TFIIS • Reactivates arrested Pol II [reviewed in (FISH and KANE 2002)] 
P-TEFb 
(Bur1 
kinase in 
yeast) 
• Phosphorylates the CTR of Spt5 (YAMADA et al. 2006) 
• Forms a transcriptionally active complex with Brd4 [reviewed in (ZHOU and 
YIK 2006)] 
• Forms a transcriptionally inactive complex termed 7SK snRNP complex 
[reviewed in (ZHOU and YIK 2006)] 
• Bur1 kinase phosphorylates Rad6 at serine120 and activates it (WOOD et al. 
2005) 
• Bur1 kinase facilitates recruitment of Paf1C by phosphorylating the CTR of 
Spt5 and the CTD of Pol II (LIU et al. 2009; QIU et al. 2012; ZHOU et al. 2009) 
• P-TEFb was previously shown to phosphorylate Ser2 of Pol II CTD that has 
now been shown to be a function of Cdk12 (Ctk1 in yeast) [reviewed in 
(KOHOUTEK and BLAZEK 2012)] 
FACT • Serves as a histone chaperone [reviewed in (WINKLER and LUGER 2011)] 
• Facilitates chromatin disassembly to allow passage of Pol II and reassembly 
upon passage of Pol II and hence also prevents cryptic initiation of 
transcription from intragenic regions [reviewed in (WINKLER and LUGER 
2011)] 
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Spt6  • Functions as a histone chaperone [reviewed in (DUINA 2011)] 
• Promotes passage of transcription machinery by disassembling nucleosomes 
and helps maintain chromatin integrity upon passage of Pol II [reviewed in 
(DUINA 2011)] 
• Facilitates the recruitment of histone H3 K36 methylase Setd2 (Set2 in yeast) 
and RNA export factor REF1 (Yra1 in yeast) and nuclear exosome factor Rrp6 
(YOH et al. 2007; YOH et al. 2008) 
Ccr4-Not 
complex 
• Deadenylation activity of the complex regulates mRNA turnover  [reviewed in 
(REESE 2013)] 
• Ubiquitination activity of the complex regulates stability of proteins such as the 
histone demethylase Jhd2 [reviewed in (REESE 2013)] 
• Facilitates the reactivation of transcription from paused Pol II (KRUK et al. 
2011) 
Chd1 • Maintains chromatin integrity and hence prevents cryptic initiation of 
transcription within gene bodies in collaboration with Isw1 chromatin 
remodeling complex by inhibiting trans-histone exchange (SMOLLE et al. 2012) 
• Increases histone exchange in the regions close to the promoter and hence 
facilitates chromatin remodeling over these regions (EHRENSBERGER and 
KORNBERG 2011; LIN et al. 2011; RADMAN-LIVAJA et al. 2012) 
Paf1C • Recruits Chd1 (SIMIC et al. 2003) 
• Promotes co-transcriptional histone modifications such as monoubiquitination 
of H2B K123, downstream methylation of H3 K4 and H3 K79 and tri-
methylation of H3 K36 [reviewed in (CRISUCCI and ARNDT 2011)] 
• Represses inducible genes by maintaining nucleosome occupancy over their 
promoters (PRUNESKI et al. 2011) 
• Facilitates 3’ RNA processing and transcription termination partly by 
promoting the Ser2 phosphorylation of Pol II CTD that serves as a platform for 
recruiting factors involved in these processes [reviewed in (CRISUCCI and 
ARNDT 2011)] 
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1.3.1 Spt5 
Among all the proteins that regulate transcription elongation, the only one that is conserved 
across all three domains of life including bacteria, archaebacteria and eukaryotes is the 
transcription elongation factor Spt5 (PONTING 2002) [reviewed in (HARTZOG and FU 2013)]. 
Spt5 and its heterodimeric partner, Spt4, were discovered in a genetic screen directed towards 
uncovering factors involved in maintaining chromatin structure during transcription (WINSTON et 
al. 1984). A seminal study in yeast strengthened the evidence for the role of Spt5 as an 
elongation factor through identification of Pol II mutants, which reduce transcription rates, as the 
suppressors of the conditional mutants of Spt5 (HARTZOG et al. 1998). This study also 
demonstrated the existence of the Spt4-Spt5 complex, showed that Spt5 also interacted with Pol 
II in vivo and identified Spt5 as the homologue of the bacterial transcription elongation factor, 
NusG (HARTZOG et al. 1998). Around the same time, the human Spt5-Spt4 complex, termed 
DSIF, was also discovered based on its identification as a factor conferring sensitivity to the 
transcription elongation inhibitor DRB (5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole) 
(WADA et al. 1998a). These and other studies that revealed physical and genetic interactions of 
the Spt4-Spt5 complex with other elongation factors such as Spt6 and TFIIS and the impact of 
Spt5 on the rate of elongation and processivity of Pol II during transcription further established 
the identity of Spt5 as an elongation factor (HARTZOG et al. 1998; LINDSTROM and HARTZOG 
2001; SWANSON and WINSTON 1992).  
Eukaryotic Spt5 is a large protein containing several domains (Figure 3). The NGN 
(NusG N-terminal) domain facilitates the interaction between Spt5 and clamp helices of Pol II 
through mainly hydrophobic interactions. These interactions between Spt5 and Pol II allow the 
clamping of Pol II onto the underlying DNA and thus enhance the processivity of Pol II 
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(HIRTREITER et al. 2010; KLEIN et al. 2011; MARTINEZ-RUCOBO et al. 2011; PONTING 2002). 
Interestingly, the binding sites of the transcription initiation factor TFIIE and Spt5 on Pol II 
overlap and their affinities for Pol II depend on the factors associated with Pol II (GROHMANN et 
al. 2011). The presence of Pol II within the initiation complex favors the binding of TFIIE while 
Spt5 can displace TFIIE and bind Pol II within an elongation complex. Spt5 also interacts with 
its heterodimeric binding partner Spt4, a small zinc finger protein, through its NGN domain via a 
β-sheet interface and several hydrogen bonds and this association with Spt4 is important for the 
stability of Spt5 (DING et al. 2010; GUO et al. 2008; MALONE et al. 1993).  
The KOW (Kyprides, Ouzounis and Woese) motifs found within Spt5 have the ability to 
bind nucleic acids and are also found within ribosomal proteins (CHARIER et al. 2004; STEINER et 
al. 2002). They resemble the Tudor domain and may facilitate the interaction of Spt5 with other 
protein known to interact with Spt5 such as Spt6, proteins of the capping machinery and Bur1-
Bur2 kinase complex (LINDSTROM et al. 2003). The C-terminal region of Spt5 has multiple 
repeats of a peptide sequence that varies among eukaryotes. The CTR of S. cerevisiae has the 
consensus sequence ST/AWGGA/Q while the repeats in Spt5 of higher eukaryotes such as 
humans, mice and Drosophila are located upstream of the C-terminus and have the sequence 
GSR/QTP (SWANSON et al. 1991; YAMADA et al. 2006). The serine residue within the consensus 
sequence of the CTR of yeast Spt5 has been shown to be phosphorylated by the Bur1-Bur2 
kinase (yeast homologue of P-TEFb) and this phosphorylation event was shown to facilitate the 
recruitment of Paf1C through a mechanism that was obscure (LIU et al. 2009; ZHOU et al. 2009). 
Additionally, the CTR of yeast Spt5 has also been shown to be important for the recruitment of 
the capping enzyme and the pre-mRNA cleavage factor 1 (MAYER et al. 2012; PEI et al. 2003). 
The phosphorylation of the threonine residue within the repeats in human Spt5 by P-TEFb 
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facilitates the release of paused Pol II (see section 1.2.2 for more discussion on paused Pol II) 
(YAMADA et al. 2006). Transcriptional activation upon phosphorylation has been shown to be 
facilitated by Paf1C and the Tat1 transcriptional activator protein in HIV (CHEN et al. 2009). 
Thus, the CTR of Spt5 like the CTD of Pol II could serve as platform for recruitment of proteins 
during stages of transcription to facilitate the movement of Pol II and co-transcriptional mRNA 
processing. 
Unlike their eukaryotic homologues, archeal and bacterial Spt5 proteins (NusG: N-
utilization substance G) are small and only have the NGN domain and one KOW domain 
[reviewed in (HARTZOG and FU 2013)]. NusG interacts with a ribosomal protein NusE and the 
termination factor Rho through its C-terminal domain in a mutually exclusive fashion 
(BURMANN et al. 2010).  Hence, transcription termination can occur only at the end of operons 
once translation and transcription are uncoupled and the interaction between NusG and NusE is 
lost, facilitating the binding of Rho to NusG. The interaction of NusG with NusE also suppresses 
the backtracking of RNA polymerase and hence rate of translation affects the rate of 
transcription during bacterial co-transcriptional translation (PROSHKIN et al. 2010). Additionally, 
bacteria express a paralogue of Spt5 called RfaH that binds to RNA polymerase in a manner 
similar to that of NusG through the hydrophobic interaction of its NGN domain with the RNA 
polymerase clamp. However, the recruitment of RfaH also requires an 8 bp consensus site, 
GGCGGTAG, termed the ops (operon polarity suppressor) element (BAILEY et al. 1996; NIETO 
et al. 1996).  This difference in the mechanisms of recruitment of RfaH and NusG prevents the 
interference from RfaH to the binding of NusG to RNA polymerase although both bind RNA 
polymerase in a similar fashion.  
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Figure 3. Schematic representation of S. cerevisiae Spt5 
Spt5 is a large protein containing an N-terminal acidic region, followed by an NGN domain, which mediates its 
binding to Spt4 and Pol II, several KOW motifs and a C-terminal region containing several repeats of a short 
hexapeptide sequence (KYRPIDES et al. 1996; PONTING 2002; SWANSON et al. 1991). 
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1.3.2 TFIIS 
The TFIIS elongation factor was discovered as a factor that was able to reactivate transcription 
from arrested RNA polymerase (SEKIMIZU et al. 1976; SEKIMIZU et al. 1979). The yeast 
homologue was discovered in a screen to identify genes that confer sensitivity to the base analog 
6-Azauracil and was also termed DST1 (DNA strand Transfer 1) since Dst1 mutants showed 
defective homologous recombination (CLARK et al. 1991) [reviewed in (UPTAIN et al. 1997)]. 
TFIIS helps reactivate arrested Pol II by stimulating the intrinsic RNA cleavage activity of 
arrested Pol II. Upon encountering a block during transcription, Pol II backtracks causing 
displacement of the 3’ end of the growing RNA transcript from the catalytic site of Pol II. This 
leads to an arrest of Pol II. The stimulation of the intrinsic RNA cleavage activity of arrested Pol 
II by TFIIS leads to cleavage of the misaligned 3’ end of the nascent transcript and creates new 
3’ end that is now properly aligned at the active site of Pol II so that it can then resume 
transcription [reviewed in (FISH and KANE 2002)]. TFIIS contains three domains, Domain I, II 
and III of which the conserved domains, domain II and III, are required to stimulate the cleavage 
of the nascent transcript and  reactivate the arrested Pol II (GUO and PRICE 1993). Domain II and 
the linker region between domains II and III facilitate the binding of TFIIS to Pol II (AGARWAL 
et al. 1991; SHIMASAKI and KANE 2000). Prokaryotic homologues of TFIIS include GreA and 
GreB, which also facilitate the release of arrested RNA polymerase by stimulating the intrinsic 
RNA cleavage ability of RNA polymerase [review in (FISH and KANE 2002)]. 
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1.3.3 P-TEFb 
P-TEFb is comprised of the kinase Cdk9 and its regulatory cyclin T1 (PENG et al. 1998). 
Treatment of HeLa cells with flavopiridol, an inhibitor of P-TEFb, indicated its requirement for 
the expression of a large number of genes (CHAO and PRICE 2001). It is also essential for 
transcription elongation of the HIV genome in HIV-1 infected cells (WEI et al. 1998). Previous 
studies had identified Ser2 of the Pol II CTD, Thr4 of the CTR of DSIF and the RD subunit of 
NELF as the substrates of P-TEFb (FUJINAGA et al. 2004; RAHL et al. 2010; WADA et al. 1998b; 
YAMADA et al. 2006; YAMAGUCHI et al. 1999).  However, recent studies have attributed the 
function of phosphorylation of the Ser2 of Pol II CTD to the kinase Cdk12 (Ctk1 in yeast) and its 
associated cyclin K (BARTKOWIAK et al. 2010; BLAZEK et al. 2011; KOHOUTEK and BLAZEK 
2012) [reviewed in (KOHOUTEK and BLAZEK 2012)]. 
Half the cellular pool of P-TEFb exists in a transcriptionally active complex with Brd4 
(bromodomain containing protein 4) protein. Brd4 interacts with cyclin T1 of P-TEFb through its 
tandem bromodomains, that it also utilizes to associate with acetylated histones and hence Brd4 
couples P-TEFb with genes primed for transcriptional activation (BISGROVE et al. 2007; JANG et 
al. 2005; YANG et al. 2005).  However, P-TEFb is also recruited by HIV-1 to stimulate 
transcription of the viral genes via a Brd4-independent mechanism. The viral regulatory protein, 
Tat, associates with P-TEFb and facilitates its incorporation into a ternary complex containing 
the TAR element (Trans-acting response RNA element), a stem-loop structure formed by a 
nascent viral transcript at the site of stalled Pol II, P-TEFb and Tat protein [reviewed in (ZHOU 
and YIK 2006)]. Upon recruitment of P-TEFb, viral transcription elongation is stimulated. 
 24 
In addition to its transcriptionally active complex, the rest of P-TEFb is sequestered in a 
transcriptionally inactive complex, the 7SK snRNP complex, from which it can be released in 
response to certain signals. The 7SK snRNP complex consists of 7SK, a Pol III transcribed 
snRNA (short nuclear RNA), HEXIM1 (hexamethylene bisacetamide inducible1), BCDIN3 
(Bicoid interacting 3) and Pip7S (P-TEFb interaction protein for 7SK stability)/LARP7 (L-
related protein 7)   (HE et al. 2008; JERONIMO et al. 2007; KRUEGER et al. 2008) [reviewed in 
(ZHOU and YIK 2006)]. HEXIM1 inhibits P-TEFb by binding to it and 7SK acts as a scaffold for 
this interaction of P-TEFb with HEXIM1 (YIK et al. 2003). BCDIN3 is a methylphosphate 
capping enzyme that protects 7SK from 5’-3’ exonucleases by capping it (JERONIMO et al. 2007). 
LARP7, on the other hand, protects 7SK from 3’-5’ exonucleases by binding to its 3’-UUU-OH 
sequence (HE et al. 2008). 
The yeast homologue of the Cdk9 kinase of P-TEFb complex is the Bur1 kinase that 
phosphorylates Ser2 of Pol II CTD during early stages of transcription elongation and the CTR 
of Spt5 (LEE and GREENLEAF 1991; LIU et al. 2009; PATTURAJAN et al. 1999; QIU et al. 2012; 
ZHOU et al. 2009). The Bur1-Bur2 complex is recruited to genes through association with the 
Ser5-phosphorylated Pol II CTD (QIU et al. 2009). Bur1-Bur2 in turn phosphorylates Ser2 of the 
Pol II CTD in the promoter-proximal regions, and upon recruitment of Ctk1, Ctk1 takes over the 
function of the phosphorylating Ser2 of the Pol II CTD (QIU et al. 2009). Furthermore, the Bur1-
Bur2 complex phosphorylates the CTR of Spt5 (discussed in section 1.1.3). Additionally, Bur1 
kinase phosphorylates Ser120 on Rad6, which activates the catalytic activity of Rad6 towards the 
monoubiquitination of H2B K123 (WOOD et al. 2005). Because Bur1 kinase facilitates the 
recruitment of Paf1C and activates Rad6, Bur1-Bur2 mutants have reduced levels of 
monoubiquitinated H2B K123 and methylated H3 K4, H3 K79 and H3 K36 (CHU et al. 2007; 
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WOOD et al. 2005). On the other hand, monoubiquitination of H2B K123 impedes the 
recruitment of Ctk1. Only upon deubiquitination of H2B K123 by the deubiquitinating enzyme 
Ubp8, can Ctk1 be recruited to genes (WYCE et al. 2007). Ctk1-catalyzed Ser2 phosphorylation 
of the Pol II CTD stimulates the recruitment of H3 K36 methyltransferase Set2 and 3’-RNA 
processing factors (AHN et al. 2004). Ctk1 is required for maintaining the boundary of H3 K4 
Me3 and H3 K4 Me2 across genes. Absence of Ctk1 results in spreading of H3 K4 Me3 and H3 
K4 Me2 towards the 3’ ends of genes (XIAO et al. 2007). This regulation of the distribution of di- 
and tri-methylated H3 K4 by Ctk1 is independent of its role in the recruitment of Set2 
methyltransferase (XIAO et al. 2007).  
1.3.4 FACT 
Genes encoding the two major subunits of the yeast FACT (Facilitates chromatin transactions) 
complex, Spt16 and Pob3, were discovered in screens to identify mutants that alter transcription 
at genes having a transposon insertion within their promoters, cause cell proliferation defects and 
genetically interact with transcriptional activators, all suggesting a role for the FACT complex in 
transcription (LYCAN et al. 1994; PRENDERGAST et al. 1990; WINSTON et al. 1984). The human 
FACT complex was discovered as an activity stimulating transcription elongation on a 
nucleosomal template in an in vitro transcription assay (ORPHANIDES et al. 1998). The 
association between Spt16 and Pob3 was discovered in the search for complexes involved in 
DNA replication highlighting the importance of this histone chaperone in DNA-templated 
processes other than transcription (WITTMEYER and FORMOSA 1997).  The function of the human 
homologue of S. cerevisiae Pob3, SSRP1 (Structure specific recognition protein 1), has been 
split between two yeast proteins, Pob3 and Nhp6. SSRP1 has an additional DNA binding domain 
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compared to Pob3, a domain also found in high-mobility group (HMG) proteins such as yeast 
Nhp6, which associates with yeast Spt16. However, the interaction between Spt16 and Nhp6 is 
not stable indicating that the DNA-binding function of Nhp6 may also be executed by other 
proteins that associate with yeast Spt16 (FORMOSA et al. 2001). In addition to the experiments 
leading to the discovery of FACT in human and yeast, its physical and functional interactions 
with other elongation factors such as Paf1C and its association with Pol II at actively transcribed 
genes, further underscored the role of FACT as a transcription elongation factor (COSTA and 
ARNDT 2000; SAUNDERS et al. 2003; SQUAZZO et al. 2002).  
FACT is a histone chaperone that can associate with both H3-H4 dimers and H2A-H2B 
dimers. Hence, it can also promote nucleosome assembly during DNA replication by facilitating 
the incorporation of H3-H4 tetramers or H2A-H2B dimers (BELOTSERKOVSKAYA et al. 2003; 
ORPHANIDES et al. 1998; ORPHANIDES et al. 1999). Due to its histone chaperoning ability, FACT 
can aid the passage of Pol II through chromatin during transcription by reorganizing the 
nucleosomes via displacement of single H2A-H2B dimer and reassemble the nucleosomes upon 
the passage of Pol II (BELOTSERKOVSKAYA et al. 2003; ORPHANIDES et al. 1999). 
Spt16 has an N-terminal domain (NTD), a dimerization domain (D) via which it 
associates with Pob3, a middle (M) and a C-terminal domain (C). Pob3 protein also contains an 
N-terminal domain (N) through which it associates with Spt16, a middle (M) and an acidic C-
terminal (C) domain. The Spt16-NTD, which bears structural similarity to aminopeptidases and 
the Pob3-M domain, which has the double pleckstrin homology motif, have the ability to bind 
the N-terminal histone tails (VANDEMARK et al. 2006; VANDEMARK et al. 2008). Additionally, 
the Pob3 M-domain also facilitates the association of FACT with replication protein A (RPA), 
which is involved in other DNA-templated processes such as replication and repair 
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(VANDEMARK et al. 2006). The Spt16 C-domain binds histones and makes the nucleosomal 
DNA more accessible while the D and M domains facilitate nucleosome reassembly and hence 
maintain chromatin integrity upon the passage of Pol II (HAINER et al. 2012; WINKLER et al. 
2011).  A recent comprehensive study has suggested that the hydrophobic interactions of the M 
domain of Spt16 with the H2A-H2B heterodimer are crucial for the histone chaperoning function 
of Spt16, although the other regions of Spt16 are also involved in the binding of Spt16 to the 
histones (HONDELE et al. 2013). This study also implicated the dimerization domain of Spt16 in 
the interaction of Spt16 with the DNA replication machinery (HONDELE et al. 2013). 
1.3.5 Spt6 
Spt6 was discovered along with Spt5, Spt4 and Spt16 in genetic screens to identify suppressors 
of the transcriptional defects conferred by transposon insertions (FASSLER and WINSTON 1988; 
WINSTON et al. 1984). The physical and functional interactions of Spt16 with other transcription 
elongation factors such as Spt5 and TFIIS and its effects on the transcription of genes such as the 
histone genes and on the transcriptional activity of human estrogen receptor provided further 
evidence for its role in transcription (BANIAHMAD et al. 1995; CLARK-ADAMS and WINSTON 
1987; COMPAGNONE-POST and OSLEY 1996; DENIS and MALVAR 1990; HARTZOG et al. 1998; 
SWANSON and WINSTON 1992). Early studies also provided evidence that Spt6 can directly 
associate with histones (with higher affinity for histone H3) and facilitate the assembly of 
nucleosomes in vitro, thus uncovering its function as a histone chaperone (BORTVIN and 
WINSTON 1996). Subsequent experiments identified its role in preventing spurious initiation of 
transcription from intragenic regions (CHEUNG et al. 2008; KAPLAN et al. 2003). Spt6 also 
maintains chromatin integrity over highly transcribed genes by facilitating nucleosome 
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reassembly in the wake of Pol II (IVANOVSKA et al. 2011). Spt6 negatively regulates the 
expression of some genes by maintaining nucleosome occupancy over promoter DNA and blocks 
the access of the promoter DNA to transcriptional activators (ADKINS and TYLER 2006; HAINER 
et al. 2011).  
That Spt6 may have additional functions independent of its role as a histone chaperone, 
was shown by the lack of a remarkable overlap between Spt6 targets identified by transcriptome 
analysis and targets requiring Spt6 for maintenance of their chromatin integrity (IVANOVSKA et 
al. 2011). Roles of Spt6 in transcription that may be independent of its histone chaperone activity 
were uncovered after the identification of the physical interactions of Spt6 with Ser2 
phosphorylated Pol II CTD and Iws1 (interacts with Spt6) (KROGAN et al. 2002; YOH et al. 
2007). Spt6 interacts with the Ser2 phosphorylated form of Pol II CTD through its SH2 domain 
(Src homology 2). The binding of Isw1 to the CTD-bound Spt6 facilitates the recruitment of 
Setd2 (SET domain 2; human homologue of Set2), human RNA export factor REF1 (homologue 
of yeast Yra1; Yeast RNA annealing protein 1) and human Rrp6 (ribosomal RNA processing), 
which is involved in RNA processing and mRNA surveillance (YOH et al. 2007; YOH et al. 
2008). Spt6 has been shown to be important for several developmental and other signaling 
pathways in higher eukaryotes (ARDEHALI et al. 2009; BANIAHMAD et al. 1995; KEEGAN et al. 
2002; SHEN et al. 2009). 
1.3.6 Ccr4-Not complex 
Ccr4 (Carbon catabolite repression 4) was named after its discovery as a gene required for the 
expression of glucose-repressed genes (DENIS 1984). While the Not1 and Not2 components were 
identified as genes required for proper cell cycle division (REED 1980; SHUSTER and BYERS 
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1989). These genes were termed the NOT genes (negative on TATA) due to their negative effect 
on expression from unconventional TATA promoters (COLLART and STRUHL 1994).  The 
presence of the Not proteins in the Ccr complex was uncovered in a proteomics analysis of the 
Ccr complex (LIU et al. 1998). These and other studies led to the identification of the nine core 
subunits of the Ccr4-Not complex: Not1-5, Ccr4, Caf1 (Ccr4-associated factor 1), Caf40 and 
Caf130 (BAI et al. 1999; CHEN et al. 2001; LIU et al. 1998). Subsequent studies led to the 
identification of several functions of this complex performed over the entire lifetime of mRNA 
from its synthesis to its degradation. Identification of the functional and physical interaction 
between the Ccr4-Not complex and the TFIID transcription initiation factor and the localization 
of Ccr4-Not over promoter regions suggested a role for this complex in transcription initiation 
(BADARINARAYANA et al. 2000; DELUEN et al. 2002). The sensitivity of the mutants of the Ccr4-
Not complex to drugs that induce greater dependency on transcription elongation factors such as 
6-Azauracil and Mycophenolic acid (MPA), genetic interactions of this complex with 
transcription elongation factors such as TFIIS and Spt16, the occupancy of this complex over 
transcribed genes, its physical interaction with Pol II, its reduced GLAM (gene length 
accumulation of mRNA) ratio and its ability to restore transcription from stalled Pol II, 
emphasized the role of the Ccr4-Not complex as a transcription elongation factor (DENIS et al. 
2001; GAILLARD et al. 2009; KRUK et al. 2011).  
Identification of the cytoplasmic deadenylation activity of the Ccr4-Not complex 
established the role of this complex in the regulation of mRNA turnover (TUCKER et al. 2001). 
The deadenylation activity is dependent on the Ccr4 subunit and Caf1 subunit. The Ccr4 subunit 
belongs to the EEP (Exonuclease/Endonuclease/Phosphatase) superfamily and has the DNaseI-
like domain that confers upon it 3’-5’ exonuclease activity on substrates such as poly(A) RNA 
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and single stranded DNA  (CHEN et al. 2002; MARCHLER-BAUER et al. 2013; TUCKER et al. 
2001). The deadenylase activity is also contributed by the Caf1 subunit, which is a member of 
the DEDD family (has catalytically important and conserved D and E residues in the exonuclease 
domain) and has the RNaseD-like domain, in higher eukaryotes but not in yeast, where it only 
tethers the Ccr4 subunit with the rest of the complex (MARCHLER-BAUER et al. 2013; TEMME et 
al. 2010; TUCKER et al. 2001).  
The Ccr4-Not complex also exhibits ubiquitination activity. This activity is contributed 
by the Not4 subunit, an E3 ubiquitin ligase that has a highly conserved RING (Really Interesting 
New Gene) finger domain (ALBERT et al. 2002). Not4 has been shown to function with two E2 
ubiquitin conjugases, Ubc4 and Ubc5, to regulate the levels of proteins such as the histone 
demethylase Jhd2 (JumonjiC domain-containing Histone Demethylase), DNA polymerase alpha, 
nascent polypeptide associated complex, cyclin C and the transcription factor Yap1 [reviewed in 
(REESE 2013)].  
Thus, the Ccr4-Not complex is a multifunctional complex that influences gene expression 
through several mechanisms. 
1.3.7 Chd1 
Chd, represents a family of chromatin remodeling complexes that possess tandem 
chromodomains at their N-terminus, a central helicase domain and a C-terminal DNA binding 
domain (WOODAGE et al. 1997). They are conserved from yeast to humans. The 6-Azauracil 
resistance of mutants of this chromatin remodeling factor had suggested a negative role for this 
complex in transcription elongation (WOODAGE et al. 1997). Subsequent studies uncovered the 
physical and functional interactions of Chd1 with transcription elongation factors such as Spt16, 
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Spt5 and Paf1C and the localization of Chd1 over actively transcribed genes, highlighting the 
role of Chd1 in transcription elongation (SIMIC et al. 2003).  
Chd1 has been shown to function with another chromatin remodeler Isw1 (Imitation 
Switch subfamily) to inhibit trans-histone exchange and hence maintain chromatin integrity over 
gene bodies and prevent spurious intragenic transcription (GKIKOPOULOS et al. 2011; LEE et al. 
2012; QUAN and HARTZOG 2010; SMOLLE et al. 2012). This function of Chd1 has been attributed 
to its ability to reduce histone turnover over the 3’ end of genes by maintaining the histones in 
the deacetylated state (QUAN and HARTZOG 2010; RADMAN-LIVAJA et al. 2012). However, Chd1 
increases histone exchange near 5’ ends of genes (RADMAN-LIVAJA et al. 2012). Consistent with 
these results, Chd1 has been shown to facilitate chromatin remodeling over the promoters in an 
activator-dependent manner upon recruitment by the Mediator coactivator complex 
(EHRENSBERGER and KORNBERG 2011; LIN et al. 2011). 
The requirement for the chromodomains of Chd1 for its recruitment to chromatin differs 
between organisms. The chromodomains of human Chd1 may mediate its recruitment to 
chromatin through association with di- and tri-methylated H3 K4 (SIMS et al. 2005). In yeast, 
however, it remains obscure if the binding of the chromodomain to methylated H3 K4 targets 
Chd1 to chromatin (PRAY-GRANT et al. 2005; SIMS et al. 2005).  Yeast Chd1 has been shown to 
be recruited to chromatin through interaction with the Rtf1 subunit of Paf1C (SIMIC et al. 2003).  
In mice, Chd1 has been shown to be important for maintaining stem cell pluripotency and 
reduced levels of Chd1 causes an increase in the heterochromatin levels (GASPAR-MAIA et al. 
2009). Furthermore, human Chd1 has been shown to function as tumor suppressor in prostrate 
cancer by positively regulating transcription mediated by androgen receptor including 
transcription of tumor suppressor genes (BURKHARDT et al. 2013).  
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1.3.8 Paf1C 
Yeast Paf1C is composed of five subunits including Paf1, Ctr9 (Cln Three Requiring), Cdc73 
(Cell Division Cycle), Leo1 (Left Open reading frame) and Rtf1 (Restores TBP Function). 
Human Paf1C is associated with an additional subunit, Ski8 (ZHU et al. 2005). Paf1 and Cdc73 
subunits were discovered during a search for accessory proteins associated with Pol II (WADE et 
al. 1996). The Rtf1 subunit was discovered in a screen to identify suppressors of a TBP mutant 
with altered specificity for DNA (STOLINSKI et al. 1997). Ctr9 was discovered in a screen to 
uncover the transcriptional regulators of G1 cyclin (KOCH et al. 1999). The role of Leo1 and 
Cdc73 in transcription was uncovered after the discovery of their association with the other 
subunits of Paf1C. The proteomic analysis of the affinity purified subunits led to identification of 
all the components of Paf1C (KOCH et al. 1999; KROGAN et al. 2002; MUELLER and JAEHNING 
2002; SQUAZZO et al. 2002). The phenotypes exhibited by the members of Paf1C such as the Spt- 
phenotype, sensitivity to drugs such as 6-AU and MPA, their effects on expression of some 
genes as determined by microarray analysis, their genetic and physical interactions with other 
elongation factors such as Spt5, Spt16 and TFIIS,  their  localization over actively transcribed 
genes, their effect on the GLAM (gene length accumulation of mRNA) ratio and their impact on 
co-transcriptional histone modifications underscored the identity of Paf1C as a transcription 
elongation complex (ADELMAN et al. 2006; GAILLARD et al. 2009; RONDON et al. 2004; 
SQUAZZO et al. 2002; STOLINSKI et al. 1997) [reviewed in (CRISUCCI and ARNDT 2011)]. The 
stimulatory effect of Paf1C alone and its synergistic effect with TFIIS on transcription over 
chromatin templates in transcription assays with biochemically defined factors suggested that 
Paf1C also has an intrinsic ability to promote transcription and it can also synergistically 
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stimulate transcription through association with other elongation factors such as TFIIS (KIM et 
al. 2010). 
Paf1C is a multifunctional complex that regulates transcription through several different 
mechanisms. One of the better-studied roles of Paf1C is the regulation of co-transcriptional 
histone modifications (Figure 4). Paf1C mediates the monoubiquitination of lysine 123 of 
histone H2B, which is catalyzed by the ubiquitin-conjugating enzyme Rad6 and the ubiquitin 
ligase Bre1, by facilitating the chromatin recruitment of Rad6 possibly by binding to Bre1 (KIM 
and ROEDER 2009; NG et al. 2003a; WOOD et al. 2003; XIAO et al. 2005). Recent studies from 
our laboratory also suggest that the Rtf1 subunit of Paf1C may facilitate this histone modification 
through interaction with nucleosomes (PIRO et al. 2012). Monoubiquitinated H2B K123 
collaborates with the histone chaperone FACT to facilitate the reassembly of nucleosomes in the 
wake of Pol II (FLEMING et al. 2008; PAVRI et al. 2006). The effect of this mark is context-
dependent. While it acts as an activating mark within the body of genes, at the promoter it acts an 
inhibitory mark by facilitating nucleosome formation (BATTA et al. 2011). This mark also serves 
as a pre-requisite for the di- and tri-methylation of H3 K79 and H3 K4 residues, which is 
catalyzed by the Dot1 and Set1 enzymes, respectively (DOVER et al. 2002; KROGAN et al. 2003a; 
NG et al. 2003b; SUN and ALLIS 2002; WOOD et al. 2003). Additionally, Paf1C also promotes H3 
K4 methylation by mediating the recruitment of the Set1 complex (KROGAN et al. 2003a). H3 K4 
Me2 and H3 K4 Me3 modifications facilitate the recruitment of histone acetyltransferases and 
histone deacetylases (discussed in section 1.1.2). By regulating the methylation of the H3 K4 
residue, Paf1C facilitates the activation of genes and prevents the initiation of cryptic 
transcription from intragenic regions (CHU et al. 2007; KIM and BURATOWSKI 2009; LIN et al. 
2011; STOLINSKI et al. 1997) (also discussed in section 1.1.2). H3 K79 methylation on the other 
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hand inhibits the binding of proteins involved in transcriptional silencing at active loci and 
restricts them to the specific silenced loci (NG et al. 2002a; VAN LEEUWEN et al. 2002). Thus, 
Paf1C is also important for telomeric silencing. Paf1C also facilitates the maintenance of 
chromatin integrity by promoting tri-methylation of H3 K36, which recruits the HDAC that 
maintains the histones in a deacetylated state and prevents spurious initiation of transcription 
from intragenic regions (discussed in section 1.1.2). This effect of Paf1C on Set2 recruitment is 
likely due to the impact of Paf1C on the phosphorylation of Ser2 of the Pol II CTD (NORDICK et 
al. 2008; PENHEITER et al. 2005).    
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Figure 4. Regulation of histone modifications by Paf1C 
Paf1C is required for the monoubiquitination of H2B K123, which is catalyzed by the Rad6 and Bre1 proteins 
[reviewed in (CRISUCCI and ARNDT 2011)]. This mark is involved in a histone cross-talk and facilitates methylation 
of H3 K79 and H3 K4 methylation marks, which are catalyzed by methyltransferase Set1 and Dot1 [reviewed in 
(CRISUCCI and ARNDT 2011)]. Additionally, Paf1C is also required for tri-methylation of H3 K36 by the Set2 
methyltransferase [reviewed in (CRISUCCI and ARNDT 2011)]. 
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 Through regulation of the Ser2 phosphorylation of the Pol II CTD, Paf1C also regulates 
transcription termination (Figure 5). The Ser2 phosphorylation of the Pol II CTD serves as a 
binding platform for recruitment of termination factors involved in cleavage and polyadenylation 
of nascent mRNA such as Pcf11 (MUELLER et al. 2004; NORDICK et al. 2008). Hence, loss of 
Paf1C subunits causes shortening of the poly(A) tails of mRNA, which destabilizes those 
mRNAs (MUELLER et al. 2004). Depletion of the components of Paf1C also results in utilization 
of alternative poly(A) sites at some genes sensitizing those transcripts to nonsense mediated 
mRNA decay, an mRNA surveillance mechanism that eliminates aberrant mRNAs with 
premature stop codons or abnormally long 3’ UTRs (untranslated  regions)  (MUHLRAD and 
PARKER 1999; PELTZ et al. 1993; PENHEITER et al. 2005). Not only does Paf1C indirectly 
influence the recruitment of termination factors through regulation of Ser2 phosphorylation of 
the Pol II CTD but it also directly facilitates the association of the termination factor Cft1 with 
the Ser5 phosphorylated Pol II CTD (NORDICK et al. 2008). Additionally, the Ski8 subunit that 
associates with human Paf1 mediates 3’-5’ mRNA degradation and hence mRNA surveillance 
co-transcriptionally by associating with actively transcribed genes through Paf1C (ZHU et al. 
2005). 
Studies from the Arndt laboratory and the Buratowski laboratory have uncovered the 
importance of Paf1C for proper termination of snoRNAs, a class of non-coding, non-
polyadenylated RNAs that facilitate post-translational modifications of ribosomal RNAs (rRNA), 
transfer RNAs (tRNAs) and small nuclear RNAs (snRNA) [reviewed in (MATERA et al. 2007)]. 
Paf1C prevents the read-through transcription of snoRNAs by facilitating the recruitment of 
Nrd1 and Nab3, which regulate snoRNA termination through the Nrd1-Nab3-Sen1 pathway 
(SHELDON et al. 2005; STEINMETZ et al. 2001). Furthermore, Paf1C also facilitates the 
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termination of snoRNA transcripts through regulation of histone modifications such as 
monoubiquitination of H2B K123 and methylation of H3 K4 and H3 K36 and additional 
unknown mechanisms (TERZI et al. 2011; TOMSON et al. 2012; TOMSON et al. 2011).  
Paf1C not only regulates transcription elongation and termination but also transcription 
initiation. Support for the role of Paf1C in transcription initiation mainly comes from studies in 
higher eukaryotes. Paf1C facilitates the expression of genes required for maintaining stem cell 
pluripotency such as Oct4 and Nanog, and the transcriptional targets of the Notch signaling 
pathway by maintaining the chromatin over promoters in a transcriptionally active state through 
promotion of tri-methylation of H3 K4 over the promoter regions (AKANUMA et al. 2007; BRAY 
et al. 2005; DING et al. 2009; TENNEY et al. 2006). Furthermore, Paf1C is recruited by the Gli 
(Glioma associated oncogene family zinc finger 1) transcription factors through a direct physical 
association with Cdc73 to activate transcription through the Hedgehog signaling pathway 
(MOSIMANN et al. 2009). Similarly, Paf1C is also deployed by the transcription factor beta-
catenin through a direct interaction with the Cdc73 subunit to activate transcription downstream 
of the Wnt signaling pathway (MOSIMANN et al. 2006). Thus, Paf1C regulates several 
developmentally important signaling pathways and hence is essential for normal development of 
multicellular organisms. Additionally, Paf1C has also been shown to repress transcription of 
genes by maintaining nucleosome occupancy over the promoter region (Figure 5) (PRUNESKI et 
al. 2011). 
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Figure 5. Functions of Paf1C 
 Paf1C performs several functions within the cell such as facilitating the passage of Pol II through chromatin 
through association with other elongation factors, maintaining histone occupancy over the promoter region to 
repress genes, mediating the recruitment of chromatin remodeling factor Chd1, promoting the phosphorylation of 
Ser2 of Pol II CTD and stimulating co-transcriptional histone modifications [reviewed in (CRISUCCI and ARNDT 
2011)]. This figure has been adapted from published material (CRISUCCI and ARNDT 2011). 
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Misregulation of Paf1C can result in severe pathological conditions (Figure 6). Paf1C 
mediates immunological response through regulation of the interleukin 6 (IL-6) signaling 
pathway by stabilizing the interaction of the transcription factor Stat3 with the promoters of IL-6 
responsive genes (YOUN et al. 2007). Influenza virus A H3N2 subtype suppresses the Paf1C-
mediated antiviral immune response by deploying its viral non-structural protein 1, a histone 
mimic, to block the activity of Paf1C by binding to it (MARAZZI et al. 2012). Mutations within 
genes encoding components of Paf1C have been identified as drivers of cancer. Germline or 
somatic mutations that cause frameshift, missense or nonsense mutations within the human 
Cdc73 protein have been identified as the underlying cause of hyperthyroidism jaw tumor 
syndrome (CARPTEN et al. 2002; HOWELL et al. 2003; SHATTUCK et al. 2003). These mutations 
have been shown to affect the association of Cdc73 with the rest of Paf1C or with a histone 
methyltransferase complex (ROZENBLATT-ROSEN et al. 2005). These reports and functional 
studies in human cell lines which showed that overexpression of Cdc73 can inhibit cell 
proliferation by silencing the cyclin D1 gene suggest the role of Cdc73 as a tumor suppressor 
(WOODARD et al. 2005). However, amplifications of the locus harboring this gene have also been 
observed in pancreatic cancer, breast cancer, brain cancer and head cancer [reviewed in 
(CHAUDHARY et al. 2007)]. Furthermore, amplification of the locus encoding PAF1 gene and the 
corresponding upregulation of the Paf1 subunit have been observed in cancers such as pancreatic 
cancer. Since overexpression of Paf1 has also been shown to induce the transformed phenotype 
in cells, the amplification of Paf1 may likely be a driver mutation in these cancers [reviewed in 
(CHAUDHARY et al. 2007)]. The ability of Paf1C to act as an oncogene may be attributed to its 
ability to positively regulate the transcription of oncogenes such as the targets of the Wnt or the 
Notch signaling pathway. 
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 In-frame translocations within the gene encoding the human histone H3 K4 
methyltransferase, MLL (Mixed Lineage Leukemia), with the region encoding one or more of 
over fifty different nuclear transcription activators such as ENL, AF4 or AF9 or cytoplasmic 
proteins like AF6 that dimerize and acquire the ability to activate transcription, results in 
oncogenic fusion proteins [reviewed in (TAN et al. 2010)]. These fusion proteins contain the N-
terminal portion of MLL, which includes the AT hook motifs and the CXXC zinc-finger motif 
that facilitates the targeting of the fusion protein to chromatin and are the underlying cause of 
myeloid, lymphoid and mixed lineage leukemias [reviewed in (TAN et al. 2010)]. The oncogenic 
ability of cells bearing these genetic lesions is likely due to the persistent activation of homeobox 
transcription factor (HOX) genes, which are involved embryonic development and hematopoetic 
differentiation mainly HOXA9 [reviewed in (HESS 2004)]. Normally, HOXA9 is briefly 
expressed in the progenitor hematopoetic cells and downregulated during differentiation. Paf1C 
is important for the transcriptional activation by the oncogenic fusion protein since it facilitates 
the recruitment of the fusion protein to HOXA9 gene (MILNE et al. 2010). Many of the proteins 
that fuse with MLL because of the genetic translocations have also been shown to be a part of the 
Super elongation complex (SEC) that positively regulates the expression of HOX genes. This 
suggests that the SEC could also be facilitating the overexpression of the HOX genes by the 
MLL fusion proteins [reviewed in (SMITH et al. 2011)]. 
Together, these studies suggest that misregulation of Paf1C can result in several diseases, 
including cancers. 
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Figure 6. Health significance of Paf1C 
Paf1C facilitates the expression of downstream targets of Notch signaling, Wnt signaling, Hedgehog signaling and 
hence is essential for normal development [reviewed in (TOMSON and ARNDT 2013)]. Overexpression of the 
components of Paf1C can lead to cancer presumably due to its role in signaling pathways such as Notch and Wnt 
(AKANUMA et al. 2007; TENNEY et al. 2006). Paf1C mediates antiviral response by facilitating transcriptional 
activation downstream of the IL-6 signaling pathway (YOUN et al. 2007). Additionally, influenza virus uses its non-
structural protein 1 to bind to Paf1C and suppress Paf1C-mediated antiviral response by the host (MARAZZI et al. 
2012). Furthermore, it regulates embryonic stem cell (ESC) pluripotency by facilitating the expression of genes 
required for maintaining a pluripotent state, such as Oct4, Nanog and Klf4 (DING et al. 2009). Also, mutations 
within the Cdc73 subunit of Paf1C are the cause of hyperparathyroidism jaw tumor syndrome (CARPTEN et al. 
2002). The chromosomal rearrangements within the MLL gene results in the production of oncogenic fusion 
proteins that require Paf1C for their oncogenic activity [reviewed in (TAN et al. 2010)]. This figure has been adapted 
from published material (TOMSON and ARNDT 2013). 
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1.4 THESIS AIMS 
Paf1C is a highly conserved transcription elongation complex composed of five members in 
yeast including Paf1, Ctr9, Leo1, Rtf1 and Cdc73. Although termed an elongation factor, Paf1C 
facilitates initiation and termination of transcription as well. Paf1C is involved in several 
important functions such as regulating co-transcriptional histone modifications, RNA 3’-end 
formation and phosphorylation of the Pol II CTD. Paf1C regulates expression of many important 
genes including those involved in development, antiviral response and maintenance of stem cell 
pluripotency. Misregulation of Paf1C has been associated with developmental defects, cancers 
and other diseases.  
However, prior to my work the mechanism of recruitment of this important complex was 
obscure. Structure-function analysis of Rtf1 had uncovered small internal deletions within the 
central region of Rtf1 that diminished the association of Paf1C with actively transcribed genes. 
My goal was to determine how this region, termed the ORF association region (OAR) based on 
its ability to facilitate the chromatin association of Paf1C to actively transcribed genes, mediated 
the recruitment of Paf1C. To gain insight into the mechanism of recruitment of Paf1C, I sought 
to find answers to many different questions such as what are the boundaries of the functional 
ORF association region of Rtf1 (OAR) and what are the functional and the structural 
consequences of the lack of this OAR? Which protein-protein interactions of Paf1C are mediated 
by the OAR?  Are the protein interactions mediated by the OAR direct or indirect? Is the OAR 
just necessary or also sufficient to mediate these interactions? Are these protein interactions 
modulated by post-translational modifications? Is the OAR sufficient for chromatin association? 
Is the chromatin association by the OAR dependent on the other members of Paf1C? Is the 
chromatin association and dissociation of the OAR regulated in the same manner as that of entire 
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of Paf1C? What are the functionally important residues of the OAR? Does the Paf1C associate 
with chromatin and execute its functions through a dual attachment mediated by the OAR of 
Rtf1 and the C-domain of Cdc73, which has been previously implicated in the recruitment of 
Paf1C? 
I performed affinity purification of an OAR deletion derivative of Rtf1 and sent it for 
mass spectrometry analysis to our collaborator, Dr. Richard Gardner, at Fred Hutchinson Cancer 
Research Centre, to identify the protein interactions that were lost in this deletion derivative. 
This subtractive proteomics approach revealed that the interaction of Paf1C with the universally 
conserved transcription elongation factor Spt5 was mediated by the OAR. I validated the mass 
spectrometry data through co-immunoprecipitation assays and gel-filtration chromatography 
analysis. I further determined if this interaction was direct by performing in vitro binding assays 
with bacterially expressed, purified recombinant derivatives of Rtf1 and Spt5, which also led to 
the identification of the minimal regions of Rtf1 and Spt5 mediating the interaction of Paf1C 
with Spt5. Pull-down assays revealed that the post-translational modification of Spt5 was 
important for this interaction. Next, by performing several chromatin immunoprecipitation 
(ChIP) assays to determine the chromatin occupancy of OAR in the context of a wild-type strain 
and many mutant strains, I identified that the OAR can associate and dissociate from chromatin 
in the same manner as that of the entire Paf1C without obligatory assistance from any other 
components of Paf1C. I also showed that Spt5 and the Bur1-Bur2 kinase complex regulate the 
chromatin association and dissociation of the entire Paf1C by targeting the OAR of Rtf1. 
Furthermore, I also identified the functionally important residues within the OAR mainly by 
performing growth assays and ChIP assays.  
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I also determined the reason for the low levels of Rtf1-mediated (H3 K4 Me3, H3 K4 
Me3 and H3 K79 Me2/3) and high levels of Rtf1-independent histone modifications (H3 K36 
Me3) promoted by Paf1C in the cells lacking the OAR, although the chromatin occupancy of the 
entire Paf1C was dramatically low in these cells. My results suggest that extremely low levels of 
Paf1C, undetectable by ChIP, may be associating with the actively transcribed genes in the 
absence of the OAR, through the C-domain of Cdc73. These low levels of Paf1C associated with 
the chromatin through the C-domain of Cdc73 in the absence of the OAR are likely responsible 
for the low levels of Rtf1-dependent histone modifications (H3 K4 Me3, H3 K4 Me2 and H3 
K79 Me2/3) and high-level of Rtf1-independent histone modification (H3 K36 Me3) regulated 
by Paf1C, in cells lacking the OAR. Only cells lacking both the OAR of Rtf1 and the C-domain 
of Cdc73 show an almost complete loss of all the Paf1C-mediated histone modifications by 
immunoblotting analysis.  
In addition to identifying the mechanism of chromatin association of Paf1C, my work on 
the histone modification domain (HMD) of Rtf1 has provided better insight into how this small 
region within Rtf1 (Rtf1 residues 63-152) mediates histone modifications. I determined that the 
HMD could execute its function of promoting histone modifications such as monoubiquitination 
of H2B K123, di-methylation of H3 K4 and di- and tri-methylation of H3 K79 without assistance 
from other components of Paf1C but it requires aid from other members of Paf1C for the H3 K4 
Me3 mark. My work also revealed the dependency of the functional activity of the HMD on the 
protein levels of the HMD. Consistent with this, I also found that fusing the HMD to a Gal-4 
DNA binding domain (GBD) caused a reduction in the levels of HMD and correspondingly 
reduced the levels of HMD-mediated histone modifications. Furthermore, I have also obtained a 
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preliminary result that suggests that the HMD may mediate the histone modification function 
through interaction with the ubiquitin ligase, Bre1.  
Collectively, my work has provided a mechanistic insight into the chromatin association 
and dissociation of Paf1C and a better understanding of how Paf1C promotes co-transcriptional 
histone modifications.  
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2.0  THE RECRUITMENT OF PAF1C OCCURS THROUGH A DIRECT 
INTERACTION BETWEEN THE OAR OF RTF1 AND THE CTR OF SPT5 
Most of the work presented in this Chapter is adapted from published material (MAYEKAR et al. 
2013) and is reprinted with some changes.  
Copyright © American Society for Microbiology, [MCB, 33, 2013, 3259-3273, 
10.1128/MCB.00270-13]. 
2.1 INTRODUCTION 
Packaging of the eukaryotic genome into chromatin hinders the movement of Pol II during 
transcription.  Hence, eukaryotes have evolved numerous initiation and elongation factors that 
orchestrate the recruitment and movement of Pol II across active genes.  Paf1C is one such 
conserved elongation factor.  In S. cerevisiae, Paf1C consists of five subunits: Paf1, Ctr9, Cdc73, 
Leo1 and Rtf1 (MUELLER and JAEHNING 2002; SHI et al. 1997; SHI et al. 1996; SQUAZZO et al. 
2002) [reviewed in (CRISUCCI and ARNDT 2011; TOMSON and ARNDT 2013)].  Paf1C regulates 
transcription and chromatin structure through several mechanisms.  The most well studied 
functions of Paf1C are its roles in regulating co-transcriptional histone modifications.  Through a 
mechanism that requires the histone modification domain of Rtf1, Paf1C is required for efficient 
monoubiquitination of histone H2B K123 by the ubiquitin-conjugating enzyme Rad6 and the 
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ubiquitin-protein ligase Bre1 (NG et al. 2003a; PIRO et al. 2012; WARNER et al. 2007; WOOD et 
al. 2003; XIAO et al. 2005).  This mark is a pre-requisite for di- and tri-methylation of H3 K4 and 
K79 by the Set1 and Dot1 histone methyltransferases, respectively (DOVER et al. 2002; KROGAN 
et al. 2003a; NG et al. 2003a; NG et al. 2003b; SUN and ALLIS 2002).  Paf1C also facilitates H3 
K36 tri-methylation on the bodies of active genes (CHU et al. 2007).  Additional functions of 
Paf1C include the Rtf1-mediated recruitment of the Chd1 chromatin remodeling protein (SIMIC 
et al. 2003), the stimulation of serine 2 phosphorylation on the C-terminal domain (CTD) of Pol 
II (MUELLER et al. 2004; NORDICK et al. 2008), the maintenance of nucleosome occupancy on 
highly expressed regions of the genome (PRUNESKI et al. 2011), and the recruitment of factors 
involved in transcription termination and RNA processing (MUELLER et al. 2004; NORDICK et al. 
2008; TOMSON et al. 2012).  Either individually or collectively, the multiple functions of Paf1C 
can influence the rate of transcription elongation (KIM et al. 2010; RONDON et al. 2004; TOUS et 
al. 2011).  In addition to its roles in elongation, Paf1C has also been shown to affect the initiation 
and termination stages of the transcription cycle (DING et al. 2009; MOSIMANN et al. 2006; 
MOSIMANN et al. 2009; MUELLER et al. 2004; TOUS et al. 2011). 
Members of Paf1C were first discovered in a search for proteins that associate with Pol II 
(WADE et al. 1996).  Consistent with its physical association with Pol II, Paf1C is enriched on 
the bodies of actively transcribed genes at levels that correlate with gene expression (MAYER et 
al. 2010).  Previous studies have implicated several proteins in the recruitment of yeast Paf1C to 
active chromatin, including the transcription elongation factors Spt16-Pob3/FACT, the Ccr4-Not 
complex, and Spt4-Spt5/DSIF (MULDER et al. 2007; PAVRI et al. 2006; QIU et al. 2012; QIU et 
al. 2006).  Conflicting results have been obtained regarding the role of the Ccr4-Not complex in 
Paf1C recruitment. Deletion of the Not4 subunit of the Ccr4-Not complex causes a reduction in 
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the levels of H3 K4 Me3 modification, but has no impact on H3 K4 Me2, H3 K4Me, H3 K79 
Me2, H3 K79Me3 and H2B Ub levels (LARIBEE et al. 2007; MULDER et al. 2007). While the 
Timmers groups attributed this reduction in H3 K4 Me3 levels to the reduced occupancy of 
Paf1C in the absence of Not4, the Strahl group observed no impact of the loss of Not4 on the 
recruitment of Paf1C. They identified the association between Ccr4-Not complex and the 
proteasome as the underlying cause of this reduction (LARIBEE et al. 2007; MULDER et al. 2007). 
FACT was implicated in the recruitment of Paf1C based on the recruitment of FACT 
prior to Paf1C to an inducible promoter and a physical interaction between FACT and Paf1C 
(PAVRI et al. 2006). That the phosphorylation of the CTR of Spt5 facilitates the recruitment of 
Paf1C to chromatin was suggested, due to reduction in the chromatin occupancy of Paf1C in 
mutant cells lacking the Spt4 subunit of the Spt4-Spt5 complex or the CTR of Spt5 or mutants 
having non-phosphorylatable Spt5 CTR (LIU et al. 2009; QIU et al. 2006; ZHOU et al. 2009). 
However, the mechanistic understanding of how the phosphorylated CTR of Spt5 facilitates the 
recruitment of Paf1C in vivo is lacking. The Bur1-Bur2 protein kinase has also been shown to 
stimulate the recruitment of Paf1C to Pol II through the phosphorylation of the C-terminal 
repeats (CTRs) of Spt5 and through a pathway independent of this function (LIU et al. 2009; QIU 
et al. 2012; QIU et al. 2006; ZHOU et al. 2009).  In addition, the Kin28 protein kinase was shown 
to promote the recruitment of Paf1C through phosphorylation of the CTD of Pol II and by 
facilitating the chromatin association of Bur1-Bur2 complex (QIU et al. 2012; QIU et al. 2009).   
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With respect to members of Paf1C, loss of the Rtf1, Cdc73 or Leo1 subunits reduces the 
occupancy of Paf1C on chromatin (DERMODY and BURATOWSKI 2010; MUELLER et al. 2004; 
WARNER et al. 2007). In vitro, recombinant Cdc73, Rtf1, and Ctr9 can bind to peptides 
corresponding to the Pol II CTD phosphorylated on serine 2 and 5 and to peptides corresponding 
to the phosphorylated Spt5 CTR (AMRICH et al. 2012; PHATNANI et al. 2004; QIU et al. 2012; 
SHI et al. 1997).  For Cdc73, this peptide binding activity maps to a domain that adopts a Ras-
like fold and is important for Paf1C recruitment in vivo (AMRICH et al. 2012; PHATNANI et al. 
2004; QIU et al. 2012; SHI et al. 1997).  The ability of Leo1 to facilitate chromatin association of 
Paf1C correlates with its ability to bind RNA (DERMODY and BURATOWSKI 2010).  The 
mechanism of chromatin association of Paf1C through the Rtf1 subunit remains obscure.  
Through genetic deletions, we previously identified a highly conserved region within 
Rtf1 that is important for the chromatin association of Paf1C and termed this region the ORF 
association region (OAR) of Rtf1 (WARNER et al. 2007).  The Rtf1 OAR contains a Plus3 motif, 
highlighted by the presence of three conserved, positively charged amino acids (DE JONG et al. 
2008).  An NMR study of the human Rtf1 Plus3 domain demonstrated that this domain is 
structurally similar to Tudor domains, which can recognize the methylation marks on histones  
and participate in protein-protein interactions, and the PAZ domains found in Dicer and 
Argonaute proteins (DE JONG et al. 2008; LINGEL et al. 2004; LU and WANG 2013; PEK et al. 
2012).  In this study, we sought to identify the mechanism of recruitment of Paf1C to active 
chromatin through this highly conserved region of Rtf1.  Using a subtractive proteomics 
approach, we discovered that the OAR of Rtf1 mediates the interaction of Paf1C with Spt5.  
Using purified recombinant proteins, I obtained evidence for a direct interaction between the 
Rtf1 OAR and Spt5, independent of the other members of Paf1C.  I also showed that both the 
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deletion of the Spt5 CTR and mutation of the Bur1-Bur2 complex impaired the recruitment of 
full-length Rtf1 and the OAR alone, suggesting that the OAR is a crucial target for recruitment 
of Paf1C by the Spt5 CTR and Bur1-Bur2 kinase complex. 
2.2 MATERIALS AND METHODS 
2.2.1 Yeast strains and growth  
S. cerevisiae strains used in this study (Table 2) are isogenic to FY2, a GAL2+ derivative of 
S288C (WINSTON et al. 1995).  Yeast transformations and matings were performed as previously 
described (AUSUBEL et al. 1988; ROSE et al. 1991).  Rich (YPD), synthetic complete (SC), and 
minimal (SD) media were made as previously described (ROSE et al. 1991).   6-azauracil (6-AU) 
was added to SC-URA medium at a final concentration of 50 µg/mL.  For serial dilution growth 
assays, yeast strains were grown overnight to saturation in the appropriate media and washed 
twice with sterile water.  Using sterile water, cells were 10-fold serially diluted from a starting 
concentration of 1 x 108 cells/mL.  2.5 µL of each dilution was then spotted onto the indicated 
media and incubated at 30°C for the specified number of days. 
2.2.2 Plasmid construction   
Some of the plasmids used in this study are described in Table 3.  Mutations encoding amino 
acid substitutions in the OAR were constructed by site-directed mutagenesis using the 
QuikChange mutagenesis kit (Agilent) and pLS21-5 (STOLINSKI et al. 1997) as the template.  
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pMM25 encoding GST-OAR was created by subcloning the coding sequence for amino acids 
235-373 of Rtf1, which was PCR-amplified from pLS21-5 with primers that introduce EcoRI 
and BamHI sites at the 5’ and 3’ ends of the PCR product and ligated to EcoRI/BamHI-digested 
pGEX-3X (SMITH and JOHNSON 1988).  pAP21 expresses GST-Rtf1-His6.  pAP21 was generated 
by insertion of the coding sequence for the His6 tag at the 3’ end of the RTF1 ORF in plasmid 
pJS4 to create a version of Rtf1 that has an N-terminal GST tag and a C-terminal His6 tag 
(WARNER et al. 2007).  pMM26, which expresses GST-Rtf1ΔOAR-His6, was constructed by 
deleting the sequence coding for Rtf1 amino acids 230-390 from pAP21 using a QuikChange 
mutagenesis kit (Agilent).  pGH25, pGH100, and pGH258 were gifts from Dr. Grant Hartzog 
and express an MBP-Spt5 CTR fusion protein (Spt5 residues 807-1063), MBP, and Flag-Spt5-
His6 plus Spt4, respectively.  The plasmid expressing His6-OAR (Rtf1 residues 235-373) was a 
gift from Dr. Andrew VanDemark.  
2.2.3 Immunoblot analyses   
Ten ml log phase cultures of yeast cells grown to an OD600 of approximately 0.8 were used to 
make trichloroacetic acid (TCA) extracts. The cell pellets were washed with 20% (w/v) TCA and 
then resuspended in 200 µl of 20% (w/v) TCA. They were lysed after addition of 250 µl acid-
washed glass beads by vigorous vortexing (setting 10) twice for 1 min and then gentle vortexing 
(setting 3) for 15 minutes. The lysate was transferred to a 1.5 ml tube and spun in a microfuge at 
8000 rpm for 10 minutes. The pellet was then gently washed (by inversion) with 0.5 M Tris, pH 
7.4 and then resuspended in 100 µl of 0.5 M Tris, pH 7.4 and 150 µl of 3X SDS PAGE loading 
buffer. The resuspended pellet was boiled for 5 minutes, cooled to room temperature and then 
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spun in a microfuge at 8000 rpm for 10 minutes. The supernatant was boiled for 5 minutes and 
then loaded on SDS-polyacrylamide gels.   
Proteins were resolved on SDS-polyacrylamide gels, transferred to nitrocellulose or 
PVDF membranes and probed with primary antibodies against either Rtf1 (SQUAZZO et al. 
2002), the HA epitope (1:2500 dilution, Roche), total histone H3 (1:30,000 dilution, (PIRO et al. 
2012)), H3 K4 Me3 (1:2000 dilution, Active Motif 39159), H3 K4 Me2 (1:2000 dilution, Upstate 
07-030), H3 K79 Me2/3 (1:2000 dilution, Abcam ab2621), Paf1 (1:1000 dilution, gift from Dr. 
Judith Jaehning), glucose-6-phosphate dehydrogenase (1:30,000 dilution, Sigma A9521), 
tobacco etch virus (TEV) protease-cleaved TAP tag (1:2500; Thermo Scientific CAB 1001) or 
an antibody that detects the uncleaved TAP tag (peroxidase-anti-peroxidase; 1:2000 dilution; 
Sigma P1291).  After incubation with the primary antibodies, membranes were probed with 
sheep anti-mouse or donkey anti-rabbit secondary antibodies (1:5000 dilution, GE Healthcare) 
and visualized using enhanced chemiluminescence substrate (Perkin Elmer). 
2.2.4 Co-immunoprecipitation (Co-IP) assays 
 Yeast transformants, grown in selective medium to a density of 1-2 x 107 cells/mL, were lysed 
by bead-beating in a lysis buffer containing 20 mM HEPES, pH 7.4, 100 mM sodium acetate, 2 
mM magnesium acetate, 10 mM EDTA, 0.1% Tween-20, 10% glycerol, 1 mM DTT and 
protease inhibitors (Halt protease inhibitor cocktail, Thermo Scientific).  500-1000 µg of the 
clarified extract was incubated with anti-Spt5 antisera (1:1000 dilution, gift from Dr. Grant 
Hartzog) for 2 hrs at 4oC, followed by incubation with Protein A-conjugated agarose (GE 
Healthcare) for 1 hr at 4oC.  The agarose beads were then washed with lysis buffer containing 
400 mM sodium acetate and the immunoprecipitated proteins were subjected to immunoblot 
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analysis using anti-Spt5 and anti-HA (1:2500, Roche) antibodies to detect the 
immunoprecipitated Spt5 and HA-Rtf1 proteins, respectively. 
2.2.5 Chromatin immunoprecipitation (ChIP) assays   
The indicated strains were grown to a density of 1-2 x 107 cells/mL.  Cells were cross-linked 
with formaldehyde, quenched with glycine, harvested, and lysed (PIRO et al. 2012).  Soluble 
chromatin was prepared by sonication (PIRO et al. 2012) and then incubated with agarose-
conjugated α-Myc antibody (Santa Cruz Biotechnology; 9E10, sc-40AC), agarose-conjugated α-
HA antibody (Santa Cruz Biotechnology; sc-7392AC), α-Spt5 antibody (gift from Dr. Grant 
Hartzog), α-Spt16 antibody (gift from Dr. Tim Formosa) or α-Rpb3 antibody (Neoclone) 
overnight at 4oC.  This was followed by 2 hours incubation at 4°C with Protein A-conjugated 
agarose (GE Healthcare) for α-Spt5 and α-Spt16 antibodies or Protein G-conjugated agarose (GE 
Healthcare) for α-Rpb3 antibody.  Input and immunoprecipitated DNA were purified and 
analyzed by quantitative real-time PCR using Maxima SYBR Green/ROX qPCR master mix 
(Fermentas) and primers (relative to ATG = +1) to the 5’ coding region of PYK1 (+253 to +346), 
3’ coding region of PYK1 (+1127 to +1270), region beyond the poly(A) site of PYK1 (+1803 to 
+1938), 5’ coding region of PMA1 (+214 to +319), 3’ coding region of PMA1 (+2107 to +2194), 
region beyond the poly(A) site of PMA1 (+3373 to +3475) or a telomeric region of chromosome 
VI (coordinates: 269495 to 269598).  Graphs represent the average values for three biological 
replicates and the error bars indicate the standard error of the mean (SEM) for those values.  
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2.2.6 Purification of TAP-tagged proteins   
Transformants of rtf1Δ strains (KY1258 or KY619) expressing plasmid-encoded Rtf1 
derivatives were grown to log phase (3–4 x 107 cells/mL).  Whole cell extracts were made by 
bead beating in a lysis buffer containing 20 mM HEPES, pH 7.4, 100 mM NaCl and 0.1% NP-
40.  Ten mgs of the clarified extracts were then subjected to one step-affinity purification by 
incubation with rabbit IgG (Sigma I5006) conjugated magnetic beads (Invitrogen, M-270 Epoxy) 
for 1 hr and 15 minutes at 4°C. They were then washed three times with the lysis buffer.  The 
bound proteins were eluted by cleavage with TEV protease (Invitrogen, 12575-015) for 3 hours 
at 15oC in a buffer containing 100 mM Tris, pH 8.0, 150 mM NaCl, 0.1% NP-40, and 0.5 mM 
EDTA, concentrated by TCA precipitation and then run on SDS-polyacrylamide gels.  For the 
identification of proteins that co-purified with the Rtf1 derivatives, samples were run 
approximately 1 cm into the gel, excised, and analyzed by tandem mass spectrometry in an 
Orbitrap mass spectrometer (Fred Hutchinson Cancer Research Centre Proteomics Facility).  The 
identified peptides were validated as described previously (AMRICH et al. 2012).  The average 
number of peptides identified from a minimum of three independent purifications is shown. 
2.2.7 Expression and purification of recombinant proteins   
Expression of FLAG-Spt5-His6 together with Spt4 in E. coli codonplus-RIL cells transformed 
with plasmid pGH258 was induced by growth in LB medium containing 0.1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) and 0.3 mM zinc chloride overnight at 20oC.  Cells were harvested 
and lysed using a homogenizer in a buffer containing 25 mM Tris, pH 8.0, 500 mM NaCl, 10% 
glycerol and 5 mM imidazole.  Spt5 was purified from the clarified lysate by nickel affinity 
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chromatography (Qiagen).  It was then subjected to a second round of purification by heparin 
affinity chromatography in a buffer containing 25 mM Tris, pH 6.5, 100 mM NaCl and 8% 
glycerol.  OAR-His6 expression was induced in E.coli codonplus-RIPL cells in ZY autoinduction 
medium (STUDIER 2005)  for ~24 hrs at 37oC and purified following the same procedure as that 
used for the purification of Spt5.  Expression of GST in E.coli codonplus-RIL cells and GST-
Rtf1-His6 and GST-Rtf1ΔOAR-His6 in E.coli codonplus-RIPL cells was induced in LB medium 
containing 0.1 mM IPTG at 37oC for 3 hrs.  As described for the purification of Spt5, GST-Rtf1-
His6 and GST- Rtf1ΔOAR-His6 were purified by nickel affinity chromatography in a buffer 
containing 25 mM Tris, pH 8.0, 250 mM NaCl, 10% glycerol and 5 mM imidazole and then 
subjected to a second round of purification with glutathione sepharose resin (GE Healthcare) in a 
buffer containing 25 mM Tris, pH 7.4, 150 mM NaCl and 10% glycerol.  Expression of GST and 
GST-OAR was induced using the procedure described for GST-Rtf1-His6 and GST-Rtf1ΔOAR-
His6, and the proteins were purified from the clarified extract by affinity purification with 
glutathione sepharose resin (GE Healthcare) in a buffer containing 20 mM HEPES, pH 7.5, 150 
mM NaCl, 10 mM MgCl2, 10% glycerol and 5 mM EDTA.  The GST-bound proteins were used 
in the binding assay.  MBP-tagged proteins were expressed in E.coli codonplus-RIPL cells by 
growth in LB medium containing 0.1 mM IPTG and 0.3 mM zinc chloride for 4 hrs at 37oC.  The 
pellets were lysed in a homogenizer in a buffer containing 25 mM Tris-Cl, pH 7.4, 250 mM 
NaCl and 10% glycerol, and the proteins were isolated by affinity purification of the clarified 
lysate with amylose resin (New England Biolabs). 
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2.2.8 In vitro protein interaction assays with purified proteins   
Four micrograms of purified recombinant FLAG-Spt5-His6/Spt4 was added to glutathione 
sepharose-bound, GST-tagged proteins in a binding buffer containing 25 mM Tris, pH 7.4, 150 
mM NaCl, 10% glycerol, 5mM EDTA, 2% NP-40 and 1 mM DTT and the mixtures were 
incubated for 1 hr at 4oC with gentle agitation.  The glutathione sepharose beads were washed six 
times in binding buffer containing 500 mM NaCl and the bound proteins were eluted from the 
beads by boiling for 5 min in 4X SDS sample buffer.  Samples were then loaded onto 12% SDS-
polyacrylamide gels.  Spt5 and the GST-tagged proteins were detected by immunoblot analysis 
with antibodies against Spt5 and GST (1:1000, Molecular Probes A5800).  For the binding assay 
with MBP-tagged proteins, 4 µg of purified recombinant OAR-His6 was incubated with 4 µg of 
MBP or MBP-CTR and magnetic nickel beads (Qiagen) for 1 hr at 4oC in a binding buffer 
containing 25 mM Tris, pH 7.4, 150 mM NaCl, 10% glycerol and 20 mM imidazole.  After 
incubation, the beads were washed three times with buffer containing 25 mM Tris, pH 7.4, 250 
mM NaCl, 10% glycerol and 25 mM imidazole.  Bound proteins were eluted from the beads with 
a buffer containing 500 mM imidazole and run on a 15% SDS-polyacrylamide gel.  MBP-tagged 
proteins and OAR-His6 were detected by immunoblotting with anti-MBP (1:10,000 dilution; 
New England Biolabs E8030S) and anti-His6 (1:500 dilution; GE Healthcare, 24-4710-01) 
antibodies. 
2.2.9 Gel filtration chromatography   
Transformants of an rtf1Δ strain (KY2529) expressing plasmid-encoded full-length Rtf1 or Rtf1 
lacking the OAR were grown to log phase (3–4 x 107 cells/mL).  Whole cell extracts were made 
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using the homogenizer in the gel filtration buffer (30 mM HEPES-KOH pH 7.4, 200 mM 
potassium acetate, 1 mM magnesium acetate, 1 mM EGTA, 0.05% Tween-20, 10% glycerol).  
The extract was then subjected to sonication with a Misonix 3000 sonicator (Farmingdale, NY) 
three times for 20 seconds at power 2 and twice for 20 seconds at power 4 with icing for at least 
1 minute in between each sonication. The extracts were clarified by ultracentrifugation at 
1,00,000 g, quantified using Bradford assay and ~16 mg of the clarified extract was run through 
a Sephacryl S-500 column previously equilibrated with the gel filtration buffer. Three ml 
fractions were collected, concentrated by TCA precipitation and then run on 8% and 10% SDS-
polyacrylamide gels. Rtf1 and Paf1 proteins were detected by immunoblotting with anti-Rtf1 
(SQUAZZO et al. 2002) and anti-Paf1 antiserum (gift from Dr. Judith Jaehning) and Ctr9-Myc6, 
Cdc73-TAP and Leo1-HA3 were detected using anti-Myc (1:1000; Santa Cruz Biotechnology; 
9E10), antibody against the uncleaved TAP tag (peroxidase anti-peroxidase), and anti-HA 
(1:2500, Roche) antibodies.  
2.2.10 GST pull-down assays using yeast extracts   
GST pull-down assays were performed to test the interaction between recombinant GST-OAR 
protein and Spt5 derivatives, provided in the form of yeast extracts.  Log phase cultures (2 liters 
at OD600= 0.6-1.0) of E.coli codonplus-RIL cells containing plasmid encoding GST (pGEX-3X) 
and E.coli codonplus-RIPL cells containing plasmid encoding GST-OAR (pMM25) were 
induced with 0.1 mM IPTG for 2 hr 45 min, lysed in phosphate-buffered saline (PBS) buffer 
containing 1 mM EDTA and protease inhibitors using a homogenizer.  Clarified lysates were 
incubated with 1 ml of BSA-blocked, 50% glutathione sepharose resin (GE Healthcare) for 1 
hour at 4°C to purify GST and GST-OAR.  The purified glutathione-bound proteins were 
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incubated with 2 mg of clarified yeast extracts, prepared by homogenization, of strains KA181, 
KA183, and KA185 for 1.5 hr in binding buffer (150 mM NaCl, 20 mM HEPES, pH 7.4, 10 mM 
MgCl2, 5 mM EDTA, 10% glycerol and protease inhibitors).  The glutathione beads containing 
the GST-tagged proteins and their interactors bound to them were then washed with binding 
buffer to remove the non-specifically bound proteins. SDS loading buffer was then added to the 
washed beads.  Samples were boiled for 5 min at 100°C and resolved on 8% and 15% SDS-
polyacrylamide gels to analyze the presence of Spt5 and GST-tagged proteins by 
immunoblotting, respectively.  
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Table 2. Saccharomyces cerevisiae strains used for the study in this Chapter 
Strain Genotype 
KY619 MATa  rtf1Δ102::ARG4 arg4-12 his4-912∂ leu2Δ1 lys2-173R2 trp1Δ63 
KY995 MATα  rtf1Δ::URA3 CTR9-6XMYC::LEU2 his3Δ200 leu2 Δ(0 or 1) ura3(Δ0 or 
52) trp1 Δ63 
KY1220 MATα  HA3-PAF1 his3Δ200 leu2Δ1 ura3Δ0   
KY1258 MATa  rtf1Δ::URA3 RAD6-13xMYC::KanMX leu2Δ1 ura3-52 trp1Δ63 
KY1758 MATα  rtf1∆101::LEU2 his4-912∂ lys2-128∂ leu2∆1 trp1∆63 arg4-12   
KY1813 MATα  paf1Δ::KanMX rtf1Δ::LEU2 his4-912∂ leu2∆1 trp1∆63 ura3-52 
KY2124 MATa  rtf1∆::KanMX4 hta1-htb1∆::LEU2 hta2-htb2∆::KanMX his3∆200 lys2-
128∂ leu2∆1 ura3-52 trp1∆63 pJH23 WT=[HTA1-HTB1/HIS3/CEN/ARS/AmpR] 
KY2125 MATa  rtf1∆::KanMX4 hta1-htb1∆::LEU2 hta2-htb2∆::KanMX his3∆200 lys2-
128∂ leu2∆1 ura3-52 trp1∆63 pJH23 FL=[HTA1-FLAG-
HTB1/HIS3/CEN/ARS/AmpR] 
KY2195 MATα  rtf1∆101::LEU2 cdc73∆::KanMX4 his4-912∂ leu2∆1 trp1∆63 
KY2410 MATa  rtf1∆101::LEU2 HA3-PAF1 his3Δ200 leu2Δ1 ura3(Δ0 or 52)   
KY2413 MATa  his3Δ200 leu2∆1 ura3(Δ0 or 52) trp1∆63  
KY2414 MATa  rtf1∆101::LEU2 HA3-PAF1 leu2Δ1 ura3(Δ0 or 52) trp1∆63  
KY2529 MATa rtf1Δ::KanMX LEO1-3XHA::HIS3 CTR9-6XMYC::LEU2 CDC73-
TAP::TRP1 SPT5-FLAG  his3Δ200 leu2Δ (0/1) ura3 Δ0 trp1Δ63 
KA150* MATα  rtf1∆101::LEU2 spt5∆5::NATR his3Δ200 lys2-128∂ leu2Δ1 ura3Δ0 
trp1∆63 arg4-12 
KA181 MATα  spt5 Δ::HIS3 rtf1Δ::KanMX his3 Δ(1/200) leu2 Δ(0/1) trp1Δ63 pHQ1494  
[LEU2 SPT5-3XHA] 
KA183 MATα  spt5 Δ::HIS3 rtf1Δ::KanMX his3 Δ(1/200) leu2 Δ(0/1) ura3 Δ0 trp1Δ63 
met15Δ0 pHQ1494 [LEU2 spt5-S1-15A-3XHA] 
KA185 MATa  spt5 Δ::HIS3 rtf1Δ::KanMX his3 Δ(1/200) leu2 Δ(0/1) pHQ1494 [LEU2 
spt5-S1-15D-3XHA] 
AY777¥ MATα  bur2-1 rtf1∆:: KanMX4 his4-912∂ lys2-128∂ suc2∆uas(-1900/-390) ura3-
52 trp1∆63  
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*Provided by Dr. Grant Hartzog 
¥ Provided by Dr. Gregory Prelich 
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Table 3. Plasmids used for the study in this Chapter 
Plasmid Construction Origin  Promoter Protein 
pMM01 pLS20 derivative (SQUAZZO et 
al. 2002), created using site-
directed mutagenesis 
CEN/ARS RTF1 
promoter 
HA3-Rtf1ΔOAR 
(lacks residues 230-
390 of Rtf1) 
pMM03 pPC59 derivative (SQUAZZO et 
al. 2002), created using site-
directed mutagenesis 
CEN/ARS RTF1 
promoter 
Rtf1ΔOAR-TAP 
(lacks residues 230-
390 of Rtf1) 
pMM35 pAP37 derivative (PIRO et al. 
2012); PCR-amplified fragment 
encoding the OAR and 
containing NdeI and PstI 
restriction sites was subcloned 
into NdeI and PstI digested 
pAP37 
2 micron ADH1 
promoter 
NLS-Myc-OAR 
(residues 230-390 of 
Rtf1) 
pMM36 pMM35 derivative, the Myc tag 
was removed and an EcoRI site 
was introduced by site-drected 
mutagenesis to create a vector 
for introducing a PCR-
amplified HA3 tag sequence 
from pLS21-5 having EcoRI 
and NcoI overhangs 
2 micron ADH1 
promoter 
NLS-HA3-OAR 
(residues 230-390 of 
Rtf1) 
pMM41 pLS20 derivative; a PCR-
amplified NLS-HA3-OAR 
encoding fragment with NdeI 
and AflII overhangs was 
subcloned into pLS21-5 
digested with NdeI and AflII to 
replace the RTF1 gene in 
pLS21-5 
CEN/ARS RTF1 
promoter 
NLS-HA3-OAR 
(residues 230-390 of 
Rtf1) 
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pMM43 pMM40 derivative (PIRO et al. 
2012); NdeI fragment of 
pLS21-5 encoding the HA3 tag 
was subcloned into NdeI-
digested pMM40 
CEN/ARS ADH1 
promoter 
HA3-Rtf1 
pMM44 pMM41 derivative; the RTF1 
promoter was replaced with the 
ADH1 promoter, which was 
PCR-amplified from pGBKT7 
(Clontech) using primers that 
introduce SalI and NdeI sites at 
the 5’ and 3’ ends of the PCR 
product 
CEN/ARS ADH1 
promoter 
NLS-HA3-OAR 
(residues 230-390 of 
Rtf1) 
pMM47 pMM01 derivative; NdeI 
restriction fragment encoding 
the HA3 tag was deleted 
CEN/ARS RTF1 
promoter 
Rtf1ΔOAR (lacks 
residues 230-390 of 
Rtf1) 
pMM61 pRS316 derivative; XhoI-SacI 
fragment from pLS20 including 
the RTF1 promoter and the 
RTF1 (untagged) coding region 
was ligated to XhoI-SacI 
digested pRS316 
CEN/ARS RTF1 
promoter 
Rtf1 
pMM62 pRS316 derivative; XhoI-SacI 
fragment from pMM47 
including the RTF1 promoter 
and the rtf1∆OAR coding region 
was ligated to XhoI-SacI 
digested pRS316 
CEN/ARS RTF1 
promoter 
Rtf1ΔOAR (lacks 
residues 230-390 of 
Rtf1) 
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2.3 RESULTS 
2.3.1 The OAR of Rtf1 is important for the chromatin association and 
transcriptional functions of Paf1C 
Full association of Paf1C with active ORFs requires the Cdc73, Leo1 and Rtf1 subunits of the 
complex.  In this study, we sought to explore the mechanism by which Rtf1 facilitates the 
recruitment of Paf1C to chromatin.  In a previous functional analysis of internal deletion 
derivatives of Rtf1, we identified a region within Rtf1, termed the ORF association region 
(OAR), which is critical for the chromatin association of Paf1C (WARNER et al. 2007).  
Together, the consecutive deletions that defined the OAR in this earlier study removed residues 
201-395 of Rtf1.  To better map the boundaries of the OAR, we examined the predicted 
secondary structure of this region as well as the degree of amino acid conservation (Figure 7A).  
Based on this analysis, I constructed a single complete OAR deletion mutation that removes 
residues 230-390 of Rtf1.  Confirming that removal of these residues did not affect the stability 
of the protein, levels of the new deletion derivative, Rtf1∆OAR, and full-length Rtf1 were 
similar, as determined by immunoblotting for the triple HA tag present on these proteins (Figure 
7B).  
Using this new deletion derivative, I assessed the impact of the OAR on chromatin 
association of Rtf1 at the 5’ and 3’ regions of two actively transcribed genes, PYK1 and PMA1, 
by performing chromatin immunoprecipitation (ChIP) assays.  I observed that deletion of the 
OAR severely reduced the ability of Rtf1 to associate with these ORFs (Figure 7C and 7D), 
indicating that residues 230-390 comprise the functional OAR of Rtf1.  To test if the absence of 
the OAR, like a complete deletion of RTF1 (MUELLER et al. 2004), diminished the association of 
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Paf1C with chromatin, I  performed ChIP analysis of the Paf1 subunit, using strains that express 
HA3-tagged Paf1 and untagged full-length Rtf1, untagged Rtf1∆OAR, or no form of Rtf1 (Figure 
7E).  The absence of the OAR reduced the association of Paf1 with active ORFs to levels similar 
to those caused by complete deletion of RTF1.  Therefore, consistent with our previous results 
(WARNER et al. 2007), the OAR of Rtf1 is important for tethering not only the Rtf1 subunit but 
also other Paf1C subunits to actively transcribed chromatin.  
Given the importance of the OAR for chromatin association of Paf1C, I  next tested if a 
full deletion of the OAR caused mutant phenotypes indicative of transcriptional defects such as 
the suppressor of Ty phenotype (Spt- phenotype) and 6-AU sensitivity (COSTA and ARNDT 
2000).  To assess the Spt- phenotype, I introduced plasmids expressing full-length Rtf1, 
Rtf1∆OAR or no form of Rtf1 into an rtf1∆ his4-912δ strain.  Suppression of the transcriptional 
effects of the Ty δ-element insertion mutation within the HIS4 promoter of the his4-912δ allele is 
indicated by growth on medium lacking histidine (WINSTON 1992).  Whereas the pattern of 
transcription initiation at his4-912δ in RTF1 cells leads to an extended, nonfunctional HIS4 
transcript and a His- phenotype, deletion of RTF1 restores transcription initiation at the normal 
start site of the HIS4 gene and growth on medium lacking histidine (STOLINSKI et al. 1997) 
(Figure 7F).  Similar to the effect of deleting RTF1 entirely, absence of the OAR caused a strong 
Spt- phenotype (Figure 7F).  Sensitivity to the uracil analogue 6-AU, which depletes certain 
nucleotide pools, is frequently used as an indicator of a defect in transcription elongation 
(EXINGER and LACROUTE 1992).  At the 6-AU concentrations used in my assay, wild-type cells 
grew normally, but cells lacking Rtf1 or just the OAR of Rtf1 grew poorly (Figure 7F).  Thus, 
removal of the OAR of Rtf1 caused strong transcription-related phenotypes that are similar to 
those caused by a complete loss of the protein (COSTA and ARNDT 2000). 
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An important function of Rtf1 is in facilitating the modification of histones during 
transcription elongation.  To test the importance of the OAR in promoting H2B K123 mono-
ubiquitination and downstream histone methylation events, I performed immunoblotting analyses 
on extracts prepared from RTF1, rtf1∆OAR, and rtf1∆ strains.  Absence of the OAR caused a 
dramatic reduction in the global levels of H3 K4 Me3 and H3 K79 Me2/3 and also led to 
diminished levels of H3 K4 Me2 (Figure 7B).  (Note that the antibody used for the analysis of 
H3 K79 methylation detects both the di-methyl and tri-methyl modification states).  Consistent 
with the reduction in H3 K4 and K79 methylation, absence of the OAR also led to greatly 
reduced levels of H2B K123 ubiquitination as revealed by immunoblotting analysis of RTF1 and 
rtf1∆OAR strains that express FLAG-tagged H2B as the only source of H2B (Figure 7G).  These 
results indicate that the OAR-mediated chromatin association of Paf1C is important for full 
levels of transcription-coupled histone modifications in agreement with our previous 
observations (WARNER et al. 2007).  
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Figure 7. OAR is a highly conserved and a functionally important region of Rtf1 
(A) Multiple sequence alignment of Rtf1 homologues developed using Clustal X 2.0 (Larkin et al. 2007) and 
secondary structure prediction developed using jNET (Cole et al. 2008).  The coloration indicates the percentage of 
identity among the residues of Rtf1 homologues.  Darker shades of grey represent a higher percentage of identity.  
Tubes and arrows denote α helices and β sheets, respectively.  “§” indicates the Plus3 residues (S. cerevisiae R251, 
R273 and K299). (B) Immunoblotting analyses were performed using indicated antibodies on transformants of an 
rtf1Δ (KY619) strain containing plasmids expressing HA3-Rtf1 (pLS21-5), HA3-Rtf1ΔOAR (pMM01) and Rtf1 
(pLS20).  An rtf1Δ strain (KY619) transformed with empty vector (pRS314) was used as the negative control.  
G6PDH and total H3 levels serve as loading controls.  (C and D) ChIP analysis was performed on strains used in (B) 
with anti-HA beads to determine the localization of HA3-tagged Rtf1 proteins at PYK1 (C) and PMA1 (D).  (E) ChIP 
analysis was performed on the strains KY2413, KY1220, KY2410 strains and the KY2414 strain transformed with 
pMM47 using anti-HA beads to determine the occupancy of HA3-Paf1 over the indicated regions.  For C-E, average 
values of three biological replicates are shown with the error bars representing the SEM.  (F) Tenfold serial 
dilutions, ranging from 108 cells/ml to 104 cells/ml, of an rtf1Δ strain (KY619) transformed with an empty vector 
(pRS314) and the strains used for ChIP analysis in (B) were spotted on SD-His-Trp, SC-Ura-Trp media containing 
50 µg/mL 6-AU, and appropriate control media and incubated for 4 days at 30°C. (G) Immunoblotting analysis was 
performed using the indicated antibodies on transformants of an rtf1Δ strain expressing FLAG-tagged H2B 
(KY2125) and either Rtf1 (pLS21-5) or Rtf1ΔOAR (pMM01) from plasmids.  An rtf1Δ strain expressing untagged 
H2B (KY2124) and Rtf1 from plasmid pLS21-5 served as a negative control for the FLAG antibody.  An rtf1Δ 
strain expressing FLAG-tagged H2B (KY2125) and containing the empty vector pRS314 served as a negative 
control for H2B K123 ubiquitination.  G6PDH served as the loading control. 
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2.3.2 The OAR of Rtf1 does not affect the integrity of the Paf1 complex 
We considered the possibility that the reduced functionality of the Rtf1 derivative lacking the 
OAR may be to the lack of integrity of Paf1C in the absence of the OAR. To test this possibility, 
I performed gel filtration chromatography analysis on yeast extracts prepared from wild-type 
strains and strains lacking the OAR of Rtf1 and analyzed several fractions by immunoblotting to 
determine the presence of all the members of Paf1C. Immunoblotting analysis of these strains 
expressing tagged versions of Ctr9, Cdc73 and Leo1 subunits showed that all the members of the 
Paf1C co-elute in similar fractions in both strains (mainly fractions 8-20) (Figure 8A and B) and 
hence suggests that the transcriptional defects exhibited by the OAR deletion may not be due to a 
general loss of Paf1C integrity in this mutant. 
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Figure 8. Members of the Paf1 complex co-elute in similar fractions in strains expressing Rtf1 and 
Rtf1ΔOAR 
 (A and B) Extracts of an rtf1Δ strain (KY2529) containing plasmid expressing Rtf1 (pMM61) (A) or Rtf1ΔOAR 
(pMM62) (B) were fractionated on a an S500 column and the indicated fractions of the eluate were subjected to 
immunoblotting using antibodies against Rtf1, Myc-tag, Paf1, TAP-tag and HA-tag to detect Rtf1, Ctr9, Paf1, 
Cdc73 and Leo1 proteins respectively.  
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2.3.3 The OAR is required for the interaction of Rtf1 with Spt5 
We hypothesized that interactions of Paf1C mediated by the OAR could be involved in tethering 
Paf1C to chromatin.  To uncover these interactions, I performed one-step affinity purification of 
TAP-tagged full-length Rtf1 and a TAP-tagged Rtf1∆OAR derivative, lacking amino acids 230-
390, from yeast extracts (see section 2.2.6). This one-step affinity purification approach allowed 
me to isolate the Rtf1 proteins under native conditions, thereby preserving potentially weak or 
transient interactions.  In parallel, untagged Rtf1 was subjected to the same purification scheme 
to identify non-specific associations.  Of the proteins identified by mass spectrometry analysis of 
our purified samples, the essential transcription elongation factor Spt5 was unique in its ability to 
interact with full-length Rtf1 but not with Rtf1 lacking the OAR (Figure 9A). Immunoblotting 
analysis indicated that the loss of this interaction was not due to reduced expression or general 
instability of the Rtf1ΔOAR-TAP protein relative to the full-length Rtf1-TAP protein or to 
reduced Spt5 levels in cells lacking the OAR (Figure 9B; Figure 9E, lanes 1 and 2).  
Furthermore, the mass spectrometry results showed that the Rtf1∆OAR protein retained its 
interactions with the four other Paf1C subunits, Paf1, Ctr9, Cdc73 and Leo1 (Figure 9A) 
consistent with my assessment of Paf1C composition by gel filtration chromatography (see 
section 2.2.9) that revealed similar co-elution profiles for all five Paf1C subunits in fractions 
obtained from RTF1 and rtf1∆OAR extracts.  Together, these observations suggest that the OAR 
does not play a major role in governing overall Paf1C integrity. 
To validate the mass spectrometry results, I performed immunoblotting analysis of the 
affinity-purified Rtf1 derivatives.  This analysis showed that both full-length Rtf1 and Rtf1 
lacking the OAR interacted with Paf1 (Figure 9C) in accordance with the mass spectrometry and 
gel filtration data and our identification of a Paf1-interacting region at the C-terminus of Rtf1, 
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which is retained in the Rtf1∆OAR protein (WARNER et al. 2007).  Interestingly, our mass 
spectrometry data showed that the Rtf1ΔOAR-TAP protein, like full-length Rtf1-TAP, interacted 
with Spt16, a result confirmed by immunoblotting with antibodies against Spt16 (Figure 9C).  
Since deletion of the OAR greatly impaired the interaction between Rtf1 and chromatin, we 
asked if chromatin occupancy of Spt16 was reduced in the rtf1∆OAR strain.  Surprisingly, my 
ChIP analysis revealed that the Spt16 levels over actively transcribed regions were not greatly 
altered in cells lacking the OAR (Figure 9D).  These results suggest that Paf1C interacts with 
some factors involved in transcription even when it is not tightly associated with chromatin.  
They also indicate that the chromatin occupancy of Spt16 is not strongly dependent on the 
chromatin occupancy of Paf1C and that the interaction between Spt16 and Rtf1∆OAR is 
insufficient to recruit the latter to chromatin. 
To uncover the mechanism of recruitment of Paf1C to chromatin through the Rtf1 OAR, 
I focused on the interaction between Rtf1 and Spt5.  Both mass spectrometry analysis and 
immunoblotting analysis of the affinity-purified proteins demonstrated that deletion of the OAR 
disrupted the interaction between Rtf1 and Spt5 (Figure 9A and 9C).  Reciprocally, 
immunoprecipitation of Spt5 resulted in the co-immunoprecipitation of full-length Rtf1 but not 
Rtf1 lacking the OAR (Figure 9E, lanes 5 and 6).  Based on reports demonstrating that the CTR 
of Spt5 is important for the chromatin association of Paf1C (LIU et al. 2009; ZHOU et al. 2009) 
and that recombinant Paf1C subunits can bind to CTR peptides in vitro (QIU et al. 2012), we 
hypothesized that the CTR of Spt5 could mediate the interaction of Spt5 with Rtf1.  Using an 
antibody against an internal region of Spt5, I immunoprecipitated Spt5 or a Spt5 mutant protein 
lacking the CTR from yeast extracts and asked if HA-tagged full-length Rtf1 could co-
immunoprecipitate with either Spt5 protein.  Interestingly, full-length Rtf1 co-
 74 
immunoprecipitated with full-length Spt5 but not with Spt5 lacking the CTR (Figure 9E, lanes 5 
and 7).  To determine if removal of the Spt5 CTR affected the co-transcriptional histone 
modification functions of Rtf1, I performed immunoblotting analysis of the spt5∆CTR strain 
used in our studies.  In agreement with previous results (LIU et al. 2009; ZHOU et al. 2009), the 
absence of the Spt5 CTR caused a reduction in H3 K4 Me3 and H3 K79 Me2/3 levels (Figure 
9F).  Together, these results demonstrate that the interaction of Rtf1 with Spt5 requires the OAR 
of Rtf1 and the CTR of Spt5, and this interaction is important for the function of Rtf1.  
Our protein interaction studies revealed a requirement for the Rtf1 OAR in mediating an 
interaction between Paf1C and Spt5.  We were, therefore, interested in determining if the OAR 
was important for the chromatin association of Spt5.  Analysis of Spt5 occupancy at the 
constitutively active genes PYK1 and PMA1 by ChIP in strains expressing full-length Rtf1 or 
Rtf1∆OAR showed that the levels of Spt5 associated with these genes were not greatly impacted 
by the lack of the OAR (Figure 9G).  This finding indicates that Spt5 acts upstream of Rtf1 in 
promoting Paf1C recruitment.  
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Figure 9. The OAR is important for the interaction of Rtf1 with Spt5 
 (A) Extracts of an rtf1Δ strain (KY1258) bearing plasmids expressing Rtf1 (pLS20), Rtf1-TAP (pPC59) and 
Rtf1ΔOAR-TAP (pMM03) were subjected to one-step affinity purification using IgG-conjugated magnetic beads, 
and mass spectrometry analysis was performed on the isolated proteins.  The average number of peptides identified 
for each protein (minimum of three trials) is listed.  A subset of the results is shown.  (B) Immunoblotting analysis 
was performed to determine the levels of Rtf1 in transformants of an rtf1Δ strain (KY619) expressing Rtf1-TAP 
(pPC59) or Rtf1ΔOAR-TAP (pMM03) by loading 9 µl, 7 µl and 5 µl of each of the indicated extracts.  G6PDH 
served as the loading control.  (C) Immunoblotting analysis of the affinity-purified Rtf1 proteins from extracts of 
transformants of an rtf1Δ strain (KY619) containing the plasmids described in (A). (D) ChIP analysis was 
performed using anti-Spt16 antibody to determine the occupancy of Spt16 over 5’ and 3’ regions of PYK1 and 
PMA1 and a telomeric region of chromosome VI.  Chromatin from transformants of an rtf1Δ strain (KY619) 
expressing HA3-Rtf1 (pLS21-5) or HA3-Rtf1ΔOAR (pMM01) was used.  As a negative control, ChIP analysis was 
performed with chromatin from HA3-Rtf1 (pLS21-5) expressing transformants without the addition of antibody (no 
ab).  (E) Spt5 was immunoprecipitated from extracts of transformants of an rtf1Δ strain (KY619) transformed with a 
plasmid expressing HA3-Rtf1 (pLS21-5) or HA3-Rtf1ΔOAR (pMM01) and a transformant of an rtf1∆ spt5∆CTR 
strain (KA150) expressing HA3-Rtf1 (pLS21-5).  Extracts of transformants expressing HA3-Rtf1 (pLS21-5) 
subjected to similar analysis without the addition of anti-Spt5 antibody served as the negative control (no ab).  
Immunoblotting with anti-HA and anti-Spt5 antibodies was performed to detect Rtf1 and Spt5, respectively.  The 
results are representative of those from three separate experiments.  (F) Immunoblotting analyses were performed 
using indicated antibodies on transformants of an rtf1Δ (KY619) strain containing plasmids expressing HA3-Rtf1 
(pLS21-5) or HA3-Rtf1ΔOAR (pMM01) and transformants of an rtf1∆ spt5ΔCTR (KA150) strain containing 
plasmid expressing Rtf1 (pLS21-5).  An rtf1Δ strain (KY619) transformed with empty vector (pRS314) was used as 
the negative control.  G6PDH and total H3 levels serve as loading controls. (G) ChIP analysis of the occupancy of 
Spt5 over 5’ and 3’ regions of PYK1 and PMA1 and over a telomeric region of chromosome VI was performed with 
chromatin prepared from strains described in (D). 
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2.3.4 The OAR of Rtf1 interacts directly with the CTR of Spt5 
Our data are consistent with the possibility that a direct physical interaction between the Spt4-
Spt5 complex and the Rtf1 OAR mediates the coupling of Paf1C to Pol II.  To determine 
whether the interaction between Rtf1 and Spt4-Spt5 is direct or indirect, I performed in vitro 
binding assays with bacterially expressed Spt4-Spt5 complex and Rtf1 derivatives.  Like in yeast 
cells (WARNER et al. 2007), I have found bacterially expressed Rtf1 to be susceptible to 
proteolytic breakdown.  To maximize recovery of recombinant, intact wild-type Rtf1 and 
Rtf1∆OAR, we designed expression constructs that encode doubly tagged forms of these 
proteins.  The N-terminal GST tag and C-terminal His6 tag were exploited in a two-step affinity 
purification strategy (see section 2.2.8) to enrich for the intact Rtf1 proteins.  Subsequently, the 
GST tagged-Rtf1 proteins were bound to glutathione sepharose and mixed with purified 
recombinant Spt4-Spt5 to test for binding.  We found that full-length Rtf1 interacted with Spt4-
Spt5 in vitro (Figure 10A, lane 2) and removal of the OAR from Rtf1 diminished this interaction 
(Figure 10A, lane 3).  Together, my in vitro and in vivo experiments indicate that the OAR is 
important for the direct interaction of Rtf1 with Spt4-Spt5.  To determine if the OAR is sufficient 
for the interaction with Spt4-Spt5, I performed an in vitro binding assay using a purified 
recombinant GST-OAR protein (amino acids 235 to 373 of Rtf1) and recombinant Spt4-Spt5.  
Interestingly, the OAR alone strongly interacted with Spt4-Spt5 (Figure 10A, lane 4).  These 
results show that the Rtf1 OAR is both necessary and sufficient for a direct interaction between 
Rtf1 and Spt4-Spt5.  
My co-immunoprecipitation experiments revealed a requirement for the CTR of Spt5 in 
the in vivo association of Spt5 with Rtf1 (Figure 9E, lane 7).  We therefore hypothesized that the 
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CTR of Spt5 could be facilitating the recruitment of Paf1C by directly interacting with the OAR 
of Rtf1.  To test this idea, I performed an in vitro binding assay to examine the binding of the 
isolated OAR to the Spt5 CTR.  I purified His6-tagged OAR and MBP-tagged Spt5 CTR proteins 
from bacterial expression strains, mixed the purified proteins, and used affinity chromatography 
to pull down the His6-OAR protein.  I then performed immunoblotting analysis to determine if 
the MBP-CTR protein or MBP alone was retained on the beads after multiple washes.  This 
analysis revealed that, relative to MBP alone, significantly higher amounts of MBP-CTR were 
bound to His6-OAR (Figure 10B, lanes 1 and 3), providing support for a direct interaction 
between the OAR of Rtf1 and the CTR of Spt5.   
To address the importance of CTR phosphorylation in regulating the physical interaction 
between Spt5 and the OAR, I performed a GST pull-down assay using GST-OAR and extracts 
prepared from yeast cells that express wild-type Spt5 or mutant derivatives of Spt5 in which the 
phosphorylated serine residues are substituted to alanine residues, as a non-phosphorylatable 
version (Spt5-S1-15A), or to aspartic acids, as a phosphomimetic version (Spt5-S1-15D) (QIU et 
al. 2012).  In accordance with the results I obtained with recombinant proteins, the GST-OAR 
protein, but not GST alone, interacted with wild-type Spt5 provided in the yeast extract (Figure 
10C. lanes 1 and 2).  A similar level of association was observed between the GST-OAR protein 
and the Spt5-S1-15D phosphomimetic derivative (Figure 10C, lane 4).  In contrast, the 
interaction between the GST-OAR protein and Spt5 was diminished by substitution of the Bur1-
phosphorylated serine residues (LIU et al. 2009) with alanine residues (Figure 10C, lane 3).  
These results are consistent with the conclusion that phosphorylation of the Spt5 CTR stimulates 
its interaction with the Rtf1 OAR. 
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Figure 10. The OAR of Rtf1 interacts directly with the CTR of Spt5 
(A) Recombinant GST (pGEX-3X), GST-Rtf1-His6 (pAP21), GST-Rtf1ΔOAR-His6 (pMM26) and GST-OAR 
(pMM25) proteins, bound to glutathione sepharose beads, were incubated with the same amount of purified 
recombinant Flag-Spt5-His6/Spt4 (pGH258).  Beads were washed and bound samples were analyzed by 
immunoblotting for Spt5 (upper panel) or GST (lower panel).  The latter serves as a control for the amount of GST-
tagged derivatives used in the assay.  The results are representative of three experiments.  (B) In vitro binding assay 
of the OAR of Rtf1 with the CTR of Spt5 was performed by incubating equal amounts of recombinant purified His6-
OAR with MBP alone or MBP-CTR.  The OAR was pulled down using magnetic nickel beads.  The amount of 
MBP or MBP-CTR and OAR was determined by immunoblotting with anti-MBP (upper panel) and anti-His6 (lower 
panel).  Results are representative of three experiments. (C) Extracts of rtf1Δ strains expressing wild-type Spt5 
(KA181), Spt5 with a non-phosphorylatable CTR (KA183) or Spt5 with a phosphomimetic version of the CTR 
(KA185) were used for GST pull-down assays with bacterially purified GST-OAR (pMM25) bound to glutathione 
beads.  A reaction using GST bound to glutathione beads and extracts of an rtf1Δ strain expressing wild-type Spt5 
(KA181) served as a negative control.  Results are representative of two experiments. 
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2.3.5 The OAR is sufficient for chromatin association and mimics the chromatin 
association pattern of Rtf1 
Since deletion of the Rtf1 OAR reduced the occupancy of Paf1C on chromatin, we hypothesized 
that the OAR alone might be able to associate with active chromatin.  To test this hypothesis, I 
constructed a plasmid that expresses the OAR (amino acids 230 to 390) as a fusion protein with a 
nuclear localization sequence (NLS) and a triple HA tag and transformed this plasmid into an 
rtf1∆ strain.  ChIP was performed to analyze the chromatin association levels of NLS-HA3-OAR 
and full-length HA3-Rtf1 at PMA1 and PYK1.  Interestingly, even in the absence of the 
remainder of the Rtf1 protein, the OAR associated with the PYK1 and PMA1 genes and not with 
an untranscribed telomeric region (Figure 11A).  The levels of association were however lower 
than those for full-length Rtf1, which is likely due to decreased cellular levels of the NLS-HA3-
OAR protein compared to full-length HA3-Rtf1 (Figure 11B).  Since the OAR lacks the C-
terminal region of Rtf1 required for the interaction with other members of Paf1C, its association 
with chromatin would not be expected to be facilitated by other members of the complex 
(WARNER et al. 2007).  To test this idea, I assessed the chromatin occupancy of Rtf1 and the 
OAR in the absence of Cdc73 or Paf1.  Consistent with previous observations that Cdc73 is 
important for Paf1C recruitment (AMRICH et al. 2012; MUELLER et al. 2004; QIU et al. 2012) and 
that Paf1 is important for Rtf1 stability (MUELLER et al. 2004), Rtf1 showed lower chromatin 
occupancy in the absence of Cdc73 or Paf1 subunits (Figure 11C and D).  This reduced 
chromatin occupancy correlated with reduced levels of Rtf1 in both the cdc73Δ and paf1Δ strains 
(Figure 11B, lanes 2, 4 and 6).  Surprisingly, chromatin occupancy of the OAR alone was 
increased in the absence of CDC73 (Figure 11C and D).  Immunoblotting analysis showed that 
levels of the OAR protein, unlike full-length Rtf1, were unaltered in the cdc73Δ and paf1Δ 
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strains compared to the PAF1 CDC73 control strain (Figure 11B, lanes 3, 5 and 7).  The higher 
chromatin levels of the OAR in a cdc73Δ strain may reflect a competition between the OAR and 
Cdc73 for a common binding partner on chromatin, consistent with observations that both can 
interact with the Spt5 CTR (Figure 10) (QIU et al. 2012).   
Although the OAR is sufficient to bind chromatin, we were interested in knowing 
whether its occupancy pattern mimicked that of full-length Rtf1.  Therefore, I used ChIP analysis 
to ask if the OAR alone, like Rtf1 and other subunits of Paf1C (KIM et al. 2004a; MAYER et al. 
2010), dissociated from chromatin near the poly(A) site of PYK1 and PMA1.  To better visualize 
the decrease in Rtf1 association, I normalized occupancy levels to those at the 5’ ends of the 
genes.  Interestingly, I observed that the OAR occupancy levels dropped significantly beyond the 
poly(A) site, similar to the pattern of Rtf1 occupancy (Figure 12A-C).  Reduction in the levels of 
the OAR beyond the poly(A) site could be explained by reduced chromatin levels of Pol II or 
Spt5 in cells expressing the OAR alone as compared to cells expressing full-length Rtf1.  
However, ChIP analysis revealed that levels of Spt5 and Pol II across PYK1 and PMA1 were 
similar in both strains (Figure 12A and D-G).  These results indicate that the lower levels of the 
OAR beyond the poly(A) site are not due to lower levels of Spt5 or Pol II at these sites 
specifically in OAR-expressing cells but are due to the dissociation of the OAR, like full-length 
Rtf1, from chromatin near the poly(A) site.  Together, our data show that the isolated OAR is 
capable of associating with chromatin independently of the other members of Paf1C in a pattern 
similar to that of full-length Rtf1. 
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Figure 11. The OAR is sufficient for chromatin association 
 (A) ChIP analyses of transformants of an rtf1Δ strain (KY619) expressing NLS-HA3-OAR (pMM44), HA3-Rtf1 
(pMM43) and untagged Rtf1 (pMM40) were performed using anti-HA beads to determine the occupancy of HA-
tagged Rtf1 derivatives over 5’ regions of PYK1 and PMA1 and a telomeric region of chromosome VI.  (B) 
Immunoblotting analysis of transformants of rtf1Δ (KY619), rtf1Δ cdc73Δ (KY2195) and rtf1Δ paf1Δ (KY1813) 
strains expressing NLS-HA3-OAR (pMM44) or HA3-Rtf1 (pMM43) was performed using antibody against the HA 
tag.  The anti-G6PDH immunoblot served as a loading control.  (C and D) ChIP analyses were performed on strains 
used in (B) to determine the chromatin occupancy of NLS-HA3-OAR (pMM44) and HA3-Rtf1 (pMM43) over 5’ 
regions of PYK1 (C) and PMA1 (D).  For (A), (C) and (D), graphs represent the average of three biological 
replicates with error bars indicating the SEM.  
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Figure 12. The OAR mimics the chromatin association pattern of Rtf1 
Occupancy of Rtf1 derivatives (B and C), Spt5 (D and E) and Pol II (F and G) at PYK1 and PMA1 was measured by 
ChIP.  Locations of PCR products are shown in A.  Transformants of an rtf1Δ strain (KY619) expressing either 
HA3-Rtf1 (pMM43) or NLS-HA3-OAR (pMM44) were used for ChIP assays with anti-HA beads (B and C), Spt5 
antisera (D and E) or Rpb3 antibody (F and G).  Occupancy levels of HA3-Rtf1 and NLS-HA3-OAR were 
normalized to their occupancy levels at the 5’ regions of the genes, which were set to 1 (panels B and C).  A no 
antibody reaction (No Ab) served as a negative control for the non-specific association of Spt5 and Pol II with the 
beads (panels D-G).  All graphs depict the average of three biological replicates with SEM.  
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2.3.6 OAR occupancy on chromatin is dependent on the CTR of Spt5 and Bur1-
Bur2 kinase complex  
Our findings so far show that the OAR is necessary for chromatin association of Paf1C, that the 
OAR can interact directly with the CTR of Spt5 in vitro, and that the isolated OAR behaves 
similarly to Paf1C in its ability to interact with chromatin both in terms of the localization pattern 
and the preference for active genes.  I also found that the phosphorylation of the CTR of Spt5 
enhances the interaction of the OAR with Spt5. Also, previous studies have shown that the 
recruitment of Paf1C is dependent on the CTR of Spt5 and on the Bur1-Bur2 protein kinase, 
which targets the CTR of Spt5 and the CTD of Pol II (LARIBEE et al. 2005; LIU et al. 2009; QIU 
et al. 2009; QIU et al. 2006; WOOD et al. 2005; ZHOU et al. 2009).  Based on all these findings, 
we hypothesized that the association of the isolated OAR with chromatin would be dependent on 
the CTR of Spt5 and Bur2.  To test this hypothesis, I analyzed the chromatin occupancy of the 
NLS-HA3-OAR protein and full-length HA3-Rtf1 in spt5ΔCTR and bur2-1 strains.  Strikingly, 
just like for full-length Rtf1, the levels of chromatin association of the OAR at PYK1 and PMA1 
were significantly reduced in the spt5ΔCTR and bur2-1 strains (Figure 13A and B).  
Immunoblotting analysis showed that the OAR protein levels were slightly reduced in the 
spt5ΔCTR and bur2-1 strains but not to the same degree as the reduction in the ChIP signals 
(Figure 13C, lanes 3, 5 and 7).  Together, these results suggest that the OAR is responsive to the 
same regulatory factors as Paf1C and underscore the central role of this domain in the chromatin 
association of Paf1C. 
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Figure 13. OAR recruitment is reduced in strains lacking the Spt5 CTR or mutated in BUR2 
 (A and B) ChIP analyses of the isolated OAR and full-length Rtf1 in transformants of rtf1Δ (KY619), rtf1Δ 
spt5ΔCTR (KA150), and rtf1Δ bur2-1 (AY777) strains expressing NLS-HA3-OAR (pMM44) or HA3-Rtf1 (pMM43) 
over 5’ regions of PYK1 (A) and PMA1 (B) using anti-HA beads.  The averaged results from three biological 
replicates with SEM are shown.  (C) Immunoblot analysis of HA3-Rtf1 and NLS-HA3-OAR levels of strains used 
for ChIP analysis in A and B was performed using antibody against the HA tag.  G6PDH levels serve as the loading 
control.  
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2.4 DISCUSSION 
Both the initial purification of Paf1 as an Pol II-associated factor (SHI et al. 1996) and the 
subsequent discovery that the subunits of Paf1C co-localize with Pol II on open reading frames 
(KROGAN et al. 2002; POKHOLOK et al. 2002) argue that the physical coupling of Paf1C to Pol II 
is likely to be important for directing the functions of Paf1C to active genes.  Our previous 
deletion analysis identified a region of Rtf1, the OAR, as being important for the chromatin 
association of Paf1C (WARNER et al. 2007); however, the nature of the interaction between the 
OAR and the Pol II elongation machinery was unknown.  In this study, we investigated the 
mechanism of recruitment of Paf1C through the Rtf1 OAR.  Affinity purification of Rtf1 
proteins containing or lacking the OAR revealed that the OAR was critical for the physical 
association of Spt5 with Paf1C, and my co-immunoprecipitation analysis demonstrated that the 
interaction between Rtf1 and Spt5 required the CTR of Spt5.  My in vitro binding assays 
performed with purified recombinant versions of Rtf1 and Spt4-Spt5 provided evidence for a 
direct interaction between these elongation factors.  In addition, these experiments suggested that 
the OAR of Rtf1 and the CTR of Spt5 mediate the direct physical interaction between Rtf1 and 
Spt5.  My GST-pull down assay with the OAR also suggested that the phosphorylation of the 
Spt5 CTR facilitated better interaction between the OAR and the Spt5 CTR. Using ChIP studies, 
I found that the OAR can occupy chromatin independently of other Paf1C components and 
exhibit a localization pattern similar to that of full-length Rtf1.  Moreover, chromatin occupancy 
of the isolated OAR was significantly reduced in strains lacking the Spt5 CTR or the Bur2 cyclin 
component of the Bur1-Bur2 protein kinase, which phosphorylates the Spt5 CTR as well as the 
CTD of Pol II (LIU et al. 2009; QIU et al. 2009; ZHOU et al. 2009).  Taken together, our results 
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suggest that the OAR of Rtf1 plays a prominent role in mediating the recruitment of Paf1C to 
elongating Pol II through an interaction with the CTR of Spt5. 
In organisms ranging from bacteria to humans, Spt5 and its homologues have 
fundamental roles in regulating transcription elongation.  In eukaryotes, Spt5 has been shown to 
promote Pol II pausing and processivity (WERNER 2012).  Spt5 consists of several domains 
including an acidic N-terminal domain, a NusG N-terminal domain (NGN), multiple KOW 
(Kyprides, Ouzounis, Woese) domains and the CTR (PONTING 2002).  There have been several 
structural studies on the interaction between Spt5 and Spt4 (GUO et al. 2008; MARTINEZ-
RUCOBO et al. 2011).  The crystal structure of the archaeal homologues of a fusion protein of 
Spt4 and the NGN domain of Spt5 revealed that Spt4 interacts with the NGN domain of Spt5 
(GUO et al. 2008).  Both the NGN and the KOW motifs of Spt5 are involved in the interaction of 
Spt5 with Pol II (HIRTREITER et al. 2010; VIKTOROVSKAYA et al. 2011).  Curiously, sequence 
homology between the KOW motifs of Spt5 and the Plus3 domain of human Rtf1 has been 
noted, although the significance of this similarity is unclear (DE JONG et al. 2008).  In this work 
we provide evidence that the Rtf1 OAR is an interacting partner for the CTR of Spt5; however, 
our results do not rule out the possibility that other regions within Spt5 or Rtf1 may enhance 
their interaction.  
The mechanisms that direct the recruitment of Paf1C to RNA polymerase II are likely to 
be important for targeting Paf1C functions to active genes, and previous studies have implicated 
several different transcription elongation factors as well as the Pol II CTD in this process 
(MULDER et al. 2007; PAVRI et al. 2006; QIU et al. 2012; QIU et al. 2006).  Particularly relevant 
to our results, mutations that alter the Spt5 CTR or its kinase, Bur1-Bur2, were previously shown 
to impair the recruitment of Paf1C to chromatin (LARIBEE et al. 2005; LIU et al. 2009; QIU et al. 
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2012; WOOD et al. 2005; ZHOU et al. 2009).  Interestingly, chromatin association levels of Paf1 
in cells expressing a mutant form of Spt5 that could not be phosphorylated on the CTR were 
higher than those in cells expressing Spt5 lacking the CTR (LIU et al. 2009).  This observation 
suggests that, while the phosphorylation of the Spt5 CTR by Bur1-Bur2 enhances the affinity of 
the OAR for the CTR, other aspects of the CTR sequence and structure are also important for 
this interaction.  Consistent with this idea, our in vitro binding assays revealed an interaction 
between recombinant OAR and CTR proteins, even though the latter is unlikely to be properly 
phosphorylated in E. coli.  
Our observation that the chromatin association pattern of the OAR was similar to that of 
full-length Rtf1 indicates that features of Paf1C that control its pattern of chromatin association 
and dissociation are contained within the OAR.  Interestingly, other components of Paf1C, 
including the Cdc73 C-domain, which interacts with the Pol II CTD in a phospho-specific 
manner, and Leo1, which binds to RNA, are also important for ensuring full levels of Paf1C 
recruitment (AMRICH et al. 2012; DERMODY and BURATOWSKI 2010; QIU et al. 2012).  Together, 
these results argue for the existence of more than one attachment point between Paf1C and 
transcribing Pol II.  Unlike its Spt5 and Pol II interaction partners which continue on to the 
transcription termination site, Paf1C dissociates from coding regions near the poly(A) site where 
3’-end processing factors are recruited to the Pol II machinery (KIM et al. 2004a; MAYER et al. 
2010).  The dissociation of Paf1C at this site may be governed by changes in the phosphorylation 
patterns of the Pol II CTD, the Spt5 CTR, or both proteins.  In addition, the association of Leo1 
with RNA may contribute to the release of Paf1C near the RNA cleavage site.  Interestingly, a 
recent study showed that the recruitment of the 3’-end RNA processing factor, RNA cleavage 
factor I, requires the CTR of Spt5 (MAYER et al. 2012).  Together with our discovery of a direct 
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physical interaction between the Rtf1 OAR and the Spt5 CTR, this observation, as well as the 
previous identification of numerous RNA processing factors in complex with Spt5 (LINDSTROM 
et al. 2003), raises the possibility that the Spt5 CTR, like the Pol II CTD, acts as a platform for 
the recruitment and exchange of proteins that coordinate the synthesis and processing of Pol II 
transcripts. 
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3.0  SURFACE-EXPOSED, CONSERVED RESIDUES WITHIN THE OAR OF RTF1 
ARE FUNCTIONALLY IMPORTANT 
Some of the work presented in this Chapter is adapted from published material (MAYEKAR et al. 
2013; WIER et al. 2013) and is reprinted with changes. The crystal structures shown in this 
Chapter represent the work of Adam Wier, Dr. Annie Heroux and Dr. Andrew VanDemark. 
Copyright © American Society for Microbiology, [MCB, 33, 2013, 3259-3273, 
10.1128/MCB.00270-13]. 
3.1 INTRODUCTION 
Transcription is a highly regulated process that involves a functional crosstalk between Pol II and 
several proteins that directly or indirectly facilitate the transit of Pol II through chromatin and 
couple the synthesis of RNA with the co-transcriptional processing of RNA. Paf1C is one such 
transcriptional regulator that has roles at various stages of transcription from initiation to 
termination including the activation of transcription upon recruitment by other transcription 
factors, regulation of co-transcriptional histone modifications and 3’ processing of newly 
synthesized RNA (MOSIMANN et al. 2006; MOSIMANN et al. 2009) [reviewed in (CRISUCCI and 
ARNDT 2011; TOMSON and ARNDT 2013)]. Since most the functions of Paf1C are co-
transcriptional the coupling of Paf1C with the transcription machinery is expected to be 
 92 
indispensable for the proper execution of these functions. In the previous Chapter, I provided a 
molecular mechanism for coupling Paf1C to the transcription machinery through the OAR of 
Rtf1. Comparison of amino acid sequences of homologues of Rtf1 from yeast to humans had 
revealed that the OAR is the most highly conserved region of Rtf1 (Figure 7A). The presence of 
highly conserved residues on the surface suggested that they could be mediating functionally-
important interactions of Paf1C with a binding partner(s) that tethers Paf1C to actively 
transcribed genes.   
My work described in Chapter 2 indicated that the OAR mediated the targeting of Paf1C 
to active chromatin through association with the phosphorylated CTR of Spt5. However, the 
OAR was still recruited to active chromatin, although at much lower levels, in the absence of the 
CTR of Spt5 (Figure 13A and B). This suggests that the OAR may also be involved in additional 
interactions required for the chromatin recruitment of Paf1C that were not identified via our 
subtractive proteomics approach (discussed in section 2.3.3). Furthermore, in the absence of 
OAR, we can still observe low levels of histone modifications, which suggest that weak 
association of Paf1C (undetectable by ChIP) with active chromatin may still occur in cells 
lacking the OAR through an OAR-independent mechanism of recruitment. Furthermore, there 
may be accessory factors that may act in a synergistic fashion with the OAR to tether Paf1C to 
chromatin. These accessory factors mediating the recruitment of Paf1C by OAR-dependent and 
OAR-independent mechanisms could be uncovered in a high-copy-number suppressor screen to 
identify proteins that when overexpressed can suppress the transcriptional defects (Spt- 
phenotype) exhibited by a hypofunctional OAR.   
To uncover functionally-important residues within the OAR that when mutated confer 
transcriptional defects without affecting the stability of Rtf1, I took a mutational-analysis 
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approach. I found that OAR mutants having amino acid substitutions for the conserved, surface-
localized residues of the OAR exhibited Spt- phenotype, suggesting that they are 
transcriptionally defective. Furthermore, I saw an exacerbation of the Spt- phenotype when more 
than one residue in the OAR was mutated. Additionally, my immunoblotting, co-
immunoprecipitation and ChIP analysis attributed the transcriptional defect in these mutants to 
reduced association of Paf1C with Spt5 that resulted in reduced chromatin association of Paf1C.  
Adam Wier, Dr. Annie Heroux and Dr. Andrew VanDemark obtained a crystal structure 
for the human OAR/Plus3 with a phosphorylated CTR of Spt5 and hence proved that the 
interaction that I discovered in yeast is conserved in humans as well. His work provided a better 
understanding of the structural basis of the OAR-CTR interaction. To determine if the 
interactions observed in the crystal structure were physiologically relevant, I performed ChIP 
analysis with the mutants predicted to affect the OAR-CTR interaction. My results show that the 
chromatin occupancy of Rtf1 along with the rest of Paf1C is significantly diminished in cells 
expressing these mutants thus suggesting that the interactions between the OAR of Rtf1 and the 
CTR of Spt5 observed in the OAR-CTR co-crystal are important for tethering Paf1C to 
chromatin.  
The Cdc73 subunit of Paf1C has also been implicated in the chromatin attachment of 
Paf1C (MUELLER et al. 2004). The chromatin association function of Cdc73 has been attributed 
to a C-terminal domain of Cdc73 (C-domain) (AMRICH et al. 2012; QIU et al. 2012). My ChIP 
and western blot analysis suggest that the chromatin association of Paf1C is mediated by a dual 
attachment via the OAR of Rtf1 and the C-domain of Cdc73.  
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3.2 MATERIALS AND METHODS 
3.2.1 Yeast growth assays 
Yeast cells (Table 4) were grown overnight in the appropriate medium. They were then washed 
twice with sterile water and 10-fold serial dilutions of the washed cells were made using sterile 
water. 2.5 µl of each dilution was then spotted onto the indicated medium and incubated at 30°C 
or 37°C for the number of days specified.  
3.2.2 Plasmids 
Plasmids pLS20 and pLS21-5 (STOLINSKI et al. 1997) express untagged and HA-tagged full-
length Rtf1, respectively, under the control of the RTF1 promoter on TRP1-marked CEN/ARS 
plasmids. The TRP1-marked CEN/ARS plasmids encoding the indicated HA3-tagged mutant 
derivatives of Rtf1 were made using the Quikchange site-directed mutagenesis kit (Agilent) and 
pLS21-5 as the template. The URA3-marked plasmids expressing untagged mutant versions of 
Rtf1 were made by first removing the HA3-tag from plasmids that express HA3-Rtf1 by NdeI 
digestion and then ligating the XhoI-SacI fragment from these plasmids, containing the RTF1 
promoter and coding region, to pRS316 digested with XhoI-SacI. pMM61 and pMM62 expresses 
untagged full-length Rtf1 and Rtf1 lacking the OAR, respectively,  under the control of the RTF1 
promoter on a URA3-marked CEN/ARS plasmids. pMM65 was generated using a QuickChange 
site-directed mutagenesis kit to introduce the R251A and Y327A substitutions in the Rtf1 
protein. pCD3, pWR4 and pCD8 express untagged Cdc73, HA-tagged Cdc73 and HA-tagged 
Cdc73 lacking the C-domain (AMRICH et al. 2012). 
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3.2.3 Western Blot Analysis 
 Trichloroacetic acid extracts were made from log phase yeast cultures (OD600 0.8-1.2) (Table 4) 
lysed by bead beating as described in Chapter 2 (section 2.2.3). These yeast extract were 
subjected to western blot analysis as described previously (MAYEKAR et al. 2013) using 
antibodies against the HA epitope (1:2500 dilution, Roche), Rtf1 (1:3000 dilution) (SQUAZZO et 
al. 2002), Histone H3 K4 Me3 (1:2000, Active motif 39159), H3 K4 Me2 (1:2000, Upstate 07-
030), H3 K79 Me2/3 (1:2000, Abcam ab2621), H3 K36 Me3 (1:1000, Abcam ab9050), total 
histone H3 (1:30,000) (PIRO et al. 2012) or, as a loading control, glucose-6-phosphate 
dehydrogenase (1:30,000 dilution, Sigma A9521). 
3.2.4 Chromatin Immunoprecipitation 
Chromatin was prepared from log phase cultures of the indicated yeast strains (Table 4) grown to 
a density of 1-2 x107 cells/ml. Cells were treated with formaldehyde, quenched with glycine, 
harvested, and lysed as previously described (MAYEKAR et al. 2013). Chromatin was fragmented 
by sonication and incubated overnight at 4°C with agarose-conjugated α-HA antibody (Santa 
Cruz Biotechnology; sc-7392AC). Quantitative real-time PCR using Maxima SYBR Green/ROX 
qPCR master mix (Fermentas) and primers to the 5’ region of PYK1 (+253 to +346/ATG=+1), 3’ 
region of PYK1 (+1127 to +1270/ATG=+1), 5’ region of PMA1 (+214 to +319/ATG=+1), 3’ 
region of PMA1 (+2107 to +2194/ATG=+1) or telomeric region of chromosome VI (coordinates: 
269495 to 269598) were used to determine the amount of PYK1, PMA1 or telomeric DNA 
associated with the HA-tagged proteins. The y-axis of the graphs depicts the average values of 
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the efficiency of the primer set(Ct of input)-(Ct of  IP) for three biological replicates and the error bars 
show the standard error of the mean (SEM). 
3.2.5 Indirect immunofluorescence  
Indirect immunofluorescence was performed as described previously (GUERRIERO et al. 2013). 
Briefly, transformants of an rtf1Δ strain (KY619) (Table 4) transformed with plasmid expressing 
HA3-Rtf1 (pLS21-5), HA3-Rtf1ΔOAR (pMM01), HA3-Rtf1-R251, R273E, K299E or untagged 
Rtf1 (pLS20; served as the negative control) were grown to mid-log phase (OD600 ~0.5), fixed 
with 4% formaldehyde for one hour and treated with zymolyase 20T at 37°C to generate 
spheroplasts. Spheroplasts were adhered to poly-lysine treated slides and then permeabilized by 
treatment with methanol and acetone. After permeabilization, they were blocked with 0.5% BSA, 
0.5% ovalbumin and 0.6% fish gelatin at 37°C and then incubated overnight with mouse anti-HA 
antibody (1:250, Roche) overnight at room temperature followed by 2 hour incubation with 
fluorophore-conjugated anti-mouse antibody (1:500; Alex 647, Molecular Probes) and DAPI 
(1:250). Prolong Antifade Gold (Invitrogen) was used as the mounting medium to image the 
slide under Olympus FV1000 (100X oil immersion lens). 
 
Table 4. Saccharomyces cerevisiae strains used for the study in this Chapter 
Strain Genotype 
KY619 MATa  rtf1Δ102::ARG4 arg4-12 his4-912∂ leu2Δ1 lys2-173R2 trp1Δ63 
KY2417 MATα rtf1Δ::LEU2 cdc73Δ::KanMx his3Δ200 leu2Δ1 ura3(Δ0 or 52) trp1Δ63 
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3.3 RESULTS 
3.3.1 Mutational analysis approach to identify the functionally important residues 
of the OAR 
Upon obtaining the crystal structure for the human OAR (WIER et al. 2013) we were interested 
in identifying the region of the OAR important for its function. One feature of functionally 
important residues of proteins is their high degree of conservation. Hence, we mapped the 
residues showing greater than 85% identity among nine homologues of Rtf1 from humans to 
yeast onto this structure (Figure 14A). These conserved residues of the OAR also included the 
three invariant basic residues within this region (R366, R388 and K414 in human Rtf1 and R251, 
R273 and K299 in S. cerevisiae Rtf1) that confer upon OAR its alternative name, the Plus3 
region. Strikingly, most of the conserved residues were clustered together on the surface 
indicating that this region may be involved in mediating functionally important protein-protein 
interactions (Figure 14A and B).  
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Figure 14.  Crystal structure of the human Plus3 domain 
(A) The residues showing greater than 85% identity among the homologues of Rtf1 were mapped onto the surface 
view of the crystal structure of human OAR and colored blue using Pymol (WIER et al. 2013).  (B) The colored 
residues represent the corresponding yeast residues that I mutated as a part of my mutational analysis to identify the 
functionally important residues of the OAR of Rtf1. The Plus3 sign indicates the three highly conserved positively 
charged residues corresponding to the S. cerevisiae residues R251, R273 and K299 that confer upon the Rtf1 OAR 
its alternative name, Plus3. 
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To test their biological significance, I mutated some of these conserved residues, either 
singly or in combination, to glutamic acid or alanine residues and then tested the ability of the 
resulting Rtf1 mutant proteins to cause Spt- phenotype.  Most of the single-residue charge-swap 
substitutions did not suppress the his4-91δ allele at 30°C (Figure 15A).  R273E was the only 
single residue substitution that caused the Spt- phenotype at 30°C, albeit weakly (Figure 15A).  
However, mutation of multiple conserved residues enhanced the Spt- phenotype (Figure 15A).  
Immunoblotting analysis indicated that the mutant Rtf1 protein levels were comparable to wild-
type Rtf1 levels at 30°C (Figure 15B and C), suggesting that the enhanced mutant phenotypes in 
the double and triple mutants were not a consequence of reduced protein levels. 
In addition to examining the Spt- phenotype at 30°C, I also tested this phenotype at 37°C 
to determine if the higher temperature exacerbated the Spt- phenotype of the mutants.  Of the 
three single amino acid substitutions, the R273E substitution caused the strongest Spt- phenotype 
at 37°C (Figure 15A).  The multiple-residue mutants also showed stronger Spt- phenotypes at 
37°C (Figure 15A).  Most multiple-residue mutants mimicked rtf1ΔOAR at 37°C although this 
may be partly due to reduced stability of the mutant proteins at 37°C (Figure 15D and E). We 
considered the possibility that the mutant phenotypes of strains expressing Rtf1 mutant proteins 
were due to loss of Rtf1 from the nucleus.  However, my indirect immunofluorescence assays 
combined with confocal microscopy revealed that the Rtf1∆OAR and Rtf1-R251E, R273E, 
K299E proteins, like wild type Rtf1, were localized to the nucleus (Figure 15F).  
To test whether the surface-localized, highly conserved residues are important for the 
Spt5-mediated recruitment of Paf1C to chromatin, I determined the impact of the R273E single-
residue substitution and R251E R273E K299E (Plus3 mutant) triple-residue substitution on the 
interaction of Rtf1 with Spt5 and assessed their chromatin association levels using ChIP analysis.  
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Even when the cells were grown at 30°C, these Rtf1 mutant proteins showed impaired 
interaction with Spt5 and exhibited significant chromatin association defects (Figure 16A and B).  
In these conditions, the levels of the mutant proteins were similar to wild-type Rtf1 (Figure 15B-
C). Impairment of the ability of Rtf1 to associate with chromatin by deletion of the OAR 
significantly reduced the levels of Rtf1-dependent histone modifications (Figure 7B).  Likewise, 
substitution of the three Plus3 residues lowered global levels of H3 K79 Me2/3 and H3 K4 Me3 
(Figure 16C, lane 5).  Quantification of the immunoblots revealed a very modest reduction in the 
levels of H3 K79 Me2/3 in the Rtf1-R273E mutant strain but no effect on H3 K4 Me2 or H3 K4 
Me3 levels (Figure 16C, lane 4).  Taken together, my results show that the surface-localized 
conserved residues of the OAR such as the Plus3 residues are important for the chromatin 
association of Rtf1 and full levels of Rtf1-mediated histone modifications.  
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Figure 15.  Mutations in the surface-localized conserved residues of the OAR of Rtf1 cause 
transcriptional defects 
(A) An rtf1Δ strain (KY619) was transformed with derivatives of HA3-Rtf1 (pLS21-5) having the indicated amino 
acid substitutions in the OAR.  Tenfold serial dilutions of these mutants, ranging from 108 cells/ml to 104 cells/ml, 
were spotted on SD-His-Trp plates to assess their Spt- phenotype and on SC-Trp as a growth control and incubated 
for four days at 30°C or 37°C. (B to E) Immunoblotting analysis was performed on strains used in A grown at either 
30°C (B and C) or 37°C (D and E), with anti-HA antibody to determine Rtf1 protein levels. Extracts of an rtf1Δ 
strains (KY619) expressing untagged Rtf1 (pLS20) grown at 30°C or 37°C served a negative control for anti-HA 
western analysis. G6PDH levels were measured as a loading control.  The R251, R273, R288 and K299 residues 
have been mutated to glutamic acid residue in the R4 mutant. (F) Indirect immunofluorescence confocal microscopy 
was used to determine the cellular localization of the indicated OAR mutants. Nucleus was stained using DAPI 
while the HA-tagged OAR mutants were visualized using antibody against the HA-tag and a fluorophore-conjugated 
anti-mouse secondary.  
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Figure 16. The Plus3 residues of the OAR are important for the chromatin association of Rtf1 and 
Rtf1-dependent co-transcriptional histone modifications 
(A) Spt5 was immunoprecipitated using an antibody against it from extracts of an rtf1Δ (KY619) strain expressing 
HA3-Rtf1 (pLS21-5) or its specified mutant derivatives. Spt5 and Rtf1 were detected by immunoblotting with anti-
Spt5 and anti-HA antibodies. An immunoprecipitation performed in parallel without the addition of anti-Spt5 
antibody to the extracts of a strain expressing HA3-Rtf1 (pLS21-5) served as a negative control. The results are 
representative of two separate experiments. (B) ChIP analyses of transformants of an rtf1Δ strain (KY619) bearing 
plasmids expressing HA3-Rtf1 (pLS21-5) or the indicated mutant proteins, which were expressed from pLS21-5 
derivatives, were performed using anti-HA beads to determine the occupancy of the Rtf1 proteins over 5’ regions of 
PYK1 and PMA1 and a telomeric region of chromosome VI.  Average of three biological replicates is shown with 
the error bars depicting the SEM.  (C) Immunoblotting analyses were performed using indicated antibodies on 
transformants of an rtf1Δ (KY619) strain containing plasmids expressing HA3-Rtf1 (pLS21-5), HA3-Rtf1ΔOAR 
(pMM01) or the indicated mutant proteins, which were expressed from derivatives of pLS21-5.  An rtf1Δ strain 
(KY619) transformed with empty vector (pRS314) was used as the negative control.  G6PDH and total H3 levels 
serve as loading controls. 
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3.3.2 Structural basis for the interaction of the OAR /Plus3 region of Rtf1 with the 
CTR of Spt5 
To determine the structural basis for the interaction of the OAR of Rtf1 and the Spt5 CTR and 
the importance of the phosphorylation of the CTR in this interaction, Adam Wier, Dr.Annie 
Heroux and Dr. Andrew VanDemark determined the structure of the human OAR-pCTR 
complex (Figure 17A). This crystal structure provides evidence that the OAR-CTR interaction 
that I discovered in S. cerevisiae is conserved in humans as well. The crystal structure shows that 
the Rtf1 OAR and the Spt5 pCTR peptide are held together partly via hydrogen bonds between 
surface localized conserved residues within the OAR including two of the Plus3 residues 
(Human Rtf1 residues R366, R388, Y400, S443, Q445) and the phosphate group of the 
phosphorylated threonine residue (pT784) within the CTR (Figure 17B). This co-crystal structure 
is consistent with my phenotypic analysis data, which suggested that S. cerevisiae Rtf1 residues 
R251 (a Plus3 residue), R273 (a Plus3 residue), Y287 and S329 corresponding to human Rtf1 
residues R366, R388, Y400 and S443, respectively, are involved in functionally important 
multivalent interactions with its binding partner (Figure 15A, 16A and 16B).  
The other interactions tethering the Rtf1 OAR to the Spt5 pCTR peptide are the Van der 
Waals interactions between the hydrophobic residues of the human OAR/Plus3 (human Rtf1 
residues N393, Y400, F437 and F441) and the Spt5-CTR (Figure 17C). This interaction involves 
two residues within the consensus human CTR sequence, G-S-R/Q-T-P (pT784 and P785) and 
two residues within the linker region (M786 and Y787) of the human Spt5 CTR (YAMADA et al. 
2006). The length of this linker region is conserved in humans (two residues) (YAMADA et al. 
2006). Although the residues within the linker region may vary, the binding pocket containing 
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the M786 is large enough to also accommodate other hydrophobic residues such as His or Leu, 
while the second binding pocket including the consensus residue Y787 can also fit Gln and His, 
the other residues found at this position in some of the linker regions of the CTR (WIER et al. 
2013). Together, Adam Wier, Dr. Annie Heroux and Dr. VanDemark’s work suggests that the 
association of the human OAR with the human CTR is held together by two sets of interactions- 
hydrophilic and hydrophobic interactions between the OAR and the phosphorylated CTR. 
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Figure 17. Rtf1 OAR and Spt5 CTR interaction is mediated by two sets of interactions 
 (A) The co-crystal of the human OAR with a peptide of Spt5 CTR. Shown in blue are the residues that are greater 
than 85% identical among the homologues of Rtf1. (B) The black dotted lines represent the hydrogen bonds 
mediating the interaction of the human OAR residues (white) Y400 (yeast Y287), R388 (yeast R273, one of the 
three plus3 residues), S443 (yeast S329), Q445 (not a conserved residue) and R366 (yeast R251, one of the three 
plus3 residues) with the phosphothreonine residue of the peptide of human Spt5 CTR (yellow). (C) The Van der 
Waals interactions between the human OAR residues (white) N393 (yeast T278), Y400 (yeast Y287), F441 (yeast 
Y327) and F437 (yeast F323) and the Spt5 CTR peptide (yellow) are depicted using pink dotted lines. 
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3.3.3 Residues of the OAR of Rtf1 mediating the human OAR-CTR interaction are 
also important for proper chromatin association in yeast 
The structural and biochemical studies performed by Adam Wier, Dr. Annie Heroux and Dr. 
VanDemark identified amino acids R366 and F441 of human Rtf1 as being important for the 
Plus3-pCTR interaction in vitro due to their involvement in the hydrophilic and hydrophobic 
interactions holding the Plus3 domain and the CTR together. To test if these residues are 
important in vivo for the recruitment of Rtf1 to chromatin, I performed chromatin 
immunoprecipitation assays in S. cerevisiae. Individually, alanine substitutions for S. cerevisiae 
Rtf1 residues R251 and Y327, which correspond to human Rtf1 residues R366 and F441, 
respectively, caused a modest decrease in Rtf1 occupancy on two active genes, PYK1 and PMA1 
(Figure 18A). Interestingly, when both the R251A and Y327A substitutions were incorporated 
into Rtf1, it caused a greater reduction in the chromatin occupancy of Rtf1. Consistent with the 
localization of the corresponding human Rtf1 residues on the surface of the OAR/Plus3 (Figure 
17A), individual and simultaneous substitution of R251 and Y327 did not affect the stability of 
yeast Rtf1 (Figure 18B).  These results indicate that the hydrophilic and hydrophobic interactions 
that mediate the OAR/Plus3-pCTR association in the co-crystal are indeed physiologically 
relevant and are important for the chromatin recruitment of Rtf1. 
Previous studies have also implicated the carboxy-terminal domain of Cdc73 (Cdc73 C-
domain) for recruitment of Paf1C to chromatin (AMRICH et al. 2012; QIU et al. 2012) in addition 
to the OAR of Rtf1, raising the possibility that the Cdc73 C-domain and the Rtf1 Plus3-Spt5 
CTR interaction surface may function collaboratively to tether Paf1C to the transcription 
machinery. To test this possibility, I constructed yeast strains that express Cdc73 mutant protein 
lacking the C-domain or Rtf1 mutant protein having alanine substitutions at the R251 and Y327 
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residues or strains expressing these mutant versions of Cdc73 and Rtf1 proteins.  Chromatin 
occupancy of Cdc73 determined through the presence of the HA-tag on the full-length Cdc73 
and Cdc73 lacking the C-domain, showed that simultaneous removal of the Cdc73 C-domain and 
the Spt5 CTR interacting residues within the OAR/Plus3 domain led to a greater defect in Paf1C 
chromatin localization than either single mutant condition (Figure 18C).  Western analysis 
demonstrated that the mutations did not affect the stability of Cdc73 protein (Figure 18D).  My 
ChIP analysis thus suggests that the Rtf1 OAR and the Cdc73 C-domain collaborate to tether 
Paf1C to active genes.  
In addition to testing the contribution of both the OAR of Rtf1 and the C-domain of 
Cdc73 for chromatin association, I also tested the impact of deleting both the Rtf1 OAR and the 
Cdc73 C-domain on all the Paf1C-regulated histone modifications. Lack of the C-domain of 
Cdc73 alone caused only a modest reduction in Paf1C-mediated histone modifications, while 
lack of the OAR alone had a large impact on the H3 K4 Me3 and H3 K79 Me2/3 levels, a small 
effect on H3 K4 Me2 and no impact on H3 K36 Me3 levels. However, my immunoblotting 
analysis suggested that the deletion of both almost completely abolished all the histone 
modifications mediated by Paf1C (Figure 18E). Thus, my ChIP and western blot analyses further 
support the importance of the OAR/Plus3-Spt5 CTR interface in Paf1C recruitment and indicate 
that the association of Paf1C with the transcription machinery is facilitated by at least two 
attachments mediated by the OAR of Rtf1 and the C-domain of Cdc73.      
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Figure 18. The OAR of Rtf1 and the C-domain of Cdc73 collaborate to mediate the chromatin 
association of Paf1C and hence facilitate Paf1C-mediated histone modifications 
 (A) ChIP analysis was performed on transformants of an rtf1∆ strain (KY619) containing plasmids expressing the 
indicated HA-tagged derivatives of Rtf1. Error bars represent the SEM from three biological replicates, and asterisks 
denote p-values of <0.05. (B) Western blot analysis of extracts prepared from yeast transformants used in (A) using 
α-HA antibody to determine the levels of Rtf1 protein. G6PDH levels serve as the loading control. (C)  ChIP 
analysis of HA3-Cdc73 was performed on transformants of an rtf1Δcdc73Δ (KY2417) strain carrying plasmid 
expressing full-length HA-tagged Cdc73 (pWR4) or Cdc73 lacking the C-domain (pCD8) and plasmid encoding 
full-length Rtf1 (pMM61) or R251A Y327A mutant of Rtf1. The error bars indicate the SEM. The chromatin 
occupancy of all the single mutants is significantly different (p>0.05) compared to wild-type and Rtf1-R251A, 
Y327A Cdc73ΔC mutant at 5’ PYK1, 3’ PYK1, 5’ PMA1 and 3’ PMA1 except where indicated (§). (D) 
Immunoblotting analysis of the extracts of strains used in (C), using α-Rtf1 and α-HA to determine the Rtf1 and 
Cdc73 protein levels. G6PDH levels were used as the loading control. (E) Western blot analysis was performed on 
transformants of an rtf1Δ cdc73Δ (KY2417) strain containing plasmid expressing full-length HA-tagged Cdc73 
(pWR4) or Cdc73 lacking the C-domain (pCD8) and plasmid encoding full-length Rtf1 (pMM61) or Rtf1 lacking 
the OAR (pMM62) or empty vector (pRS316) using the indicated antibodies. 
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3.4 DISCUSSION 
Sequence alignments indicate that the OAR is the most highly conserved region of Rtf1 across 
eukaryotes (WARNER et al. 2007).  This conservation suggests that the OAR makes key 
contribution(s) to the function of Paf1C, which in higher eukaryotes has crucial roles in 
preventing cancer, promoting stem cell pluripotency, and ensuring proper cellular differentiation 
and organismal development [reviewed in (TOMSON and ARNDT 2013)].  In this study, we sought 
to identify the residues of the OAR that are important for its function. My work described in the 
previous chapter, provided a mechanism for the chromatin association of Paf1C through the 
OAR of Rtf1 where I found that an interaction of the OAR of Rtf1 with the phosphorylated CTR 
of Spt5 tethers Paf1C to actively transcribed genes. Performing a genetic screen for suppressors 
of a hypofunctional OAR could lead to the identification of additional regulators of chromatin 
association of Paf1C. Thus uncovering the functionally important residues within the OAR could 
lead to the identification of an OAR mutant that might be a useful for genetic screens in the 
future.  
To identify the functionally important residues, I took a mutational analysis approach. 
We anticipated that conserved residues on the surface would play a functionally important role. 
Upon mutating conserved residues on the surface of the OAR to oppositely charged residues or 
alanine residues, I observed that these substitutions caused Spt- phenotype, indicative of 
transcriptional defects (Figure 14A and B and 15A). My co-immunoprecipitation analysis 
indicated that the interaction of these mutant Rtf1 proteins with Spt5 was impaired (Figure 16A). 
My ChIP analysis showed that the strength of the Spt- phenotype caused by the substitutions, 
which is indicative of transcriptional defects correlated with the degree of defect in chromatin-
association, suggesting that the defect in chromatin association was the cause of the Spt- 
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phenotype (Figure 16B). The single-residue OAR/Plus3 mutant (Rtf1-R273E) which caused a 
weak Spt- phenotype, caused a small defect in the chromatin association of Paf1C, while the 
triple-residue OAR/Plus3 mutant which caused a strong Spt- phenotype, caused a greater defect 
in the ability of Paf1C to associate with actively transcribed genes. My immunoblotting analysis 
with these mutants suggested that a large chromatin association defect causes only a small defect 
in the levels of H3 K4 Me3 and H3 K79 Me2/3 and no defect in H3 K4 Me2 levels and a two-
fold defect in chromatin association is not enough to influence the level of histone modifications 
(Figure 16C). These results suggest that low levels of chromatin-associated Paf1C are sufficient 
for the regulation of histone modifications by Paf1C.  
The molecular details about the interactions involved in the association of the Rtf1 
OAR/Plus3 with the Spt5 CTR were provided by determining the structure of the OAR/Plus3-
CTR co-crystals (Figure 17A). This co-crystal structure supports that the interaction between the 
OAR and the phosphorylated CTR that I uncovered, is also conserved in humans. The co-crystal 
structure revealed that the OAR of Rtf1 and the CTR of Spt5 are held together by two sets of 
interactions. A set of hydrophilic interactions were mediated by the phosphorylated residue 
within the CTR and the conserved surface-localized polar residues of the OAR, that I had also 
identified as being important for preventing transcriptional defects through mutational analysis 
(Figure 17B). These hydrophilic interactions with the phosphorylated residues also provided an 
explanation for the impaired interaction of the OAR with mutant Spt5 having a non-
phosphorylatable CTR (Spt5-S1-15A mutant) (Figure 10C). Additionally, a set of Van der Waals 
interactions are mediated by the non-polar residues within the CTR and the aromatic residues 
within the OAR (Figure 17C). When I mutated residues of S. cerevisiae Rtf1 (R251 and Y327) 
corresponding to residues of the human OAR (R366 and F441) involved in the hydrophilic 
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and/or Van der Waals interactions, I observed a reduction in the chromatin occupancy of Paf1C 
(Figure 18A), thus suggesting that the interactions observed in the OAR-CTR crystal structure 
are indeed functionally important. 
In a screen for conditional rtf1 mutations, we previously identified two point mutations 
that alter residues within the OAR and confer Spt- phenotype at 37°C (SHELDON et al. 2005).  
The crystal structure of the human Rtf1 Plus3 domain indicated that the corresponding human 
residues are buried within the protein and substitution of these residues is likely to destabilize the 
core of the structure.  In contrast, the Plus3 residues that I mutated here are surface-exposed.  
Interestingly, in vitro studies performed with the human Plus3 domain suggested that this domain 
has the ability to bind single stranded DNA (DE JONG et al. 2008), suggesting models in which 
this domain interacts with the Pol II transcription bubble.  Our data strongly suggest that the S. 
cerevisiae Rtf1 OAR interacts with the phosphorylated CTR of Spt5.  However, we have not 
ruled out the possibility that the OAR could mediate recruitment of Paf1C through additional 
mechanisms such as through interactions with single-stranded DNA.  
Previous studies had indicated that the C-domain of the Cdc73 subunit of Paf1C was also 
important for the chromatin association of Paf1C (AMRICH et al. 2012; QIU et al. 2012). 
However, deletion of C-domain alone did not greatly affect the histone modification function of 
Paf1C (AMRICH et al. 2012). This result is consistent with my observations that the OAR 
mutants that cause significant chromatin association defects have much less bearing on the levels 
of histone modifications. Although I could not detect any chromatin association of Paf1C lacking 
the OAR by ChIP analysis, I could still observe low levels of Rtf1-mediated histone modification 
and the levels of an Rtf1-independent, Paf1-mediated histone modification (H3 K36 Me3) was 
unaffected by the lack of OAR. I reasoned that these low levels of histone modifications were a 
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result of very low levels (undetectable by my ChIP analysis) of chromatin-associated Paf1C and 
the small reduction in chromatin association levels caused by the C-domain were not enough to 
impact the regulation of histone modifications by Paf1C. Hence, I hypothesized that removing 
two attachment points of Paf1C, the OAR of Rtf1 and the C-domain of Cdc73 would abolish all 
Paf1C-mediated histone modifications. My immunoblotting analysis is consistent with this 
hypothesis (Figure 18E). My ChIP analysis with mutations in both the OAR and the C-domain 
also suggested that the OAR and C-domain collaborate to facilitate the chromatin association of 
Paf1C (Figure 18C). 
Collectively my results described in this Chapter, provide in vivo evidence to support the 
OAR-CTR co-crystal structure and a dual-attachment hypothesis in which Paf1C is tethered to 
actively transcribed genes through the OAR of Rtf1 and C-domain of Cdc73. My data indicate 
that the OAR is a major contributor to chromatin recruitment of Paf1C. The removal of both the 
Rtf1 OAR and the Cdc73 C-domain can almost completely detach Paf1C from chromatin as 
indicated by the almost complete loss of all Paf1C-mediated histone modifications in the 
immunoblotting analysis. 
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4.0  THE HMD OF RTF1 IS SUFFICIENT TO REGULATE CO-
TRANSCRIPTIONAL HISTONE MODIFICATIONS    
Some of the figures in this Chapter have been taken from published material and reprinted with 
some changes (PIRO et al. 2012).  I have performed all the experiments for the figures shown in 
this Chapter. The work of others required for understanding the rationale behind those 
experiments has been summarized without including the corresponding figures and citing the 
paper wherever necessary. 
4.1 INTRODUCTION 
Eukaryotic transcription occurs within restrictive chromatin that can be dynamically modified 
during transcription. One of the major mechanisms through which chromatin can be altered is 
through the post-translational modification of histones. These modifications can either create 
docking sites for proteins that recognize these marks and hence facilitate their recruitment or 
alter the strength of DNA-histone interactions enhancing or diminishing the accessibility of 
DNA. Acetylated and methylated histones can target proteins containing bromodomains or 
chromodomains, respectively, to chromatin [reviewed in (SMITH and SHILATIFARD 2010)]. The 
recognition by these chromatin-binding proteins is highly specific and dependent on the number 
of groups of each modification that are covalently conjugated to histones and the residue 
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modified. Proteins with closely related recognition domains can have different specificities and 
hence different outcomes. For example, the tri-methylation of H3 K4 residues serves as a 
docking site for the PHD domain of the NuA3 histone acetyltransferase complex (TAVERNA et 
al. 2006). Since this mark predominates near the 5’ end of genes it helps maintain histones in an 
acetylated state in the regions close to the promoter. Since this modification also weakens the 
electrostatic interaction between the histone and DNA, it makes the DNA more accessible to the 
transcriptional activators and transcription machinery (TAVERNA et al. 2006). The H3 K4 Me2 
mark, on the other hand, is recognized by the PHD domain within the histone deacetylase 
complex known as the Set3 complex (KIM and BURATOWSKI 2009). Since this mark is enriched 
downstream of the H3 K4 Me3 modification, it maintains the histones in that region in the 
deacetylated state and prevents spurious initiation of transcription from intragenic regions in the 
wake of Pol II (KIM and BURATOWSKI 2009). Histones can also be subjected to additional 
modifications such as phosphorylation, ubiquitination and sumoylation.  
The chromatin alterations that influence the transit of Pol II through a chromatin template 
are regulated by transcription elongation factors coupled to the transcription machinery.  One 
such elongation factor is the Paf1 transcription elongation complex. The Paf1 complex regulates 
tri-methylation of H3 K36 by facilitating the recruitment of H3 K36 methyltransferase Set2 (CHU 
et al. 2007). Additionally, the Rtf1 subunit of Paf1C is required for the monoubiquitination of 
H2B K123 (WOOD et al. 2003). This mark is a pre-requisite for downstream H3 K4 di- and tri-
methylation and H3 K79 di- and tri-methylation (DOVER et al. 2002; KROGAN et al. 2003a; 
KROGAN et al. 2003b; NG et al. 2003a; NG et al. 2003b; WOOD et al. 2003). The Paf1 complex 
can facilitate these modifications by facilitating the recruitment of the ubiquitin-conjugating 
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enzyme Rad6, the ubiquitin ligase Bre1 and the H3 K4 methyltransferase Set1 (KIM and ROEDER 
2009; KROGAN et al. 2003a; NG et al. 2003b; WOOD et al. 2003; XIAO et al. 2005).  
Functional analysis using sequential internal deletion derivatives of Rtf1 resulted in the 
identification of a region within Rtf1 that is necessary for facilitating these Rtf1-mediated 
histone modifications (WARNER et al. 2007). We hypothesized that this region within Rtf1, 
which we termed the histone-modification domain (HMD), may play a direct role in facilitating 
these co-transcriptional histone modifications. To test this hypothesis, we determined if the 
HMD could regulate these modifications on its own with/without being tethered to a chromatin-
targeting domain, the Gal4 DNA binding domain (GBD), and attempted to uncover the 
interactions mediated by the HMD. We found that the HMD on its own was sufficient to perform 
Rtf1-mediated histone modifications even without being tethered to the GBD. However, the lack 
of association of the HMD with the rest of Paf1C may lead to the mistargeting of these marks to 
transcriptionally inactive loci. The HMD can facilitate Rtf1-dependent co-transcriptional histone 
modifications through interaction with chromatin (PIRO et al. 2012) and possibly Bre1. Our 
findings suggest that Paf1C may play an active role in facilitating co-transcriptional histone 
modifications. 
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4.2 MATERIALS AND METHODS 
4.2.1 Yeast strains and growth 
Yeast strains (Table 5) are isogenic to FY2 (WINSTON et al. 1995) and were generated through 
transformation or tetrad analysis (ROSE et al. 1990). Rich (YPD) and synthetic complete (SC) 
media were prepared as previously described (ROSE et al. 1990).  
4.2.2 Plasmids 
Plasmids pGBKT7 and pGBT9 are commercially available plasmids. For the rest of the 
plasmids, the second and the third letters in the names of the plasmids indicate the initials of the 
person who constructed them. Specifically, I constructed the “pMM” plasmids. “pMW” plasmids 
were made by Dr. Marcie Warner and “pAP” plasmids were made by Anthony Piro. The “pLS” 
and “pPC” plasmids were made by Lori Stolinski and Dr. Patrick Costa (SQUAZZO et al. 2002; 
STOLINSKI et al. 1997). Plasmid pRG147 is a gift from Dr. Richard Gardner. 
pMW8 and pAP44 are derivatives of pGBKT7 (Clontech).  pMW8 expresses an amino-
terminal fusion of GBD-Myc to amino acids 63-152 of S. cerevisiae Rtf1 (GBD-Myc-HMD).  To 
construct pMW8, PCR was performed to amplify base pairs 187-456 of RTF1 using plasmid 
pLS21-5 (STOLINSKI et al. 1997) as a template and primers that introduce NdeI and EcoRI sites 
at the 5' and 3' ends of the product, respectively. The resulting PCR product was cloned into the 
polylinker of pGBKT7.  pAP44 is analogous to pMW8, expresses the full-length Rtf1 protein as 
a fusion to GBD-Myc (GBD-Myc-Rtf1), and was constructed in the same manner.  pLS28 
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(SIMIC et al. 2003) is a derivative of pGBT9 (Clontech) and expresses an amino-terminal fusion 
of the GBD to the full-length Rtf1 protein (GBD-Rtf1).  
pAP37 expresses an amino-terminal fusion of the Large T antigen nuclear localization 
signal (NLS) to the c-Myc epitope.  To construct pAP37, oligonucleotides corresponding to the 
sense and antisense strands of the NLS were hybridized, phosphorylated using T4 polynucleotide 
kinase, and ligated to MluI/SpeI digested pAP36.  pAP39 expresses an amino-terminal fusion of 
NLS-Myc to Rtf1 residues 63-152 (NLS-Myc-HMD), and was derived from pMW8 in the same 
step-wise-manner as pAP37 was derived from pGBKT7.  pAP45 expresses the c-Myc epitope 
fused to the full-length Rtf1 protein (Myc-Rtf1), and was constructed by amplifying the RTF1 
coding sequence from pLS21-5, as for pAP44, and cloning it into pAP36 using the NdeI and 
EcoRI sites present within the polylinker.  
pMM38 is a derivative of the CEN/ARS plasmid pLS20 (STOLINSKI et al. 1997) and 
directs the expression of the NLS-Myc-HMD (Rtf1 residues 63-152) under the control of the 
RTF1 promoter.  A fragment containing the NLS-Myc-HMD coding sequence was amplified by 
PCR from template pAP39 using primers that introduce NcoI and EcoRI restriction sites at the 5' 
and the 3' ends of the product, respectively.  After digestion of the PCR product with NcoI and 
EcoRI, the ends were made blunt by treatment with Klenow and then ligated to pLS20, which 
had been digested with NdeI and AflII to remove the RTF1 coding region and blunt-ended with 
Klenow.  pMM39 encodes NLS-Myc-HMD under the control of the ADH1 promoter and is also 
a derivative of pLS20 (STOLINSKI et al. 1997).  A DNA fragment containing the ADH1 
promoter-NLS-Myc-HMD sequence was amplified from pAP39 using primers that introduce SalI 
and AflII restriction sites at the 5' and the 3' ends of the product, respectively.  The PCR product 
was then ligated to pLS20 that had been digested with SalI and AflII to remove the RTF1 coding 
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region and 800 bp of 5’ sequence.  pMM40 encodes full-length Rtf1 under the control of the 
ADH1 promoter.  The ADH1 promoter sequence was PCR-amplified from pGBKT7 with 
primers that introduce SalI and NdeI restriction sites at the 5' and the 3' ends of the product, 
respectively.  The PCR product was then ligated to pLS20, which had been digested with SalI 
and NdeI to remove 800 bp upstream of the RTF1 coding region. All final plasmids were 
confirmed by DNA sequencing. 
pPC59 encodes C-terminally TAP-tagged full length Rtf1 (SQUAZZO et al. 2002). 
pMW11 encoding TAP-tagged derivative of Rtf1, lacking the region encoding PID (Paf1C 
interaction domain, residues 491-558), was created by introducing the TAP tag at the last amino 
acid of region 11 (residue 490) by homologous recombination. Plasmid pMW13 encodes 
Rtf1Δ3-TAP (lacks Rtf1 residues 62-109) and it was obtained by site-directed mutagenesis using 
pPC59 as the template. Plasmid pMW14 encodes Rtf1Δ3ΔPID-TAP (lacks Rtf1 residues 62-109 
and residues 491-558) and was made using site-directed mutagenesis of plasmid pMW11. 
Plasmid pRG147 is a URA3-marked 2 micron plasmid expressing HA3-tagged ubiquitin (gift of 
Dr. Richard Gardner). 
4.2.3 Immunoblotting Analysis 
TCA extracts were made and western blot analysis was performed as described in Chapter 2 
(section 2.2.3). Nitrocellulose or PVDF membranes containing proteins transferred from the 
SDS-polyacrylamide gels were probed with anti-H3 K4 Me3 (1:2,000; Active Motif 39159), 
anti-H3 K4 Me2 (1:2,000; Millipore 07-030;), anti-H3 K79 Me2/3 (1:1,000; Abcam ab2621), 
anti-H3 (TOMSON et al. 2011), anti-G6PDH (1:30,000; A9521 Sigma), anti-Gal4 (DBD) (1:000; 
sc-577), anti-FLAG (1:1000; ), primary antibodies, followed by incubation with donkey anti-
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rabbit horseradish peroxidase-conjugated secondary antibody (1:5,000, GE Healthcare) or sheep 
anti-mouse horseradish peroxidase-conjugated secondary antibody (1:5000; GE Healthcare).   
4.2.4 Chromatin Immunoprecipitation 
ChIP analyses described in this Chapter were performed as described in Chapter 2 (section 
2.2.5). Immunoprecipitation was performed using Rtf1 antiserum (SQUAZZO et al. 2002) 
followed by incubation by protein A-conjugated agarose (GE Healthcare). Quantitative real-time 
PCR was performed on immunoprecipitated DNA using Maxima SYBR Green/ROX qPCR mix 
(Fermentas) in an Applied Biosystems 7300 Real Time PCR machine, and data analysis was 
performed using 7300 System SDS Software.  The association of immunoprecipitated protein 
was examined at the 5' end of PYK1 (+253 to +346; ATG = +1), GAL7 UAS (-238 to -128; ATG 
= +1) or the telomere on the right arm of chromosome VI (coordinates: 269495/269598). 
Immunoprecipitated chromatin from three independent transformants was analyzed.  Graphs 
represent (primer set efficiency)(Ct Input- Ct IP) and error bars represent the standard error of the 
mean for the three biological replicates.  
A sequential ChIP assay was used to measure chromatin-associated levels of H2B K123 
ubiquitination (CHANDRASEKHARAN et al. 2011).  Chromatin was prepared from transformants of 
yeast strain KY2085, containing plasmids pAP37, pAP39, or pAP45 and pRG147.  Strain 
KY2086, which expresses FLAG-tagged H2B K123R, served as a control to demonstrate that the 
ubiquitination signal was dependent on K123.  Chromatin was subjected to 20 cycles of 
sonication using a Misonix 3000 sonicator.  The first two cycles were performed at an output 
setting 2, and the remaining cycles were performed at an output setting 4.  Each cycle consisted 
of 20 seconds of sonication followed by a 1 min rest.  The solubilized chromatin was recovered 
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by centrifugation.  FLAG-tagged H2B was immunoprecipitated from 2.5 mg solubilized 
chromatin using anti-FLAG antibody (Sigma) and protein G beads and then eluted using 
3XFLAG peptide (Sigma) as described (CHANDRASEKHARAN et al. 2011).  50 µl of the eluate 
were set aside as input and 400 µl were incubated with anti-HA conjugated agarose (sc-7392AC) 
overnight at 4oC with end-over-end mixing.  Beads were washed twice with FA140 buffer 
(CHANDRASEKHARAN et al. 2011), once with buffer containing 10 mM Tris-HCl, pH 8, 0.25 M 
LiCl, 1 mM EDTA, 0.5% NP-40 and 0.5% sodium deoxycholate and once with buffer containing 
10 mM Tris-HCl, pH 8 and 1 mM EDTA.  The immunoprecipitated chromatin was eluted from 
the beads, pronase-treated and reverse-crosslinked as described (KURAS and STRUHL 1999).  The 
immunoprecipitated DNA from two independent chromatin preparations was used in quantitative 
real-time PCR reactions performed with SYBR Green (Fermentas).  Mean values are shown with 
error bars representing the range of the measurements.  
4.2.5 Purification of TAP-tagged proteins 
One step-affinity purification and mass spectrometry analysis was performed as described in 
Chapter 2 (section 2.2.6). However, for the targeted approach to detect the interaction of the 
HMD with Bre1 protein, the bead-bound proteins were not eluted using TEV protease. Instead, 
the washed beads were boiled for 5 minutes after resuspension in SDS loading buffer. They were 
then resolved on SDS polyacrylamide gels, transferred to nitrocellulose membranes and probed 
with anti-FLAG (1:1000; Sigma) and anti-TAP tag (1:2500; Thermo Scientific CAB 1001) 
primary antibodies and sheep anti-mouse and donkey anti-rabbit secondary antibodies (1:5000 
dilution, GE Healthcare), respectively. They were then visualized using enhanced 
chemiluminescence substrate (Perkin Elmer). 
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Table 5. Saccharomyces cerevisiae strains used for the study in this Chapter 
Strain Genotype 
KY619 MATa rtf1∆102::ARG4 arg4-12 his4-912∂ leu2∆1 lys2-173R2 trp1∆63 
KY1021 MATa his4-912∂ leu2∆1 lys2-128∂ trp1∆63 
KY1258 MATa  rtf1Δ::URA3 RAD6-13xMYC::KanMX leu2Δ1 ura3-52 trp1Δ63 
KY1876 MATa leu2Δ1 ura3-52 trp1Δ63 arg4-12 gal4∆::LEU2 rtf1∆::NatMx HSV-SET1 
BRE1-FLAG RAD6-13xMYC::KanMX 
KY2084 MATα rtf1∆::KanMX4 hta1-htb1∆::LEU2 hta2-htb2∆::KanMX ubp8∆::NatMX 
his3∆200 leu2∆1 lys2-128∂ trp1∆63 ura3-52 pJH23WT =[HTA1-
HTB1/HIS3/CEN/ARS/AmpR] 
KY2085 MATα rtf1∆::KanMX4 hta1-htb1∆::LEU2 hta2-htb2∆::KanMX ubp8∆::NatMX 
his3∆200 leu2∆1 lys2-128∂ trp1∆63 ura3-52 pJH23FL =[HTA1-FLAG-
HTB1/HIS3/CEN/ARS/AmpR] 
KY2086 MATα hta1-htb1∆::LEU2 hta2-htb2∆::KanMX ubp8∆::NatMX his3∆200 
leu2∆1 lys2-128∂ trp1∆63 ura3-52 pCD2 =[HTA1-FLAG-HTB1-
K123R/HIS3/CEN/ARS/AmpR] 
KY2123 MATa rtf1∆::KanMX4 gal4∆::LEU2 leu2∆1 lys2-128∂ trp1∆63 ura3-52 
KY2124 MATa rtf1∆::KanMX4 hta1-htb1∆::LEU2 hta2-htb2∆::KanMX his3∆200 
leu2∆1 lys2-128∂ trp1∆63 ura3-52 pJH23WT =[HTA1-HTB1/HIS3/ 
CEN/ARS/AmpR] 
KY2125 MATa rtf1∆::KanMX4 hta1-htb1∆::LEU2 hta2-htb2∆::KanMX his3∆200 
leu2∆1 lys2-128∂ trp1∆63 ura3-52 pJH23FL =[HTA1-FLAG-HTB1/HIS3/ 
CEN/ARS/AmpR] 
KY2195 MATα rtf1∆101::LEU2 cdc73∆::KanMX4 his4-912∂ leu2∆1 trp1∆63 
KY2232 MATa rtf1∆::KanMX paf1∆::URA3 hta1-htb1∆::LEU2 hta2-htb2∆::KanMX 
ubp8∆::NatMX his3∆200 leu2∆1 lys2-128∂ trp1∆63 ura3-52 pJH23FL 
=[HTA1-FLAG-HTB1/HIS3/CEN/ARS/AmpR] 
KY2234 MATα rtf1∆::KanMX ctr9∆::URA3 hta1-htb1∆::LEU2 hta2-htb2∆::KanMX 
ubp8∆::NatMX his3∆200 leu2∆1 lys2-128∂ trp1∆63 ura3-52 pJH23FL 
=[HTA1-FLAG-HTB1/HIS3/CEN/ARS/AmpR] 
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GHY1144* MATa rtf1∆101::LEU2 leo1∆::URA3 his4-912∂ leu2∆1 lys2-128∂ trp1∆63 
ura3-52 
*provided by Dr. Grant Hartzog 
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4.3 RESULTS 
4.3.1 The Rtf1 HMD is sufficient to promote Rtf1-dependent histone modifications  
Previous studies involving functional analysis of sequential internal deletion derivatives of Rtf1 
led to the identification of a region within Rtf1 (Rtf1 residues 62-152) that when deleted leads to 
the loss of Rtf1-dependent histone modifications including H2B K123 Ub, H3 K4 Me3 and H3 
K79 Me2 and hence this region was termed the histone modification domain (HMD) (WARNER 
et al. 2007). This finding laid the foundation for future work on the HMD in the Arndt laboratory 
that was aimed at exploring the mechanism by which the HMD facilitates histone modifications. 
This functional analysis of Rtf1 had also led to the identification of a central region within Rtf1 
that was important for the chromatin association of Paf1C (WARNER et al. 2007). Based on these 
results, it was hypothesized that if the HMD was expressed in conjunction with a chromatin-
targeting domain such as the Gal4 DNA binding domain (GBD), which can bind to the GAL7 
upstream activating sequence (UAS), it could facilitate histone modifications at that region 
(GAL7 UAS). 
ChIP analysis and immunoblotting analysis performed with the GBD-Myc-HMD 
expressed under the ADH1 promoter suggested that the Rtf1 HMD (Rtf1 residues 63-152) can 
indeed bind to the GAL7 UAS and facilitate Rtf1-dependent co-transcriptional histone 
modifications including H3 K4 Me3 and H3 K79 Me2 at this locus (PIRO et al. 2012). 
Interestingly, ChIP analysis also suggested that the fusion protein of the HMD with the GBD 
also facilitated these modifications at other transcriptionally active loci not normally bound by 
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the GBD (PIRO et al. 2012). The appearance of Rtf1-mediated histone modifications at the PYK1 
gene suggested that the GBD-HMD may have the ability to bind this locus. Since the GBD does 
not specifically bind to the PYK1 gene, it was anticipated that the overexpression of either the 
GBD or the HMD could be leading to association of the GBD-HMD protein with the locus. To 
confirm that the GBD-HMD could bind to loci other than the GAL7 UAS, I performed ChIP 
analysis on the GBD-HMD protein. As expected, the GBD-HMD protein showed high levels of 
occupancy at the GAL7 UAS. However, it also showed binding to the PYK1 gene and a telomeric 
region although at much lower levels compared to that at the GAL7 UAS (Figure 19A).  
To test the possibility that the binding of the GBD-HMD fusion protein to loci other than 
the GAL7 UAS was mediated by the HMD, the region encoding the HMD was fused to a nuclear 
localization signal (NLS) to direct the HMD to the nucleus. Immunoblotting and ChIP analyses 
were then performed with the NLS-Myc-HMD protein. Just like the GBD-HMD (Figure 19A), 
the NLS-Myc-HMD protein bound to the active genes and facilitated H3 K4 Me3 and H3 K79 
Me2/3 at these loci (PIRO et al. 2012). Additionally, it also bound non-transcribed loci and 
facilitated low level of H3 K79 Me2/3 at a non-transcribed locus (PIRO et al. 2012). Thus, the 
HMD may have the ability to bind to chromatin in a non-specific manner, which subsequently 
may lead to the targeting of a co-transcriptional histone modification at a non-transcribed locus. 
Consistent with the ChIP analysis, my western blot analysis also suggests that the NLS-Myc-
HMD protein also facilitates H3 K4 Me3, H3 K4 Me2 and H3 K79 Me2/3 at global levels 
(Figure 19B).  
We wanted to determine if the HMD was facilitating these methylation marks through the 
known pathway for H3 K4 Me2/3 and H3 K79 Me2/3, which requires the H2B K123 Ub mark as 
a pre-requisite (DOVER et al. 2002; NG et al. 2002b). Hence, I performed ChIP analysis and 
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western blot analyses to determine the levels of H2B K123 Ub mark at an active gene and the 
global levels of H2B K123 Ub in cells expressing NLS-Myc-HMD protein. I performed 
sequential ChIP analysis using cells expressing FLAG-tagged H2B and overexpressing HA-
tagged ubiquitin on plasmids to determine the levels of H2B K123 Ub at the PYK1 gene, since 
we lacked an antibody specific for the H2B K123 Ub mark and a good antibody against 
ubiquitin. The presence of FLAG-tagged H2B allowed me to immunoprecipitate H2B from 
crosslinked chromatin of these cells using an antibody against the FLAG tag. I then 
immunoprecipitated ubiquitinated H2B from this immunoprecipitated fraction using an antibody 
against the HA tag of the overexpressed ubiquitin. Strains expressing FLAG-tagged H2B K123 
that cannot be ubiquitinated at lysine 123 (H2B K123R) and overexpressing HA-tagged ubiquitin 
served as a negative control in this sequential ChIP analysis since these cells lack the H2B K123 
Ub mark. Consistent with the ability of the NLS-Myc-HMD protein to facilitate methylation of 
H3 K4 and H3 K79, my sequential ChIP analysis also indicated that the NLS-Myc-HMD protein 
can promote monoubiquitination of histone H2B at lysine 123 at an active gene (Figure 19C).  
 To confirm the rescue of the H2B K123 Ub mark by the NLS-Myc-HMD protein at the 
global level, I performed western blot analysis with an antibody against the FLAG tag in strains 
expressing FLAG-tagged histone H2B to visualize both the unmodified H2B as well as 
monoubiquitinated H2B. Since monoubiquitinated H2B runs slower than the unmodified H2B on 
a 15% SDS-PAGE gel it can be differentiated from unmodified H2B. An rtf1Δ strain containing 
the vector alone serves as a negative control for H2B K123 Ub in this western analysis since 
rtf1Δ strains are incapable of monoubiquitinating H2B K123 [reviewed in (CRISUCCI and ARNDT 
2011)] and hence the extracts of these strains lack the lower mobility band corresponding to the 
ubiquitinated form of H2B K123 (Figure 19D, lane 2). A strain expressing untagged H2B served 
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as negative control for the FLAG western analysis since they lack the bands corresponding to 
both the unmodified H2B and H2B that is monoubiquitinated at lysine 123 (Figure 19D, lane 1). 
In accordance with my ChIP analysis, my western blot analysis also suggested that the HMD can 
facilitate H2B K123 Ub at a global level (Figure 19D, lane 3). 
However, I found that global levels of H3 K4 Me3, H3 K4 Me2 and H3 K79 Me2/3 in 
cells expressing NLS-Myc-HMD protein were higher than those of cells expressing a fusion 
protein of GBD and HMD indicating that fusion to the GBD was impairing the function of the 
HMD (Figure 19B, lanes 2 and 3). However, fusing the GBD to full-length Rtf1 did not greatly 
affect the levels of histone modifications (Figure 19B, lanes 4 and 5). This functional impairment 
of the HMD could be a result of diminished protein levels of the GBD-HMD fusion protein or 
reduced activity of the GBD-HMD protein or both. To test the effect of protein levels, I 
performed immunoblot analysis. This analysis indicated that both the GBD-HMD and the GBD-
Rtf1 fusion proteins were expressed at much lower levels than the NLS-Myc-HMD and Myc-
Rtf1 proteins (Figure 19E). This suggests that reduction of total protein levels by fusion of the 
GBD to the HMD greatly affects the ability of the HMD to promote the co-transcriptional 
modification of histones while full-length Rtf1 even when expressed at lower levels by fusion to 
the GBD continues to function as well as Rtf1 alone. However, we cannot rule out the possibility 
that the lower signal for the GBD-HMD and the GBD-Rtf1 proteins with anti-Rtf1 antibody 
could be an impact of reduced accessibility of the epitope. Thus, although our western blot 
analysis that the functional impairment of the GBD-HMD was due to diminished protein levels, 
we cannot rule out the possibility that fusion to the GBD could have affected the ability of the 
HMD to facilitate the addition of the ubiquitin and methyl groups to histones.  
 133 
Since the GBD-HMD was observed to be hypofunctional and the NLS-Myc-HMD 
protein was found to be capable of associating with chromatin and modifying histones, the rest of 
the studies aimed at uncovering the mechanism of regulation of histone modifications by the 
HMD were pursued using the construct expressing the NLS-Myc-HMD fusion protein.  
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 Figure 19. The HMD is sufficient to promote H3 K4 and K79 methylation and H2B K123 
monoubiquitination 
(A) ChIP analysis of Rtf1 levels at the GAL7 UAS, 5’ region of PYK1 or at telomeric region in rtf1∆ gal4∆ 
(KY2123) transformants expressing GBD-Myc (pGBKT7) or GBD-Myc-HMD (pMW8). (B) Immunoblot analysis 
of histone modifications in rtf1∆ gal4∆ (KY2123) transformants expressing GBD-Myc (pGBKT7), GBD-Myc-
HMD (pMW8), NLS-Myc-HMD (pAP39), GBD-Myc-Rtf1 (pAP44) and Myc-Rtf1 (pAP45). Immunoblot analysis 
of H3 served as a control for total amount of histones and G6PDH levels as a control for the amount of extract 
loaded. (C) Sequential ChIP analysis of FLAG-H2B K123 Ub at the 5’ region of  PYK1. An rtf1Δ strain (KY2085), 
containing a FLAG-HTB1 expression plasmid as the sole source of H2B, was co-transformed with a 2-micron 
plasmid expressing HA3-ubiquitin (pRG147) and a 2-micron plasmid expressing NLS-Myc (pAP37), NLS-Myc-
HMD (pAP39) or Myc-Rtf1 (pAP45). A strain (KY2086) containing FLAG-H2B-K123R as the sole source of H2B 
and transformed with HA3-ubiquitin (pRG147) provides a specificity control for the H2B K123ub mark. Mean 
values from two biological replicates are shown with error bars representing the range of the data. (D) Anti-FLAG 
immunoblot analysis of rtf1Δ strains expressing untagged H2B (KY2084) or rtf1Δ strains (KY2085), rtf1Δ paf1Δ 
strains (KY2232) or rtf1Δ ctr9Δ strains (KY2234) expressing FLAG-H2B and, NLS-Myc vector (pAP37), NLS-
Myc-HMD (pAP39) or Myc-Rtf1 (pAP45). (E) Immunoblot analysis of the Rtf1/HMD levels was performed using 
extracts of strains described in (B).  
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4.3.2 The over-expression of the HMD is required for the full-functionality of the 
HMD 
Our immunoblotting and ChIP analyses with the GBD-HMD fusion protein suggested that the 
functionality of the HMD might be dependent on the levels of the HMD protein. To test the 
dependency of the functionality of the HMD on the levels of the HMD expressed, I made 
plasmid constructs expressing the NLS-Myc-HMD protein on a low-copy-number plasmid 
(CEN/ARS origin) or a high-copy-number plasmid (2µ origin of replication) and under the 
control of the endogenous RTF1 promoter or a strong promoter (ADH1). I performed 
immunoblotting analysis with transformants of cells expressing varying levels of the NLS-Myc-
HMD protein and full-length Rtf1 protein to determine the impact of the HMD protein levels on 
the histone modifications. When similar amounts of extracts were loaded on SDS-
polyacrylamide gels for western blot analysis, the HMD and Rtf1 signals for the high-copy and 
low-copy plasmids with the ADH1 promoter were saturated. Hence, I stripped this blot partially 
by a short incubation with stripping buffer and redeveloped it, which allowed a comparison of 
the HMD expression levels under a strong promoter on high and low copy plasmids in the linear 
range. However, this partial stripping protocol led to complete stripping of the relatively weak 
Rtf1 signal for the HMD expressed under its endogenous promoter on a low copy plasmid 
(Figure 20A). Hence, I separately analyzed the expression of the HMD and Rtf1 on CEN/ARS 
plasmids (biological duplicates) (Figure 20B). As expected, the HMD expressed on a high-copy-
number plasmid under a strong promoter showed highest level of expression, followed by the 
HMD expressed on a low copy number plasmid under a strong promoter (Figure 20A). The 
HMD expressed on a low-copy-number plasmid under the endogenous RTF1 promoter was 
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expressed at the lowest levels (Figure 20A and B). Consistent with the dependency of the full-
functionality of the HMD on the total levels of the HMD protein, I found the highest levels of H3 
K4 Me3, H3 K4 Me2 and H3 K79 Me2/3 in cells expressing the HMD on a high-copy-number 
plasmid under a strong promoter followed by a low-copy-number plasmid under a strong 
promoter. The cells expressing the HMD on a low-copy-number plasmid under the endogenous 
RTF1 promoter did not show any detectable levels of these Rtf1-mediated histone modifications 
(Figure 20C). 
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Figure 20. Overexpression of the HMD is essential for the HMD protein to promote Rtf1-dependent 
histone modifications 
 (A-C) Immunoblot analysis was performed using polyclonal Rtf1 antiserum to measure the levels of Rtf1 proteins 
(A and B) and histone modifications (C) in rtf1∆ gal4∆ strains (KY2123) transformed with either empty vector 
(pAP37) or 2-micron (ADH1 promoter) plasmids encoding NLS-Myc-HMD (pAP39) or Myc-Rtf1 (pAP45) or rtf1∆ 
strains (KY619) transformed with CEN/ARS (RTF1 promoter) plasmids that express NLS-Myc-HMD (pMM38) or 
Rtf1 (pLS20) or rtf1∆ strains (KY619) transformed with CEN/ARS (ADH1 promoter) plasmids that express NLS-
Myc-HMD (pAP39) or Rtf1 (pMM40).  G6PDH and H3 levels serve as loading controls. Figure (B) shows a 
comparison of Rtf1 and HMD expression driven by the ADH1 and the RTF1 promoters in two different 
transformants for the indicated CEN/ARS plasmids. 
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4.3.3 The HMD can facilitate most of the Rtf1-mediated histone modifications in 
the absence of other members of Paf1C 
Although the HMD lacks the domain of Rtf1 indispensable for the interaction of Rtf1 with the 
rest of Paf1C, it is possible that it could still be aided by the rest of Paf1C in promoting the 
histone modifications. To test this possibility, I performed immunoblotting analysis with cells 
lacking the Cdc73 or the Leo1 subunit of Paf1C and expressing the HMD and determined the 
levels of the Rtf1-mediated histone modifications in these cells. My immunoblotting analysis 
indicated that lack of Leo1 had no effect on the levels of the histone modifications tested and the 
total HMD levels. The absence of Cdc73 had no effect on the levels of H3 K79 Me2/3, a small 
effect on H3 K4 Me2 levels and a bigger impact on the H3 K4 Me3 levels with no apparent 
effect on the levels of the HMD expressed (Figure 21A and B). The absence of Paf1 and Ctr9  
subunits were also shown to have similar effect as Cdc73 on the H3 K4 Me3, H3 K4 Me2 and 
H3 K79 Me2/3 levels and the proteins levels of the HMD (PIRO et al. 2012). However, the 
absence of Paf1 and Ctr9 subunits did not greatly affect the ratio of global levels of modified 
H2B (H2B K123 Ub) to unmodified H2B facilitated by the NLS-Myc-HMD protein (Figure 
19D; lanes 3, 4, 6, 7, 9 and 10). This suggests that other members of Paf1C may facilitate the 
higher extent of methylation on the histone H3 K4 residue through an unknown mechanism.  
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Figure 21. The HMD functions independently of other Paf1C members 
(A and B) Immunoblot analysis of H3 K4 and K79 methylation (A) or Rtf1 protein levels (B) in rtf1∆ (KY2123), 
rtf1∆ cdc73∆ (KY2195) or rtf1∆ leo1∆ (GHY1144) strains expressing NLS-Myc-HMD (pAP39), Myc-Rtf1 
(pAP45) or transformed with vector (pAP37) or a wild-type strain (KY1021). 
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4.3.4 The HMD physically associates with Bre1 
Uncovering the protein-protein interactions mediated by the HMD using a targeted approach and 
an unbiased proteomics approach could provide us better insight into the mechanism through 
which the HMD facilitates histone modifications. To do this, we decided to take two 
complementary approaches. As part of the subtractive proteomics approach, I performed one-
step affinity purification with extracts of strains expressing a TAP-tagged derivative of Rtf1 that 
lacked a part of the HMD, the removal of which was previously shown by our laboratory to 
abolish the Rtf1-dependent histone modifications (WARNER et al. 2007). Additionally, I also 
performed one-step affinity purification with a TAP-tagged derivative that lacked the domain of 
Rtf1 important for the interaction of Rtf1 with the other members of Paf1C which we termed the 
PID (Paf1C interaction domain) (WARNER et al. 2007) alone and in combination with partial 
deletion of the HMD. Identifying the interactions lost in these TAP-tagged deletion derivatives 
of Rtf1 could allow the identification of the interactions that were collaboratively maintained by 
the HMD and the other members of Paf1C in order to facilitate Rtf1-dependent histone 
modifications. I also performed one-step affinity purification in parallel with full-length TAP-
tagged and untagged Rtf1 to identify all the interactions mediated by Rtf1 and the non-specific 
interactions occurring through the non-specific binding of the proteins in the clarified yeast 
extracts to the IgG-conjugated magnetic beads. Consistent with our previous observations 
(WARNER et al. 2007), the mass spectrometry data showed that the interaction of Rtf1 with the 
rest of the members of Paf1C was lost in the affinity-purified derivatives of TAP-tagged Rtf1 
that lacked the PID alone and PID in combination with part of the HMD (Figure 22A). However, 
we could not identify any interactions that were consistently lost in the affinity-purified 
derivatives of TAP-tagged Rtf1 that lacked part of the HMD nor did we detect any interactions 
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that were retained in the PID deletion derivative but lost in the double deletion derivative lacking 
the PID and part of the HMD (Figure 22A). 
As a complementary approach, I also performed one-step affinity purification of TAP-
tagged HMD, TAP-tagged Rtf1, untagged Rtf1 and untagged HMD and attempted to identify the 
specific interactions of Rtf1 that were mediated by the HMD using immunoblotting analysis. The 
strains that I used in this analysis expressed FLAG-tagged Bre1 from the endogenous locus to 
allow detection of a possible interaction between the HMD and Bre1 protein by immunoblotting 
with an antibody against the FLAG tag. Since the HMD is required for the monoubiquitination of 
H2B K123 catalyzed by the ubiquitin-conjugating enzyme Rad6 and ubiquitin-ligating enzyme 
Bre1 and Bre1 is required for targeting Rad6 to H2B K123 (KIM and ROEDER 2009), we 
anticipated that the HMD could be facilitating the monoubiquitination of H2B K123 through an 
interaction with Bre1.  
When I performed immunoblotting analysis on the one-step affinity purified Rtf1-TAP, 
NLS-HMD-TAP and untagged Rtf1 and NLS-HMD, I detected a band corresponding to FLAG-
Bre1 in the bound fractions of Rtf1-TAP and HMD-TAP but not in the bound fractions of 
untagged Rtf1 and HMD proteins (Figure 22B). This suggests that the HMD may be interacting 
with Bre1 protein and hence facilitating the monoubiquitination of H2B K123. However, this 
experiment was performed only once and hence needs to be repeated to confirm the result. Also, 
Bre1 was not identified as an interactor in the mass spectrometry analysis of the Rtf1-TAP 
protein. This may be due to association of small amounts of Bre1 with the HMD protein that 
could lead to the masking of the mass spectrometry signal for Bre1 peptides by the peptides of 
other major interactors present in higher amounts in the affinity purified Rtf1-TAP. 
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A.  
Proteins Rtf1 Rtf1-
TAP 
Rtf1Δ3-
TAP 
Rtf1ΔPID-
TAP 
Rtf1Δ3ΔPID-
TAP 
CTR9 1 54 43 5 1 
PAF1 1 34 35 0 0 
RTF1 1 33 21 37 28 
PAB1 3 25 16 21 19 
LEO1 0 24 21 1 0 
CDC73 0 22 19 1 0 
IMD3 2 17 15 16 20 
VMA2 2 16 12 8 8 
TY1B-DR1 0 14 6 0 4 
SPT5 0 13 8 10 11 
TY1B-DR5 0 13 0 1 10 
SPT16 0 12 9 5 9 
RRP5 0 12 5 13 14 
DED1 1 11 10 17 12 
URA2 0 11 3 2 1 
RPL4A 3 10 5 8 9 
CPA2 0 9 2 1 0 
ATP2 2 8 5 3 4 
PFK1 1 8 3 3 2 
KAP123 1 8 6 3 3 
HTB2 2 7 6 8 9 
SSBR1 1 7 5 6 5 
TY1B-ER1 0 7 13 8 10 
CKA2 0 7 5 12 8 
KEM1 2 7 3 5 5 
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Figure 22. Identifying the HMD-mediated interactions of Rtf1 
(A) Extracts of rtf1Δ strains (KY1258) bearing plasmids expressing Rtf1 (pLS20), Rtf1-TAP (pPC59), Rtf1Δ3-TAP 
(pMW13), Rtf1ΔPID-TAP (pMW11) and Rtf1Δ3ΔPID-TAP (pMW14) were subjected to one-step affinity 
purification using IgG-conjugated magnetic beads, and mass spectrometry analysis was performed on the isolated 
proteins.  The average number of peptides identified for each protein in four trials is listed.  The first 25 hits sorted 
by the results for Rtf1-TAP are shown after elimination of the interactors that showed less than three-fold 
enrichment for Rtf1-TAP over untagged full-length Rtf1. (B) Immunoblotting analysis was performed with antibody 
against the FLAG tag to determine if one step affinity purified HMD (expressed from pAP46) from an rtf1Δ strain 
expressing FLAG-tagged Bre1 (KY1876) could interact with Bre1. One-step affinity purified Rtf1-TAP (expressed 
from pPC59) served as control to show that an interaction observed with the HMD alone was not an artifact arising 
from overexpression of the isolated HMD. Untagged Rtf1 (expressed from pLS20) and HMD (expressed from 
pAP39) served as negative controls for the affinity purification. Immunoblotting with antibody against the TAP tag 
served as a control to show the successful pull-down of the TAP-tagged proteins. Rtf1 protein has a seven-peptide 
sequence similar to that of FLAG epitope (Rtf1 residues 196-202) that leads to detection of Rtf1 by an antibody 
against the FLAG tag. 
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4.4 DISCUSSION 
Paf1C regulates the expression of several genes within the cell such as those required for 
maintaining stem cell pluripotency, genes involved in eliciting an antiviral immune response and 
the downstream target genes of crucial signaling pathways including Notch, Hedgehog and Wnt 
signaling pathways [reviewed in (TOMSON and ARNDT 2013)]. One of the major mechanism 
through which Paf1C affects gene expression is through its role in promoting co-transcriptional 
histone modifications. Our laboratory previously identified the region (HMD) necessary for 
Paf1C mediated histone modifications including H2B K123 Ub, H3 K4 Me3, H3 K4 Me2 and 
H3 K79 Me2 (WARNER et al. 2007). This study laid the foundation for future studies in our lab 
directed towards uncovering the mechanism of regulation of histone modifications by the HMD 
of Rtf1.  
The work described in this Chapter mainly represents my contribution to a recently 
published study from the Arndt laboratory which showed that the HMD is not only necessary but 
also sufficient to mediate most of the Rtf1-dependent histone modifications and it does so by 
binding to chromatin (PIRO et al. 2012). I showed that the HMD when fused to the GBD not only 
binds to GAL7 UAS but also another actively transcribed locus not normally bound by GBD and 
also a transcriptionally inactive locus (a telomeric region) although at lower levels compared to 
its occupancy at the GAL7 UAS (Figure 19A). This and additional ChIP analyses performed with 
the HMD alone, which showed that the HMD binds to non-transcribed loci and leads to the 
targeting of a co-transcriptional histone modification (H3 K79 M2/3) at the telomeric region 
(PIRO et al. 2012), suggest that if the HMD is expressed on its own in the absence of the rest of 
the Rtf1 protein, it may not be targeted to specific areas of the genome. My work described in 
Chapter 2 showed that the region of Rtf1 previously implicated in the chromatin association of 
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the entire Paf1C, the OAR of Rtf1, can however mimic the chromatin association pattern of the 
entire Paf1C (Figure11 and 12). Thus, the OAR of Rtf1 is critical for the proper chromatin 
targeting of Paf1C and dictates the localization pattern of the HMD, which also appears to have 
some intrinsic chromatin-association activity.  
Additionally, I also showed that the HMD does not require aid from the other members of 
Paf1C to monoubiquitinate lysine 123 of histone H2B (Figure 20D) and also to methylate H3 
K79 and H3 K4 (Figure 21) (PIRO et al. 2012). However, it does need some assistance from the 
rest of Paf1C for mainly H3 K4 Me3 and to a small extent for full levels of H3 K4 Me2 (Figure 
21). The effect of the absence of the other members of Paf1C on the functionality of the HMD 
seems to recapitulate the effect of the absence of the Cps40 and Cps60 subunits of COMPASS 
(Complex of proteins associated with Set1) on these modifications (SCHNEIDER et al. 2005). The 
absence of these subunits affects the extent of methylation by COMPASS without affecting the 
association of Set1. The rest of Paf1C may be required for the chromatin association of Cps40 or 
Cps60 subunits, which could be tested using ChIP analyses. The other mechanism by which the 
rest of Paf1C could influence the higher states of H3 K4 methylation could be by facilitating the 
longer residence of the methyltransferase Set1 on genes, which may be essential for the addition 
of multiple methyl groups. This could be tested by looking at the rate at which Set1 dissociates 
from a long gene YLR454 (an 8 kb long gene) under the GAL1 promoter upon shifting the cells 
from an activating galactose-containing medium to a repressing glucose-containing medium in 
cells expressing the HMD and lacking or containing the rest of Paf1C. Another mechanism by 
which the absence of the rest of Paf1C could result in reduced H3 K4 tri-methylation could be 
that the other members of Paf1C may protect the methylation groups from the action of the H3 
K4 demethylase. This could be tested by determining if the chromatin bound or global levels of 
 148 
Jhd2 protein, the demethylase for the methylation at the H3 K4 residue (HUANG et al. 2010), are 
increased in cells lacking the Paf1, Ctr9 or Cdc73 subunits of Paf1C using ChIP and 
immunoblotting analyses, since the absence of these subunits greatly reduced the effect of the 
HMD on H3 K4 Me3 levels (Figure 21A) (PIRO et al. 2012). 
Furthermore, I showed that the ability of the HMD to facilitate histone modifications 
correlates with the levels of HMD expression (Figure 20). The HMD when expressed at high 
levels on a high-copy-number plasmid under a strong promoter (ADH1) showed complete rescue 
of all the Rtf1-mediated modifications, but when it was expressed on a low-copy-number 
plasmid under endogenous RTF1 promoter, which is weaker compared to ADH1 promoter, it did 
not show any detectable rescue of histone modifications (Figure 20). Consistent with this, I also 
observed that fusion of the HMD to the GBD diminished the levels of total protein and 
correspondingly resulted in a reduction in the global levels of histone modifications (Figure 19B 
and E). This suggests that the HMD has to be present at high levels to facilitate Paf1C-mediated 
functions on its own. This may be due to weaker or transient association of the HMD that is 
stabilized in the presence of the rest of Rtf1. A much higher amount of HMD may be required to 
stabilize the association of the HMD with chromatin when the rest of Rtf1 is lacking. That 
overexpression of the HMD does not override the need for the components of the canonical H2B 
ubiquitination pathway, mainly Rad6 and Bre1, suggests that overexpression of the HMD does 
not lead to histone modifications by an alternative mechanism (PIRO et al. 2012).  
My affinity purification and immunoblotting with TAP-tagged HMD suggests that Bre1 
may interact with the HMD (Figure 22B). Work by Anthony Piro also suggested that the HMD 
can interact with nucleosomes using a nucleosome pull-down assay and immunoblotting, and 
mutations within the HMD that greatly reduce the levels of Rtf1-mediated histone modifications 
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also correspondingly impair the ability of the HMD to interact with nucleosomes  (PIRO et al. 
2012; TOMSON et al. 2011). These results suggest that interaction of the HMD with both the 
enzyme (Bre1) and the substrate (histones) may regulate the monoubiquitination of lysine 123 at 
histone H2B. The impact of the HMD on the chromatin association of Bre1 can be tested by 
determining the levels of Bre1 on chromatin in cells expressing HMD and HMD mutants that 
nearly abolish the Rtf1-mediated histone modifications.  
Cumulatively, my work described in this Chapter has provided better insights into the 
mechanism of regulation of histone modifications by the HMD and has raised more interesting 
questions that can be addressed in the future.  
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5.0  CONCLUSIONS AND FUTURE DIRECTIONS 
5.1 THE OAR OF RTF1 FACILITATES THE RECRUITMENT OF PAF1C 
THROUGH INTERACTION WITH THE CTR OF SPT5 
Regulation of transcription is essential for proper gene expression. Chromatin obstructs the 
binding and the movement of the transcription machinery. Hence, eukaryotes have evolved 
numerous accessory factors that associate with the transcriptional machinery to facilitate its 
passage through chromatin. One such factor is the conserved Paf1C that regulates transcription 
through several mechanisms including promoting co-transcriptional histone modifications, 
recruiting chromatin remodelers, maintaining nucleosome stability during transcription and 
regulating 3’-end formation of RNA. Paf1C positively regulates the expression of several genes 
including those involved in maintaining stem cell pluripotency, antiviral response and cell cycle 
progression. Misregulation of Paf1C can cause developmental defects and diseases such as 
cancer. However, the mechanism of recruitment of this important complex was unclear when I 
began my studies. The Spt4-Spt5 complex, the Bur1-Bur2 kinase complex, the Ccr4-Not 
complex and Spt16 were previously implicated in the recruitment of Paf1C to actively 
transcribed genes [reviewed in (JAEHNING 2010)], but a detailed molecular mechanism for the 
recruitment of Paf1C was lacking. My work provided a molecular mechanism for tethering 
Paf1C to the transcription machinery, supported by both studies in vivo and in vitro.  
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Previous work in our laboratory had indicated that a central region within Rtf1, termed 
the ORF association region or the OAR, is important for the chromatin occupancy of Paf1C. 
OAR is the most conserved region of Rtf1 suggesting its involvement in a crucial functional role. 
Hence, we decided to uncover the details of the mechanism involved in the functioning of the 
OAR. After mapping the boundaries of the functional OAR by analysis of the predicted 
secondary structure and degree of conservation, I took a subtractive proteomics approach and 
discovered that the OAR of Rtf1 mediates the interaction of Paf1C with the evolutionarily 
conserved transcription elongation factor Spt5 (Figure 7 and 9). Since Spt5 can directly interact 
with Pol II and has other regions that can facilitate its interactions with other elongation factors, 
it seemed to be a perfect candidate for coupling Paf1C to the transcription machinery. Using co-
immunoprecipitation analysis, I further demonstrated that the CTR of Spt5 is important for the 
OAR-mediated interaction between Spt5 and Paf1C (Figure 9). After I successfully identified the 
regions of both Paf1C and Spt5 that facilitate the interaction of Paf1C with Spt5 and hence allow 
the targeting of Paf1C to chromatin under physiologically relevant conditions, I then performed 
in vitro binding assays with purified recombinant derivatives of Rtf1 and Spt5 and showed that 
the Rtf1 OAR and the Spt5 CTR are necessary and sufficient for the interaction of Rtf1 with 
Spt5 (Figure 10). 
To test if the OAR is also functionally sufficient to associate with chromatin in a 
regulated manner, I performed ChIP analyses and showed that that OAR alone associates with 
actively transcribed genes in a pattern similar to that of Paf1C (dissociating from the chromatin 
at the poly(A) site), does not require assistance from other subunits of Paf1C to accomplish its 
function and associates with chromatin in a manner dependent on the Spt5 CTR and the Bur1-
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Bur2 kinase complex suggesting that the interaction of the OAR with phosphorylated Spt5 CTR 
is functionally important for the OAR (Figure 10-13). 
Our collaborators, Adam Wier, Dr. Annie Heroux and Dr. Andrew VanDemark, obtained 
the crystal structure of both the human OAR/Plus3 alone and the human OAR/Plus3 in a 
complex with the phosphorylated human Spt5 CTR. The OAR-CTR crystal structure showed 
that the interaction that I discovered in yeast is conserved in humans as well (Figure 17). Most of 
the residues that I found to be functionally important using Spt- phenotypic analysis, a phenotype 
caused by transcriptional defects, and ChIP analysis were at the OAR-CTR interface mediating 
the OAR-CTR interaction, thus providing a structural validation of my mutational analysis 
(Figure 15-17). The OAR-CTR co-crystal is held by two interactions, a set of electrostatic 
interactions between the phosphate groups of the phosphorylated Spt5 CTR and the polar 
residues of the OAR and a set of Van Der Waals interactions between the aromatic residues of 
the OAR and the CTR (Figure 17). My ChIP analysis with the OAR mutant (Rtf1-R251A, 
Y327A) that impaired both the interactions suggested that the contacts observed in the context of 
the OAR-CTR crystal were indeed facilitating the chromatin association of Paf1C in the S. 
cerevisiae cells (Figure 17 and 18). 
Low but measurable chromatin occupancy of the OAR alone in a strain expressing Spt5 
lacking the CTR suggests the involvement of additional factors that could be mediating the 
recruitment of Paf1C through the OAR (Figure 13). Since these factors were not uncovered by 
our subtractive proteomics approach, we could perform affinity purification and mass 
spectrometry analysis with OAR-TAP to enrich for important interactions of the OAR that 
facilitate the chromatin association of Paf1C.   
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As an alternative approach to identify novel direct or indirect regulators of the chromatin 
association of Paf1C we can perform a high-copy suppressor screen to identify proteins that 
when overexpressed can suppress the Spt- phenotype caused by the impaired association of 
Paf1C in an OAR mutant such as the Plus3 mutant (Rtf1-R251E R273E K299E). Paf1C 
dissociates from the chromatin at the poly(A) site while Spt5 continues further with Pol II. Why 
is it important for Paf1C to dissociate from chromatin at the poly(A) site? To address this 
question, we could construct a fusion protein of Spt5 with Rtf1 and first determine if the fusion 
protein is functional. This can be done by performing growth assays to determine to test if the 
cells expressing the Spt5-Rtf1 fusion protein exhibit phenotypes indicative of transcriptional 
defects such as Spt- phenotype and sensitivity to the nucleotide analog 6-Azauracil. 
Immunoblotting analysis can also be performed to determine the levels of Paf1C-mediated co-
transcriptional histone modifications in these cells. If the fusion protein is functional, we could 
use the cells expressing the fusion protein to determine the consequence of lack of dissociation 
of Paf1C from Spt5 at the poly(A) site. The presence of Rtf1 will also lead to the association of 
the rest of Paf1C with Spt5 through the PID (Paf1C interaction domain) of Rtf1.  
ChIP analysis can then be performed to determine if Paf1C associates with chromatin 
beyond the poly(A) site in these cells. The cells expressing this fusion protein can then be 
subjected to several analyses to determine the biological outcome of tethering Paf1C beyond the 
poly(A) site such as determining if these cells have termination defects. Since the CTR of Spt5 
can bind both elongation factors (Paf1C) and termination factors (CFI complex) the chromatin 
association of which is enriched at the poly(A) site, it is possible that these cells will exhibit 
termination defects due to impaired recruitment of termination factors (MAYEKAR et al. 2013; 
MAYER et al. 2012). If they do exhibit termination defects, ChIP analysis can be performed to 
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determine if the chromatin association of the termination factors known to bind to the CTR of 
Spt5 (members of CFI complex) is impaired in these strains.  
Which event at the poly(A) site leads to an exchange of Paf1C for termination factors? 
Since we know that affinity of Paf1C for the CTR of Spt5 is greatly reduced by the lack of 
phosphorylation of the Spt5 CTR (Figure 10C) (WIER et al. 2013), we can predict that the 
dephosphorylation of Spt5 at the poly(A) site could be facilitating the exchange of termination 
factors for an elongation factor. Terminations factors such as Rna14, Rna15 and Hrp1, which are 
all subunits of the yeast cleavage factor I complex important for cleavage and polyadenylation of 
mRNA, were shown to bind the CTR of Spt5 in GST-pull down assay (GROSS and MOORE 2001; 
MAYER et al. 2012) [reviewed in (RICHARD and MANLEY 2009)]. To uncover if phosphorylation 
of the Spt5 CTR alters its affinity for the termination factors, GST pull-down assays could be 
performed with GST-tagged termination factors using extracts of cells expressing wild-type 
Spt5, phosphomimetic Spt5 and non-phosphorylatable Spt5 to determine if the termination 
factors exhibit higher affinity for non-phosphorylatable Spt5. If the termination factors do exhibit 
higher affinity for the non-phosphorylatable Spt5 compared to phosphomimetic Spt5, it should 
then be determined if they can directly bind the CTR of Spt5 in an in vitro binding assay with 
purified recombinant proteins. If the termination factors directly bind to the CTR of Spt5 then 
fluorescence anisotropy assays can be performed with fluorescently labeled phosphorylated CTR 
and non-phosphorylated CTR to determine their affinity for phosphorylated and non-
phosphorylated CTR. If their affinity for the non-phosphorylated Spt5 CTR is higher than that 
for the phosphorylated one, it will support our hypothesis that the dephosphorylation of the Spt5 
CTR at the poly(A) site triggers the exchange of an elongation factor for a termination factor 
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similar to the Pol II CTD, the phosphorylation and dephosphorylation of the Spt5 CTR could 
facilitate the association of specific factors during specific stages of transcription. 
To identify other elongation factors that are recruited by the phosphorylated Spt5 CTR, 
quantitative mass spectrometry analysis could be performed with affinity purified TAP-tagged 
non-phosphorylatable Spt5 and wild-type Spt5. This could lead to the identification of the 
physical interactions of Spt5 that are impaired by the lack of phosphorylation of the Spt5 CTR. 
On the other hand, mass spectrometry analysis of affinity purified TAP-tagged phosphomimetic 
Spt5 and wild-type Spt5 could lead to the identification of the physical interactions of Spt5 that 
are impaired by the lack of dephosphorylation of Spt5 CTR. If our hypothesis that the 
dephosphorylation of the Spt5 CTR at the poly(A) site facilitates the exchange of an elongation 
factor for a termination factor is true, then a quantitative proteomic analysis could uncover the 
termination factors that preferably associate with non-phosphorylatable Spt5 CTR. ChIP analysis 
can then be performed to determine if the association of these termination factors with chromatin 
beyond the poly(A) site is diminished in cells lacking the CTR of Spt5.  
5.2 DUAL ATTACHMENT OF PAF1C TO CHROMATIN IS MEDIATED BY THE 
OAR OF RTF1 AND THE C-DOMAIN OF CDC73 
Our previous analysis had suggested that the C-domain of Cdc73 also contributes to the 
chromatin association of Paf1C (AMRICH et al. 2012). My ChIP analysis with the OAR and C-
domain mutants indicated a greater reduction in the chromatin association of Paf1C in a double 
mutant strain, in which the both the Rtf1 OAR and Cdc73 C-domain were mutated, than either of 
the single mutants thus supporting our hypothesis that the chromatin attachment of Paf1C is 
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facilitated through a dual attachment mediated by the OAR of Rtf1 and the C-domain of Cdc73 
(Figure 17). This ChIP analysis also suggested that the reduction in the chromatin occupancy 
caused by the lack of the C-domain is comparable to the reduction caused by the OAR point 
mutants, while complete deletion of the OAR has a much greater impact on the chromatin 
occupancy of Paf1C (Figure 7 and 17). This also provides an explanation for the lack of 
influence of the deletion of the C-domain of Cdc73 alone on the co-transcriptional histone 
modifications mediated by Paf1C (AMRICH et al. 2012) and suggests that even low levels of 
chromatin association of Paf1C are enough for Paf1C to exert its impact on co-transcriptional 
histone modifications.  
We were curious about the residual histone modifications that seem to persist in cells 
expressing Rtf1 derivative lacking the OAR even though the chromatin occupancy of Paf1C is 
severely reduced in this strain (Figure 7). I anticipated that the C-domain of Cdc73 would be 
responsible for the low levels of histone modifications in the OAR deletion derivative. This 
hypothesis is supported by my analysis of Paf1C-mediated histone modifications in the strains 
lacking both the Rtf1 OAR and the Cdc73 C-domain, which showed an almost complete loss of 
all Paf1C-mediated histone modifications in the cells lacking these two domains (Figure 18). 
The global levels of Ser2 phosphorylated Pol II CTD also could be measured in cells 
lacking both the Rtf1 OAR and the Cdc73 C-domain by immunoblotting analysis. Just as the 
histone modifications, we expect the Ser2 phosphorylation of the Pol II CTD, which is most 
dramatically impacted by the deletion of Paf1 or Ctr9 subunits alone, would be greatly reduced 
by the removal of both the OAR of Rtf1 and C-domain of Cdc73 even in the presence of Ctr9 
and Paf1 subunits due to the inability of Paf1 and Ctr9 to independently associate with chromatin 
(NORDICK et al. 2008). Individual deletions of PAF1 or CTR9 cause stronger phenotypes than the 
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deletion of CDC73 or RTF1. This is at least partly due to the reduced levels of other subunits of 
Paf1C in the absence of the Paf1 or Ctr9 subunits (MUELLER et al. 2004). Also, some functions 
of Paf1C such as the regulation of H3 K36 Me3 levels are impacted mainly by the Paf1 and Ctr9 
subunits (CHU et al. 2007). To uncover the functions of Paf1 and Ctr9 subunits alone that require 
their chromatin association, we can express fusion proteins of OAR with Paf1 or Ctr9 in strains 
lacking the other subunits of Paf1C. A quick test to determine if fusion to the OAR allows the 
Paf1 and Ctr9 to perform some functions in the absence of the other members of Paf1C would be 
to compare the growth rate of cells expressing Paf1 or Ctr9 subunit alone or Paf1-OAR or Ctr9-
OAR fusion protein alone in the absence of other subunits of Paf1C. If expressing the fusion 
protein improves the growth rate of these cells it will indicate that at least some of the functions 
of Paf1C could be rescued by targeting the Paf1 or Ctr9 subunit alone to chromatin by fusion to 
the OAR in the absence of other members of Paf1C. Identifying the physical interactions of the 
one-step affinity purified TAP-tagged OAR-Paf1 and OAR-Ctr9 fusion proteins using mass 
spectrometry analysis could provide insight into Paf1- or Ctr9-specific functional interactions of 
Paf1C and hence facilitate a mechanistic understanding of these functions.  
The Hinnebusch laboratory showed that the Cdc73 subunit of Paf1C can bind in vitro to 
both the phosphorylated CTR peptide of Spt5 and a Pol II CTD peptide phosphorylated at Ser2 
and Ser5 (QIU et al. 2012). However, this could be an artifact of an in vitro binding assay with 
purified recombinant proteins uncovering interactions that may not be physiologically relevant. 
However, my co-immunoprecipitation assay and affinity purification, which uncover 
physiologically relevant interactions, indicate that the OAR is important for the interaction of 
Paf1C with Spt5 and my GST pull-down assay suggests that the Rtf1 OAR interacts with the 
phosphorylated CTR of Spt5 even in the presence of other yeast proteins. However, I did see an 
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increase in the chromatin association of the isolated OAR in cells lacking the Cdc73 subunit of 
Paf1C (Figure 11C and D). This suggests that Cdc73 may interfere with the binding of the OAR 
to chromatin. It would be interesting to test if the OAR and Cdc73 compete for the 
phosphorylated CTR or if OAR induces an allosteric change in the phosphorylated CTR that 
facilitates the binding of Cdc73 to the Spt5 CTR. Whether Cdc73 competes with the OAR for 
binding the phosphorylated Spt5 CTR can be determined by comparing the affinity of the OAR 
alone and the OAR in the presence of increasing concentration of Cdc73 using native gel 
electrophoresis and western blot analysis. To uncover if the OAR facilitates the binding of 
Cdc73 to the phosphorylated Spt5 CTR, the amount of Cdc73 binding to the phosphorylated 
CTR can be determined in the presence of increasing concentration of the OAR using native gel 
electrophoresis and immunoblotting analysis. 
5.3 IS THE OAR IMPORTANT FOR PROPER CHROMATIN TARGETING OF 
THE HISTONE MODIFICATION DOMAIN (HMD) OF RTF1? 
Our studies with the HMD suggested that when overexpressed, the HMD alone can bind to 
chromatin and facilitate Rtf1-mediated histone modifications of Paf1C (PIRO et al. 2012). 
However, the lack of association of this HMD with the rest of Paf1C may lead to the non-
specific binding of the HMD to transcriptionally inactive loci such as the telomeric regions and 
the appearance of the Rtf1-mediated histone modification at these regions (PIRO et al. 2012). The 
OAR alone, however specifically binds to chromatin in the same pattern as that of Paf1C (Figure 
11). This suggests that the OAR facilitates the targeting of the HMD to the proper loci. To 
confirm this, we can express the OAR as a fusion protein with the HMD and determine if this 
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fusion protein can target Rtf1-dependent histone modifications to chromatin in the same manner 
as that of Paf1C and prevent the targeting of these modifications to transcriptionally inactive 
loci.  
5.4 DOES THE HMD FACILITATE THE RECRUITMENT OF BRE1? 
My one-step affinity purification and immunoblotting analysis with TAP-HMD suggests that 
HMD associates with Bre1 in vivo. If this result is reproducible, in vitro binding assays could be 
performed with purified recombinant proteins to determine if the interaction between the HMD 
and Bre1 protein is direct. Also, the occupancy of Rad6 and Bre1 over the ORFs of actively 
transcribed genes has been previously shown to be dependent on Paf1C (XIAO et al. 2005). To 
uncover if the interaction of Bre1 with the HMD facilitates the recruitment of Rad6 and Bre1 to 
chromatin, ChIP analysis can be performed to determine the occupancy of the ubiquitin 
conjugase and ubiquitin ligase, Rad6 and Bre1, in strains expressing the NLS-Myc-HMD 
protein. 
Collectively, my work has provided a molecular mechanism for association of Paf1C 
with the transcription machinery and has improved our understanding of how a small region 
within Paf1C facilitates co-transcriptional histone modifications. Given the importance of Paf1C 
in the expression of downstream targets of important signaling pathways such as the Notch 
signaling and Hedgehog signaling and expression of genes required for mounting an antiviral 
response, genes important for proper transitions through the cell cycle and genes essential for 
maintaining stem cell pluripotency it was very important to understand how Paf1C gets to 
chromatin to execute all these essential functions [reviewed in (TOMSON and ARNDT 2013)]. 
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While filling voids in the field of transcriptional regulation, my work has also raised interesting 
questions that could be addressed in the future to gain better insights into regulation of spatio-
temporal recruitment of factors facilitating transcription. 
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APPENDIX A 
A.1 PHOSPHOMIMETIC SPT5 IMPAIRS THE DISSOCIATION OF SPT5 AT THE 
POLY(A) SITE 
Transcription of mRNAs commences with the assembly of the transcription initiations factors 
along with Pol II at the promoter. Once transcription is initiated, Pol II releases its contacts with 
the initiation factors and exchanges them for elongation factors. This exchange of elongation 
factors for initiation factors is facilitated by the CTD of Pol II. The CTD of Pol II consists of 
multiple repeats of the sequence Y1S2P3T4S5P6S7, most residues of which are dynamically 
phosphorylated during transcription [reviewed in (HSIN and MANLEY 2012)]. The sequence is 
highly conserved across species although the number of repeats varies between species 
[reviewed in (HSIN and MANLEY 2012)]. The hypophosphorylated form of the CTD 
predominates during the initiation stage of transcription. The phosphorylation of Ser5 by 
Kin28/Cdk7 of Pol II CTD triggers the exchange of initiation factors for elongation factors 
[reviewed in (BURATOWSKI 2009; HSIN and MANLEY 2012)]. The localization of Kin28/Cdk7 
phosphorylated Ser7 Pol II is similar to that of Ser5 phosphorylated Pol II (AKHTAR et al. 2009; 
CHAPMAN et al. 2007). This mark has been shown to be important for the recruitment of Rpap2 
protein, which is required for the proper expression of snRNA genes (EGLOFF et al. 2012). 
During the later stages of transcription the Ser2 phosphorylated form of CTD catalyzed by 
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Ctk1/Cdk12 is enriched and this facilitates the recruitment of termination factors [reviewed in 
(BURATOWSKI 2009; HSIN and MANLEY 2012)]. Some elongation factors, such as Spt5 and Spt6, 
continue along with Pol II beyond the poly(A) site while other elongations factors, including 
Paf1C and Bur1-Bur2 kinase complex, dissociate at or near the poly(A) site (MAYER et al. 2010). 
In turn, 3’ RNA processing factors are recruited by the transcribing machinery at the poly(A) site 
(MAYER et al. 2010). The mechanism underlying the exchange of elongation factors for the 
termination factors at the poly(A) site remains obscure.  
Of the plethora of accessory factors that associate with Pol II and facilitate transcription, 
Spt5 is the only factor that has been conserved through evolution and is found in all the three 
kingdoms of life. The bacterial Spt5/NusG and archeal Spt5 have the NusG domain and the 
KOW motif [reviewed in (HARTZOG and FU 2013)]. The eukaryotic Spt5 is a much larger protein 
having multiple C-terminal repeats (CTR) in addition to KOW motifs and the NusG domain 
[reviewed in (HARTZOG and FU 2013)]. Although the actual sequence of the CTR is not 
conserved among eukaryotes, the nature of the residues in this region is conserved (WIER et al. 
2013). The serine/threonine within this repeat is a substrate for phosphorylation by P-TEFb in 
higher eukaryotes and by Bur1-Bur2 kinase in yeast. The CTR of Spt5 just like the CTD of Pol II 
could serve as a platform for recruitment of regulatory factors during transcription. In accordance 
with this hypothesis, the CTR of Spt5 has been shown to bind the capping enzymes and 
termination factors (MAYER et al. 2012; PEI and SHUMAN 2002). Additionally, my work 
described in Chapter 2 indicated that Paf1C is recruited to chromatin through the binding of the 
Rtf1 OAR to the CTR of Spt5.  
Both elongation factors and termination factors can be recruited through association with 
the CTR of Spt5. Paf1C binds to the phosphorylated CTR of Spt5 and dissociates at the poly(A) 
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site where termination factors such as the members of cleavage factor I complex are recruited 
through association with the CTR of Spt5 (MAYEKAR et al. 2013; MAYER et al. 2012). What 
alters the affinity of the Spt5 CTR for Paf1C at the poly(A) site that makes it relinquish its 
contacts with Paf1C and in turn associate with termination factors? My work in Chapter 2 
(Figure 10C) and work from the VanDemark laboratory (WIER et al. 2013) suggests that 
dephosphorylation of the CTR dramatically diminishes the affinity of the Spt5 CTR for the Rtf1 
OAR. Hence, we hypothesized that just like the Pol II CTD, the phosphorylation and 
dephosphorylation of the Spt5 CTR could act as a molecular switch for swapping termination 
factors for elongation factors at the poly(A) site.  
To test this hypothesis, I determined the chromatin occupancy pattern of Rtf1 relative to 
Spt5 using ChIP analysis in strains expressing wild-type Spt5, a phosphomimetic mutant of Spt5 
in which all the phosphorylatable serine residues in the CTR have been mutated to aspartic acid, 
a phosphomimetic residue, (Spt5-S1-15D) and in strains expressing a mutant of Spt5 in which all 
the phosphorylatable serine residues in the CTR have been mutated to alanine making them non-
phosphorylatable (Spt5-S1-15A). The occupancy of Rtf1 relative to that of Spt5 is much lower in 
cells expressing than wild-type Spt5 than cells expressing non-phosphorylatable Spt5 (Spt5-S1-
15A) on actively transcribed genes in the regions before the poly(A) site (Figure 23A-C). This 
result is consistent with my results described in Chapter 2, which indicated that the affinity of the 
OAR of Rtf1 for Spt5 having non-phosphorylatable CTR is dramatically lower than that for 
wild-type or the phosphomimetic Spt5 derivative (Figure 10C). Beyond the poly(A) site, where 
Paf1C dissociates from chromatin, the levels of  Rtf1 relative to Spt5 are similar in the wild-type 
cells and the non-phosphorylatable Spt5 mutant cells  (Figure 23A-C). This result is in 
accordance with our hypothesis which predicts that the unphosphorylated form of Spt5 
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predominates beyond the poly(A) site. Excitingly, I found that the occupancy of Rtf1 relative to 
Spt5 is significantly increased beyond the poly(A) site in the strains expressing the 
phosphomimetic Spt5 derivative, while remaining comparable to that of wild-type at regions of 
actively transcribed genes 5’ to the poly(A) site (Figure 23). These results suggest that the 
presence of phosphomimetic Spt5 beyond the poly(A) site impairs the detachment of Paf1C from 
chromatin at the poly(A) site. Thus my results imply that the dephosphorylation of the CTR of 
Spt5 at the poly(A) site may lead to the dissociation of Paf1C from chromatin. 
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Figure 23. Ratio of Rtf1 to Spt5 increases beyond the poly(A) 
 (A) The bars labeled A, B and C indicate the regions of PYK1 and PMA1 genes amplified in the real time PCR 
reactions to determine the occupancy of Rtf1 and Spt5 across these genes. (B and C) ChIP analysis was performed 
to determine the occupancy of Rtf1 and Spt5 in strains (Table 6) expressing wild-type Spt5 (HQY1379), Spt5 
having a phosphomimetic CTR (HQY1441) and Spt5 having non-phosphorylatable CTR (HQY1414). ChIP analysis 
was performed as described in Chapter 2 (section 2.2.5). Briefly, crosslinked chromatin was obtained from the yeast 
strains and Rtf1 or Spt5 was immunoprecipitated by overnight incubation of the chromatin at 4°C with Rtf1 
antiserum or antibody against Spt5 followed by incubation at 4°C with protein A beads for 2 hours. The 
immunoprecipitated chromatin was treated with proteinase K and the crosslinks were reversed by incubation 
overnight at 65°C. The amount of chromatin associated with the immunoprecipitated protein was then measured 
using real time PCR and primers sets specific to the indicated loci. The values shown above represent the average of 
the ratio of Rtf1 occupancy to Spt5 occupancy for each biological replicate. Error bars represent the standard error 
of the mean.  The symbol “§” indicates that the relative occupancy of Rtf1 in the phosphomimetic mutant is 
significantly different compared to that of wild-type (p-value < 0.05) beyond the poly(A) site at both PYK1 and 
PMA1 genes while it was similar to that of wild-type at the other loci tested. 
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A.2 IDENTIFYING THE PHOSPHATASE FOR THE CTR OF SPT5 
To begin to identify the phosphatase for the CTR of Spt5, I assessed the levels of phosphorylated 
Spt5 in selected phosphatase mutants using immunoblotting analysis. Our selection of 
phosphatase mutants to be tested was guided by Dr. Nathan Clark (University of Pittsburgh 
School of Medicine). He performed evolutionary rate covariance analysis with the proteins 
involved in the recruitment of Paf1C (all members of Paf1C, Spt5, Bur1-Bur2 kinase complex 
and Pol II) and all the phosphatases in yeast to identify the phosphatases that have co-evolved 
with the proteins involved in the recruitment of Paf1C (indicated by the p-values for the 
evolutionary rate covariance) (CLARK et al. 2012). This analysis is based on the assumption that 
proteins involved in similar functions co-evolve (CLARK et al. 2012). Fcp1, Ssu72, Ptp1 and 
Oca1 seemed to co-evolve with Spt5 and the subunits of Paf1C in this analysis (Figure 24A). 
Oca1 is a putative tyrosine phosphatase required for the cell cycle arrest induced upon oxidative 
damage of DNA (ALIC et al. 2001). Ptp1 is also a tyrosine phosphatase that dephosphorylates 
Fpr3 protein, an immunophilin, and it localizes in the cytoplasm (GUAN et al. 1991; WILSON et 
al. 1995). Since both Ptp1 and Oca1 are tyrosine phosphatases, they may not be the phosphatases 
dephosphorylating the phosphorylated serine residues of the Spt5 CTR. However, to confirm this 
we need to determine the levels of phosphorylated Spt5 in Oca1 and Ptp1 deletion mutants using 
immunoblotting analysis. To begin, we decided to focus on phosphatases previously known to 
have roles in transcription (Fcp1 and Ssu72) or known to interact with Spt5 (PP4).  
Since Fcp1 and Ssu72 have well-characterized roles in transcription, they seemed to be 
the strongest candidates for the Spt5 CTR phosphatase. Fcp1 is the phosphatase for the 
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phosphorylated Ser2 of the Pol II CTD and Ssu72 dephosphorylates Ser5 and Ser7 of the Pol II 
CTD (CHO et al. 2001; KRISHNAMURTHY et al. 2004; ZHANG et al. 2012a). Additionally, Ssu72 
also facilitates gene looping through interaction with TFIIB and it plays a role in RNA 
termination and 3’end processing through association with the APT complex (NEDEA et al. 2003; 
SINGH and HAMPSEY 2007). In addition, Ssu72 is enriched near the poly(A) site, making it a 
good candidate for the Spt5 CTR phosphatase since we anticipate that this dephosphorylation 
event may occur near the poly(A) site (DICHTL et al. 2002; NEDEA et al. 2003; SINGH and 
HAMPSEY 2007). The Fcp1 mutant that I tested was previously shown by an undergraduate 
researcher in our laboratory to be synthetically lethal with Rtf1. The functional implications of 
this mutant are however unknown. The Ssu72 mutant that I tested was previously shown by the 
Brow laboratory to impact the Nrd1-dependent and poly(A)-dependent termination of 
transcription (STEINMETZ and BROW 2003). However, the location of the residue mutated is not 
close to the catalytic site and its effect on the enzymatic activity of Ssu72 is unknown.  
I also made a Psy2 null strain to test using this analysis, since proteomic studies with 
Psy2, a regulatory subunit of the phosphatase PP4 complex, have uncovered Spt5 as an interactor 
(GINGRAS et al. 2005; O'NEILL et al. 2007). Additionally, I also included mutants of other 
phosphatases previously shown to have roles in transcription such as Rtr1, Glc7 and Sit4. Rtr1 
dephosphorylates Ser5 of the Pol II CTD and facilitates the transition of the Pol II CTD from its 
Ser5 phosphorylated form to its Ser2 phosphorylated form (MOSLEY et al. 2009). Glc7 is a 
serine/threonine phosphatase known to act on a variety of substrates and its targeting to specific 
substrates is achieved through association with regulatory subunits. For example, association 
with the Reg1 subunit targets Glc7 to the Snf1 protein (TU and CARLSON 1995). Interestingly, 
binding to the Ref2 subunit facilitates the association of Glc7 with cleavage and poly-
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adenylation factor containing complex and hence Glc7 associated with Ref2 protein and seemed 
to be a good candidate for Spt5 CTR phosphatase since this form of Glc7 is enriched at the 
poly(A) site, our predicted site for Spt5 CTR dephosphorylation (NEDEA et al. 2003). A REF2 
null strain would have been a better strain that I could have used in my analysis, but we first 
decided to test the strains previously used in our laboratory (glc7-T152K and reg1Δ). Glc7-
T152K is known to affect the association of Glc7 with Reg1 regulatory subunit (TU and 
CARLSON 1995). However, this mutant grows slower than a reg1Δ strain suggesting that it may 
have additional effects on the functioning of Glc7. We also included Sit4 in our analysis since 
Sit4 mutants exhibit Spt- phenotype indicative of transcriptional defects (SHIRRA et al. 2005). 
Sit4, also like Glc7, is the catalytic subunit found in many complexes and its association with 
specific regulatory subunits targets it to specific substrates (LUKE et al. 1996). I also used a 
bur2Δ strain as negative control in my western blot analysis. This mutant has a defective Bur1-
Bur2 kinase complex and hence it diminishes the levels Spt5 phosphorylated at the CTR. 
My immunoblotting analysis suggests that the Fcp1 point mutant that I tested causes a 
reduction and not an increase in the levels of phosphorylated Spt5 suggesting that Fcp1 impacts 
the CTR of Spt5 indirectly and not by directly dephosphorylating its CTR (Figure 24B). On the 
other hand, the temperature sensitive Ssu72 point mutation does not lower the levels of 
phosphorylated Spt5 after 1 hour incubation at the restrictive temperature (Figure 24C). 
However, the absence of increased levels of phosphorylated Spt5 in these mutants does not rule 
out the possibility that Fcp1 or Ssu72 could dephosphorylate the Spt5 CTR. Immunoblotting 
analysis should be performed with other hypofunctional mutants of Fcp1 or Ssu72 to confirm the 
effect of Fcp1 and Ssu72 on the levels of phosphorylated Spt5.  
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Interestingly, this analysis showed that Glc7 and Psy2 mutants may have increased levels 
of phosphorylated Spt5 (Figure 24B). However, this experiment has been performed only once. 
This experiment needs to be repeated with biological triplicates to make it possible to determine 
if the ratio of phosphorylated to total Spt5 in these mutants is statistically different from that of 
wild-type strains. Furthermore, since the reg1Δ strain did not show elevated levels of 
phosphorylated Spt5 it suggests that the glc7-T152K mutant may affect the level of 
phosphorylated Spt5 independently of Reg1 (Figure 24B). 
Thus, Glc7 and Pph3 (catalytic subunit of PP4 complex) seem to be promising candidates 
as the phosphatases of the Spt5 CTR and the mutants of these phosphatases along with others 
need to be further tested by immunoblotting analysis to identify the phosphatase of Spt5 CTR 
that when mutated increases the levels of phosphorylated Spt5 and may hence induce 
terminations defects. 
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Figure 24. Screen for the phosphatase of the Spt5 CTR 
(A) Covariance analysis was performed by Dr. Nathan Clarke to determine the p-values for the correlation of the 
covariance rates of the members of Paf1C and the proteins involved in recruitment of Paf1C including Bur1-Bur2 
kinase complex, Spt5 and Pol II and the yeast phosphatases (CLARK et al. 2012). The degree of redness of the boxes 
correlates with the p-values with dark red indicating very low p-values (>0.05) and very light red indicating a p-
value of less than 0.1. (B and C) Immunoblotting analysis was performed on TCA extracts of the indicated 
phosphatase mutants (prepared as described in Chapter 2, section 2.2.3) using antibody against the phosphorylated 
CTR of Spt5 (Gift from Dr. Steve Hahn). Immunoblotting analysis performed with antibody against Spt5 that 
recognizes both the phosphorylated and unphosphorylated forms of Spt5 served as a control for total Spt5 levels. 
G6PDH levels served as a control for the total amount of extract.  
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 Table 6. Saccharomyces cerevisiae strains used in this study 
Strain Genotype 
KY1200 MATα his3Δ200 leu2Δ1 ura3-52 trp1∆63  
KY1351 MATα bur2∆::URA3 his3Δ200 lys2-128∂ ura3 leu2 CTR9-6xMYC::LEU2 
KY2094 MATα psy2∆::KanMX his3∆200 lys2-128∂ leu2Δ1 ura3-52 ade8 
PY501 MATa sit4Δ::HIS3 his3Δ200 leu2Δ1 ura3-52 
PY1048 MATa reg1∆::KanMX his3Δ200 leu2Δ1 ura3-52 trp1∆63 
SRY55 MATα fcp1-Y276H MATα lys2-128∂ leu2Δ1 ura3-52 trp1∆63 ade8 
¥ MATα rtr1∆::KanMx his3Δ1 leu2Δ0 ura3Δ0 met15Δ0  
OKA45ξ MATa glc7-T152K his3Δ200 lys2-801 ura3-52 trp1 Δ1 
OKA65£ MATα cup1∆::URA3 his3 trp1 lys2 ade2 leu2  
OKA257£ MATα ssu72-G33A cup1∆::URA3 his3 trp1 lys2 ade2 leu2 
HQY1379§ MATa spt5Δ::HIS3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 PAF1-13xMYC::KanMX4  
pHQ1494  [LEU2 SPT5-3XHA] 
HQY1414§ MATa spt5Δ::HIS3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 PAF1-13xMYC::KanMX4  
pHQ1876 [LEU2 spt5-S1-15A-3XHA] 
HQY1441§ MATa spt5Δ::HIS3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 PAF1-13xMYC::KanMX4  
pHQ1894 [LEU2 spt5-S1-15D-3XHA] 
 
¥ Strain from the yeast deletion collection 
ξ Provided by Dr. Marian Carlson 
£ Provided by Dr. David Brow 
§ Provided by Dr. Alan Hinnebusch 
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